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1 Summary
The main goal of this PhD project was to contribute to our understanding of the
molecular mechanisms of interaction between AAV2 and one of its helper viruses,
HSV-1, and the host cell.
In the first part of the thesis I examined the localization and activation of DNA
damage repair (DDR) proteins upon infection with HSV-1 alone or coinfection with
AAV2 and HSV-1. I observed that consistent with previous reports the catalytic
subunit (cs) of one of the main kinases in DDR, DNA-PK, was degraded in an HSV-1
ICP0-dependent manner. This degradation was observed also in cells coinfected with
HSV-1 and AAV2, although it was markedly delayed. The delayed degradation of
DNA-PKcs by AAV2 coinfection affected signaling to downstream substrates such as
RPA32. In addition, p53 and Chk2 (targets of DNA-PK and ATM) were found
activated in ATM-deficient cells only when coinfected with AAV2 and HSV-1 but not
in ATM-deficient cells infected with HSV-1 alone.
During the AAV2 DNA replication process, DNA lesions (gaps) are created by the
AAV2 Rep protein. The virus may therefore benefit from the activation of cellular
DDR signaling because cellular repair factors are recruited into viral replication
compartments (RCs). Indeed, I found several proteins of the cellular base excision
repair (BER)/ single-strand break repair (SSBR) machinery in HSV-1 supported
AAV2 RCs, including PARP1, XRCC1, RCF1, and ligase I.
I also investigated the influence of two different central elements of the DDR on
AAV2 DNA replication. I found that while the MRN complex (the main sensor of ds
breaks in cells) was not necessary to mediate activation of DDR signaling via RPA32,
experiments in NBS1 negative cells indicated that the presence of a functional MRN
complex or NBS1 clearly aids HSV-1-supported AAV2 DNA replication. In contrast,
the presence of ATM (one of the three main kinase in DDR) clearly reduced HSV-1
supported AAV2 DNA replication, although the kinase was found activated and
recruited into AAV2 RCs in coinfected cells.
In the last part of the thesis I set out to investigate how AAV2 can mediate the
observed delay in the HSV-1 induced degradation of DNA-PKcs. To explore potential
mechanisms responsible for this, I compared (i) levels, (ii) activity, and (iii) subcellular
localization of ICP0 in coinfected cells and cells infected with HSV-1 alone, and I
investigated a possible role of (iv) Ku70 and (v) AAV2 Rep 78/68 in the protection of
DNA-PKcs from proteasomal degradation. The results can be summarized as
follows: the levels of ICP0 were comparable and USP7, another target of ICP0-
induced proteasomal degradation, was degraded equally efficient in cells infected
with HSV-1 alone and in coinfected cells. Using recombinant HSV-1 expressing
either cytosol- or nuclear-restricted ICP0 I observed that nuclear ICP0 was both
essential and sufficient to mediate degradation of DNA-PKcs. Ku70 is known to
recruit DNA-PKcs to cellular DNA and localized to AAV2 RCs in coinfected cells.
However, stabilization of DNA-PKcs and recruitment to RCs was Ku70-independent.
AAV2 Rep 78/68 in absence of AAV2 DNA did not prevent HSV-1-mediated
degradation of DNA-PKcs. Finally, I could also exclude AAV2 DNA as exclusive
source of increased stabilization of DNA-PKcs in coinfected cells. On the basis of
these results, I hypothesized that Rep 78/68 mediates recruitment of DNA-PKcs to
sites of AAV2 DNA within AAV2 RCs, which further triggers phosphorylation of DNA-
PKcs and stabilization.
In conclusion, I identified several factors of the cellular DNA sensing and repair
machinery as components of HSV-1 and/or HSV-1 supported AAV2 RCs. In addition,
I investigated the influence of two main players of the cellular DDR (NBS1 and ATM)
on AAV2 DNA replication. The data contribute to a better understanding of the
complex mechanisms of interaction between AAV2, its helper viruses, and the
coinfected cell. Since AAV2 is a widely used vector in biomedical applications, the
detailed knowledge of the activation and localization pattern of cellular proteins
during AAV2 infection, may have important practical implications in the field of AAV2
vector research and gene therapy.
2 Zusammenfassung
Auf Grund seiner geringen genetischen Komplexität ist das Adeno-assoziierte Virus
Typ 2 (AAV2) nicht nur abhängig von einer Wirtszelle, sondern auch von der
Kopräsenz eines Helfervirus, wie zum Beispiel dem Herpes simplex Virus Typ 1
(HSV-1). In diesem Dissertationsprojekt hatte ich die Möglichkeit, die komplexe und
faszinierende Interaktion der beiden Viren (AAV2 und HSV-1) und der Wirtszelle zu
studieren. Das Hauptziel dieser Doktorarbeit war es, einen Beitrag zum Verständnis
der molekularen Mechanismen der Interaktionen zwischen AAV2, HSV-1 sowie der
koinfizierten Wirtszelle zu leisten.
Im ersten Teil der Arbeit untersuchte ich die Lokalisation und Aktivierung einer
Auswahl von DNA Sensor- und Signaltransduktionsproteinen. Diese Proteine werden
im Allgemeinen als „DNA damage response (DDR) factors“ bezeichnet. Im Einklang
mit früheren Berichten beobachtete ich, dass eine der wichtigsten DDR Kinasen der
Signaltransduktion nach Erkennung von DNA Schäden, DNA-PKcs, durch die
Infektion mit dem HSV-1 Virus abgebaut wird. Dieser Abbau findet auch in Zellen
statt, welche mit AAV2 und HSV-1 koinfiziert sind. In diesem Fall konnte jedoch eine
deutliche Verzögerung dieses Prozesses beobachtet werden. Neben einem
verzögerten Abbau von DNA-PKcs konnte auch dessen Phosphorylierung (an der
Aminosäure Serin 2059) sowie Lokalisation in HSV-1-unterstützten AAV2
Replikationskompartimenten nachgewiesen werden. Die beobachtete
Aminosäurephosphorylierung steht im Zusammenhang mit der Aktivierung der
Kinaseaktivität des Enzymes. In der Tat konnte ich eine Auswirkung auf die
Signaltransduktion von nachgeschalteten Substraten wie RPA32, p53 und Chk2
feststellen.
Eine Folge der Aktivierung der zellulären DDR Signalisierung in infizierten Zellen
könnte die Rekrutierung von zellulären Reparaturfaktoren in virale
Replikationszentren sein. Tatsächlich fand ich mehrere Proteine des zellulären
Basenexzisionsreparatur (BER) bzw. des DNA Einzelstrangbruch-Reparatur (SSBR)-
Mechanismus in AAV2 Replikationszentren wie z.B. PARP1, XRCC1, RCF1 und
Ligase I. Während der AAV2 DNA-Replikation werden, für die DNA Replikation
essentielle, DNA-Läsionen (gaps) von AAV2 Rep-Proteinen erzeugt. Um die
Integrität des AAV2 Genoms zu wahren, müssen diese gaps wieder ligiert werden.
Die identifizierten BER/SSBR Proteine könnten möglicherweise in diesem
Zusammenhang eine zentrale Rolle für die AAV2 DNA Replikation und
Aufrechterhaltung der Genomintegrität spielen.
Im Weiteren untersuchte ich den Einfluss von zwei verschiedenen zentralen
Proteinen der Signaltransduktion auf die AAV2 DNA-Replikation. Ich konnte
beobachten, dass in koinfizierten Zellen der MRN-Komplex (einer der Hauptsensoren
von DNA Schäden) zwar nicht erforderlich für die Signaltransduktion zum RPA32
Protein ist, aber dass das Vorhandensein eines funktionellen MRN Komplex (oder
dessen Untereinheit NBS1) eine deutlich unterstützende Wirkung auf die AAV2 DNA-
Replikation hat. Im Gegensatz dazu zeigte die Anwesenheit von ATM (neben DNA-
PK und ATR die dritte Hauptkinase der DDR Signaltransduktion) eine deutlich
hemmende Wirkung auf die HSV-1 unterstützte AAV2 Replikation.
Da ich eine Stabilisierung von DNA-PKcs in koinfizierten Zellen beobachten konnte,
untersuchte ich im letzten Teil meiner Doktorarbeit mögliche Mechanismen des
verzögerten Abbaus dieser Kinase. Es war bekannt, dass das HSV-1 Protein ICP0
den Abbau von DNA-PKcs induziert. Deshalb untersuchte ich (i) die Expression, (ii)
die Aktivität und (iii) die subzelluläre Lokalisation von ICP0 in koinfizierten Zellen.
Des Weiteren wurde eine mögliche Rolle (iv) des zellulären Ku70 und (v) des viralen
Rep 78/68 Proteins (beides DNA-PKcs-Interaktionspartner) in der Stabilisierung von
DNA-PKcs untersucht. Die Ergebnisse können wie folgt zusammengefasst werden:
die Höhe der ICP0-Expression ist vergleichbar in HSV-1 infizierten und HSV-1 und
AAV2 koinfizierten Zellen. Ein weiteres Protein welches in Anwesenheit von ICP0 in
der Zelle degradiert wird, USP7, wurde auch in HSV-1 und AAV2 koinfizierten Zellen
effizient degradiert. Unter Verwendung von rekombinanten HSV-1 Viren, die
entweder cytoplasmatisch oder nukleär lokalisiertes ICP0 exprimieren, konnte ich
beobachten, dass die nukleäre Form des ICP0 sowohl notwendig als auch
ausreichend für den ICP0-vermittelten Abbau von DNA-PKcs ist. Ku70 ist dafür
bekannt, dass es DNA-PKcs an zelluläre DNA-Läsionen rekrutiert und ebenso in
AAV2 Replikationszentren nachzuweisen ist. Jedoch konnten ich in koinfizierten
Zellen nicht nur eine Ku70 unabhängige Stabilisierung sondern auch Rekrutierung
von DNA-PKcs in AAV2 Replikationszentren beobachten. Obwohl die AAV2 Rep 78
und 68 Proteine die Degradation von DNA-PKcs, in Abwesenheit der AAV2-DNA-
Replikation und der Formation von viralen Replikationszentren, nicht verhindern
konnten, ist zu vermuten, dass DNA-PKcs durch die Assoziation mit den AAV2 Rep
78/68 Proteinen auch in Abwesenheit von Ku70 in AAV2 Replikationszentren
rekrutiert wird. In einem letzten Experiment konnte ich ausschließen, dass die durch
die AAV2 DNA verursachte Phosphorylierung von DNA-PKcs an der Aminosäure
Serin 2059 für die Stabilisierung der Kinase verantwortlich ist.
Auf der Grundlage dieser Ergebnisse stelle ich die Hypothese auf, dass die Rep
78/68 vermittelte Rekrutierung von DNA-PKcs an die AAV2 DNA innerhalb AAV2
Replikationszentren nicht nur die Phosphorylierung von DNA-PKcs initiiert, sondern
auch einen geschützten Raum für DNA-PKcs gegen die HSV-1-ICP0-induzierte
Degradation der Kinase schafft, was schließlich zur beobachteten Verzögerung des
Abbaus der Kinase führt.
Insgesamt konnte ich in dieser Arbeit mehrere Faktoren des zellulären Sensor-und
Reparaturapparates von DNA-Läsionen als Komponenten von HSV-1 und/oder HSV-
1 unterstützten AAV2 Replikationszentren definieren. Darüber hinaus untersuchte ich
den Einfluss zweier Hauptakteure des zellulären DDR (NBS1 und ATM) auf die AAV2
DNA-Replikation. Diese Daten tragen zu einem besseren Verständnis der komplexen
Mechanismen der Interaktion zwischen AAV2, seinem Helfervirus HSV-1 und der
koinfizierten Wirtszelle bei. Da AAV2 ein weit verbreiteter Vektor in biomedizinischen
Anwendungen ist, kann das detaillierte Wissen über die Aktivierung und Lokalisation
von zellulären Proteinen während der AAV2 Infektion einen wichtigen Beitrag leisten,
um die Anwendung von AAV2 als Vektor für die Gentherapie weiter voran zu treiben.
3 Introduction
3.1 Viruses: origin, diversity and classification
The word virus comes from Latin and means toxin or poison. At the end of the 19th
century, the Russian scientist D. Ivanovsky (67), the Dutch scientist M. Beijernick
(208), and the German scientists F. Loeffler and P. Frosch (109) discovered
pathogenic agents smaller than any known bacterium. M. Beijernick and F.
Loeffler/P. Frosch could further show that these pathogens are the causative agents
of tabacco mosaic disease and foot-and-mouth disease, respectively (109, 208). In
general, viruses are infectious, obligate intracellular parasites (52). Within a
susceptible host cell, the virus replicates and new virions (progeny infectious virus
particles) are released (52).
Because they infect all three domains of life, Archaea, Bacteria and Eukarya, it is
suggested that viruses originated very early in the evolution of life (54). Three
different theories of virus evolution are under debate, the “virus first theory”, the “virus
escape theory”, and the “virus reduction theory” (54). The “virus first theory”
implicates an independent emergence of viruses from the last universal common
ancestor (LUCA) of all known life forms (54). In this case viruses may have emerged
in a non-cellular context, in a world of competing proteins and nucleic acids (54).
However, the hypothesis of a LUCA without membrane is reviewed as contradictory
and, therefore, the “virus escape theory” and the “virus reduction theory” may be
more likely (54). The “virus escape theory” suggests that viruses have derived from
fragmented genomes of ancestral RNA cells and have become autonomous and
infectious RNA elements (54). The “virus reduction theory” suggests that a small
RNA cell has become an endosymbiont of a larger RNA cell by losing its own
translation machinery, becoming infectious and conserving the capability to replicate
autonomously (54). While RNA viruses may have originated by escape or reduction
from RNA cells, DNA viruses might have evolved directly from RNA viruses (54). In
this context, it is suggested that genes encoding enzymes required for RNA-DNA-
transition first appeared in viral genomes (54).
Out of these ancient viruses numerous different viruses evolved. One method to
classify all of the different virus types is the Baltimore classification (first defined in
1971), which places viruses into one of seven groups depending on the method of
viral mRNA synthesis (13). DNA and RNA viruses can have a double-stranded (ds)
or single-stranded (ss) genome; however most of the DNA viruses contain ds
genomes (e.g. polyoma-, adeno-, herpesviruses), while most of the RNA viruses
contain ss genomes (e.g. retro-, flavi-, orthomyxoviruses; (52)). ss RNA viruses can
be further divided into positive stranded RNA viruses (e.g. picornvirus), whose
genomes can be directly transcribed by the cellular translation machinery, or negative
stranded RNA viruses (e.g. paramyxovirus) which first have to convert their genomes
into positive stranded RNA (by RNA-dependent RNA polymerase) before translation
can occur (52). Positive and negative stranded viral ss DNA is not a feature of
different categories of DNA viruses, but the replication product of linear ss DNA
genomes of e.g. parvoviruses, as both positive and negative sense viral genomes are
packaged into infectious virions (52). Another classification system of viruses was
developed by the International Committee on Taxonomy of Viruses. The classification
system is organized in a branching hierarchy of the following viral taxa: Species,
genus (-virus), sub-family (-virinae), family (-viridae), and order (-virales) (77). The
members of each taxa share some significant properties including host range, cell
and tissue tropism, pathogenicity, or vector specificity (77). In addition, the degree of
relatedness of their genomes or genes is an important aspect for classification (77).
3.2 Adeno-associated virus 2 (AAV2)
3.2.1 Classification and pathogenesis.
Adeno-associated virus 2 (AAV2) is classified as a Dependovirus due to its
replication deficiency in the absence of a helper virus (69). The genus Dependovirus
belongs to the subfamily of Parvovirinae (77). Due to the ss nature of the viral
genome, the family of Parvoviridae belongs to the group II viruses, according to the
Baltomore classification system (13).
AAV2 has first been detected in electron microphotographs of simian adenovirus
preparations (10, 112). Until now, over 100 AAV2 variants from different animal
species have been isolated (58). The different serotypes display diverse genome and
capsid structures as well as tissue tropisms, including host receptor usage and
intracellular processing (58).
In humans, different AAV2 serotypes can infect various tissues (58) without causing
any known pathology (179). The seroprevalence of AAV2 in the human population is
more than 50% (179).
3.2.2 AAV2 structure and genome organization.
AAV2 is a small, non-enveloped virus with an icosahedral capsid of roughly 20 nm in
diameter (Fig. 1A; (190)). The capsid is composed of 60 copies of three different
structural proteins, VP1, VP2, and VP3, in a 1:1:10 ratio, protecting a linear, ss DNA
genome of approximately 4.7-kb (190). AAV2 has a very simple genomic
organization. The central part of the genome consists of two open reading frames
(ORF), carrying the rep and cap genes (Fig. 1B, (190)). However, different
promoters, alternative splicing, and non-conventional translational start codons give
rise to 8 different AAV2 proteins. The overlapping, in-frame coding regions within the
rep ORF are transcribed form two different promoters, p5 and p19, generating
mRNAs which encode Rep 78 and Rep 52, respectively; alternative spliced mRNAs
from these promoters encode Rep 68 and Rep 40 (Fig. 1B). Alternative splicing plays
also an important role in the generation of the two different RNAs generated from the
p40 promoter, encoding the AAV2 capsid proteins VP1 (2.4-kb mRNA, minor splicing
product) as well as VP2 and VP3 (2.3-kb mRNA, main splicing product, Fig. 1B;
(141)). Subsequently, the use of two different start codons on the 2.3-kb mRNA,
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gives rise to both VP2 and VP3 (Fig. 1B; (18, 119)). More recently, a new AAV2
protein was identified and designated as assembly-activating protein (AAP; (162)).
This protein is also encoded by the 2.3-kb mRNA of the cap gene and translated from
a nonconventional CUG translation initiation codon of a nested, alternative ORF (Fig.
1B; (162)). The four non-structural, multifunctional Rep proteins provide functions
necessary for regulation of AAV2 promoters (72, 96, 97, 137), genome replication
(71, 73), packaging of viral genomes into capsids (36, 91, 118, 167), and rescue of
the integrated AAV2 genome (21, 181). More precisely, Rep 52 and Rep 40 display
ATPase enzymatic activity and are involved in the generation of ss viral genomes
from ds replicative intermediates and subsequent encapsidation (36). Rep 78 and
Rep 68 proteins have a high degree of homology concerning sequence and function.
Both possess endonuclease, helicase, ATPase, and possibly ligase activities (121)
and are important for AAV2 DNA replication, site-specific integration, and
transcriptional regulation (71–73, 96, 97, 137). In addition, Rep 78/68 enhance or
suppress AAV2 gene expression in presence or absence of a helper virus,
respectively (137). The three colinear structural virus proteins VP1, VP2, and VP3
together form the AAV2 capsid (190). It has been shown that VP1 contains a
conserved phospholipase activity that appears to be essential for infectivity of AAV2
(62). While VP1 and VP3 are essential for the production of intact virions, VP2 was
shown to be dispensable for efficient packaging and infectivity and even tolerate
large ligand-insertions useful e.g. to retarget AAV2 vectors to alternative receptors in
gene therapy applications (185). The fourth, newly discovered gene product of the
cap ORF, AAP, was shown to be essential for the assembly of the capsid subunits
and the reproduction of AAV2 (162).
The AAV2 rep and cap ORFs are flanked by hairpin structured, self-priming inverted
terminal repeats (ITRs) of 145 nucleotides (Fig. 1B; (24)). These essential
multipalindromic DNA termini contain all cis-acting elements required for replication,
packaging, and site specific integration events (190). The important sequence
elements of the ITRs are the Rep binding element (RBE), a small palindrome that
comprises a single tip of an internal hairpin (RBE’), and the terminal resolution site,
TRS, located 13 nucleotides upstream of RBS (Fig. 1B; (190); discussed in more
detail below).
3.2.3 AAV2 entry.
Previous experiments showed that replication of AAV2 in cell culture was only
successful when AAV2 was inoculated simultaneously with adenoviruses (Ad; (10)),
leading to the suggestion that these Ad-associated particles behave as defective
viruses (10). Today, it is well known that AAV2 has a unique biphasic life cycle,
determined by the permissiveness of the cells and the presence of a helper virus.
Although AAV2 entry does not depend on a helper virus, it was shown that it is
influenced by the presence of a helper virus (203). AAV2 can infect dividing as well
as non-dividing and terminally differentiated cells (23, 45, 202). The virus is
internalized by the formation of clathrin-coated pits after receptor binding (15).
Heparan sulfate proteoglycans (HSPGs, C. (165)) as well as the coreceptors αvβ5
integrin (165), α5β1 integrin (9), fibroblast growth factor receptor (FGFR1, (140)), and
hepatocyte growth factor receptor (c-met; (86)) were identified as receptors for AAV2
entry.
A recent study showed that following uptake, AAV2 exploits the microtubule network
for rapid cytoplasmic trafficking in endosomal compartments, unidirectional towards
the perinuclear region, where viral escape is mediated by endosomal acidification
(201). However, crucial cellular factors involved in trafficking as well as viral
uncoating and nuclear entry are not yet characterized. It has been suggested that
viral uncoating occurs before or during nuclear entry (203). In the presence of Ad,
however, nuclear translocation of intact AAV2 capsid into the nucleus was observed
(203).
3.2.4 AAV2 latency.
In the absence of a helper virus, AAV2 establishes latent infection. During latency,
the AAV2 genome is maintained in an episomal state in the cell nucleus or integrated
preferentially into a specific site (19q13.3-qter or AAVS1) on human chromosome 19
(95, 148), but integration into other host chromosomes have also been reported (76).
In addition, there is indication that integration occurs adjacent to accessible open
chromatin regions. The observed site specific integration of AAV2 in human cell lines
occurs in 70–95% of events (94, 95, 148). However, in latently-infected human
tissues the majority of wtAAV2 genomes were detected in form of circular episomes
(2); therefore, the significance of site-specific integration of wtAAV2 in natural
infection remains elusive. In case of AAV2 integration, the proviral structures of AAV2
integrants are typically arranged in head-to-tail concatemers, with microsequence
homology at the viral–cellular junctions (191). Both the ITRs and the AAV2 Rep 78/68
proteins are essential elements for AAV2 integration (191). Rep is responsible for
targeting integration into AAVS1 by forming a bridge between viral ITRs and the
target site in AAVS1 Specifically, Rep 78/68 proteins recognize the RBE sequence
motifs within the AAV2 and the cellular genome (42). Besides the site-specific binding
activity, also the endonuclease activity was shown to be required for site-specific
integration of the AAV2 genome (190). In contrast, a functional TRS and replication
of the donor ITR may not be a prerequisite for AAV2 integration (191). Another
component of the AAV2 genome implicated in site-specific integration is the p5
promoter (138). It was shown that the p5 promoter functions as a primary target
sequence for Rep upon site-specific integration (138). In this context, it is suggested
that the p5 promoter is a key component to regulate lytic vs latent infection by
conversion from a transcription initiation complex into a structure that facilitates
efficient Rep-dependent integration (68). Although the data is inconsistent, the
cellular non-homologous end joining (NHEJ) machinery (described in more detail
below) may influence AAV2 integration events (113). In cell culture experiments, one
of the main factors of NHEJ, the catalytic subunit of DNA dependent protein kinase
(DNA-PKcs), was shown to enhance integration of both ss rAAV2 and ds rAAV2 DNA
(31). Another report showed that in particular the NHEJ protein ligase IV supports
site-specific integration of incoming ss AAV2 vectors (43). Another factor implicated
in NHEJ mediated V(D)J recombination events is the high mobility group protein 1
(HMG1; (151)). This protein was shown to bind to Rep 78 and enhance both RBS
binding and nicking activities of Rep, thereby also supporting site-specific integration
of the AAV2 genome (41). The occurrence of variable deletions of the ITR and
chromosome sequences at the junction regions between host and viral DNA supports
the model of recombination mediated AAV2 integration (191). Although this data
suggests a supportive role of the NHEJ machinery on AAV2 integration, it has to be
mentioned also that in an animal experiment, rAAV2 genome integration was shown
to be strongly enhanced in DNA-PKcs-deficient SCID mice (161). The reason for the
discrepancy of the function of DNA-PKcs in the different experiments is not clear.
3.2.5 AAV2 lytic infection.
In presence of a helper virus, latent AAV2 genomes can be rescued and enter a lytic
replication cycle (190). Besides Ad and herpesviruses (190), also other viruses,
including papillomavirus (16, 30, 178), can provide helper functions for AAV2
infection. Upon lytic infection, AAV2 DNA replication occurs at discrete sites in the
nucleus, so-called replication compartments or replication centers (RCs). Several
small RCs rapidly expand and fuse to large structures, which suspend the cellular
chromatin and fill the entire nucleus (55, 70, 75, 164, 188). AAV2 DNA replication
occurs as a self-priming, single-strand displacement mechanism (168).The initial step
of AAV2 replication is the conversion of the incoming viral ss DNA into a ds DNA
(190). This step is believed to be mediated through the host replication machinery;
besides the AAV2 Rep 78/68 proteins also helper virus factors may be implicated
(190). The complementary self-annealing sequence of the AAV2 ITR is the basis for
initial second-strand synthesis, by providing a base-paired 3’ hydroxyl group primer
for unidirectional DNA synthesis (190). By providing its own DNA primer, AAV2 DNA
replication exclusively uses leading-strand DNA synthesis (20). Although both helper
viruses, Ad and HSV-1, express their own polymerases for viral DNA replication,
AAV2 seems to use only the HSV-1 polymerase (6), while the Ad DNA polymerase is
not used for AAV2 replication (80, 144). Polymerase delta was found in AAV2 RCs
(123) and therefore might be the cellular polymerase for Ad supported AAV2 DNA
replication. Interestingly, polymerase delta was also found in HSV-1 supported AAV2
RCs (128). Although the HSV-1 polymerase complex was shown to be an important,
albeit not essential, helper virus factor, the cellular polymerase may also be
implicated in HSV-1 supported AAV2 replication. Second-strand synthesis of the ss
AAV2 genome leads to the formation of a duplex DNA molecule that is covalently
closed at one end by a hairpin structure. In order to complete replication of the viral
genome, in a next step, called terminal resolution, the remaining hairpin has to be
resolved and replicated to produce a linear double-stranded DNA (ds DNA, (190)).
The AAV2 Rep 78/68 proteins initiate terminal resolution by binding to the RBS motif
within the ITR and cleavage of one DNA strand at the TRS (190). The regenerated
free 3’hydroxyl-group then provides the primer for the replication through the viral
ITR, thereby maintaining the integrity of the 5′ terminus of the AAV2 DNA (190). In
contrast to biding to the RBE, binding of Rep to the RBE′ at the tip of the ITR hairpin
seems to be required for strand unwinding during terminal resolution but not for
cleavage (28). In a last step called reinitiation, a double-hairpinned intermediate is
formed by denaturation and reannealing of the linear ITR (190). This last step
initiates a new round of strand displacement synthesis generating a single-stranded
AAV2 genome that can be packaged into a capsid (190).
3.2.6 The p5 promoter: an alternative origin of AAV2 DNA replication.
Besides its function in transcription and site-specific integration (see above), the p5
promoter can also serve as a Rep-dependent origin of DNA replication (56, 133, 172,
182). Upon HSV-1 coinfection, it was demonstrated that the RBS and TRS, present
within the p5 promoter, function as a Rep- and HSV-1-dependent origin of AAV2
DNA replication (64). Further, replication from the two alternative AAV2 replication
origins, p5 and ITR, was shown to occur simultaneously and independently (64). The
distinct p5 and ITR RCs were juxtaposed to each other (64).
3.2.7 Cellular proteins supporting AAV2 replication in absence of a helper virus.
Cells exposed to a variety of genotoxic agents (e.g. HU or IR) can support wtAAV2
replication even in absence of a helper virus (204–206), suggesting that cellular
factors of the DNA damage sensing and repair machinery are involved in AAV2
replication steps. A more recent study showed that although significant helper-
independent AAV2 rep expression can be observed in cells exposed to genotoxic
agents, only low levels of AAV2 DNA replication occurs(129). It is suggested that the
interference of AAV2 with the cellular DDR and repair machinery promotes second-
strand synthesis of the AAV2 genome to allow AAV2 gene expression (32, 50, 51,
129, 146). Two different groups examined the requirement for helper virus-
independent AAV2 DNA replication in in vitro systems. In absence of a helper virus,
the AAV2 Rep 78 or 68 proteins as well as the cellular replication factors
proliferating-cell-nuclear-antigen (PCNA), polymerase delta, mini-chromosome
maintenance (MCM) proteins, and replication factor C (RFC) were shown to be
required and sufficient to reconstitute efficient AAV2 DNA replication in the in vitro
replication system (122, 132). These cellular proteins can be substituted completely
by the HSV-1 helicase-primase complex (UL5, UL8, and UL52), the HSV-1 major ss
DNA binding protein ICP8 (UL29), and the HSV-1 polymerase complex (UL30 and
UL42) to initiate replication on duplex DNA containing the AAV2 origins of replication
in vitro (184).
3.3 Herpes simplex virus type 1 (HSV-1)
3.3.1 Classification and pathogenesis.
Herpes simplex virus type 1 (HSV-1), also referred to as human herpesvirus 1 (HHV-
1), belongs to the genus Simplexvirus in the subfamily of the Alphaherpesvirinae
(77). Viruses of the family of Herpesviridae have a ds DNA genome and, therefore,
belong to the group I viruses according to the Baltimore classification system (13).
HSV-1 is a common human neurotropic pathogen, with a worldwide seroprevalence
of up to 80% in adults (5). The virus causes lytic infection at the site of host entry and
life-long latent infection in the proximal trigeminal ganglia (170). Hallmarks of the
lasting infection are recurrent lesions with shedding of virions (52). However, also
upon latent infection, hosts are still capable of spreading infection to other humans
via asymptomatic shedding of virions (5). Most commonly, HSV-1 lytic infection takes
place in orofacial mucosal epithelia cells, causing cold sore or fever blisters, but also
genital mucosa epithelia cells (98) or cutaneous sites, such as fingers, toes or knees
(134) can become infected. In some cases HSV-1 infection can cause severe
meningo-encephalitis and kerato-conjunctivitis that can lead to permanent
neurological damage with high mortality or corneal blindness, respectively (207).
Genital herpes infections can also result in mother-to-infant transmission (163). HSV-
1 infection of newborns can cause lesions of the skin, eyes, mouth, or encephalitis
(163). In addition, HSV-1 infection of the preterm infant seems to be associated with
lethargy, hypotension, temperature instability, and elevated aspartate
aminotransferase levels (163).
3.3.2 HSV-1 structure and genome organization.
The HSV-1 virion has a diameter of approximately 300 nm and consists of four
distinct compartments: the envelope, the tegument, the capsid, and the enclosed viral
linear ds DNA genome of 152-kbp (Fig. 2A; (52)). The viral envelope is derived from
host membranes and contains 11 viral glycoproteins, some of which play an
important role in viral entry (134). The tegument is a thick layer of virus-encoded
proteins involved in initial steps of HSV-1 infection, including trafficking to the
nucleus, inhibition of cellular gene expression, and initiation of viral gene expression
(5). The HSV-1 capsid is 160 Å thick and has a diameter of 1,25 Å (139). HSV-1
proteins, expressed form the genes UL18, UL19, UL26, UL26.5, UL35, UL38, and
UL6 constitute the icosahedral capsid (74). More precisely, the major capsid protein
VP5 and VP26 (UL19 and UL35) make up 162 capsomers (150 hexons and 12
pentons), which are connected by 320 triplexes of VP19C (UL18) and VP23 (UL38;
(125, 209)). HSV-1 contain also large amounts of VP22a protein (UL26.5) and
smaller amounts of VP24 and VP21 proteins (both expressed from UL 26), which are
involved in the formation and processing of the capsid scaffold (74). The scaffolding
proteins form a core (the scaffold) and interact with VP5 to support capsid assembly
(74). In addition, the HSV-1 capsid shell also contains trace amounts of a few other
proteins, including products of the UL6, UL12.5, UL15 and UL25 genes (74).
The HSV-1 capsid protects one copy of a tightly condensed viral ds DNA, free of
bound histones or other proteins (74). The genome consists of two covalently linked
fragments, designated long (L) and short (S) segments (52). Each segment is flanked
by inverted repeats (155). The junction regions between the segments are arranged
as follow: ab-UL-b′a′c′-US-ca (Fig. 2A; (192)). HSV-1 encodes about 89 proteins
(134), approximately half of which are essential for virus replication in cell culture
(Fig. 2A; (3)). Each HSV-1 gene promoter has a TATA box homology upstream of the
start site of transcription (52), allowing viral gene expression by the cellar RNA
polymerase II (52). To facilitate viral DNA replication, two replication origins are
present in the repeated c region (OriS) and a third replication origin is located in the
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Fig 2. (B) Structure of the linear ds HSV-1 genome and schematic map of the essential
HSV-1 genes (purple) and ICP0. The genome consists of two covalently linked
segments: unique long (UL) and unique short (US). Each segment is flanked by inverted
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arrangement of the regions. The genome conatins three origins of DNA replication (ori).
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U
L1
U
L5
-9
U
L1
4-
15
U
L1
7-
19
U
L2
2-
25
U
L2
9
U
L3
0-
38
U
L4
2
U
L4
8-
49
U
L5
2-
53
U
L5
4
UL segment of the genome (OriL; (192)). Both, OriL and OriS contain A/T-rich
regions, flanked by two recognition sites for the HSV-1 origin-binding proteins (OBPI,
OBPII, and UL9; (192)). For packaging of the viral genome, three identical DNA
cleavage/packaging signals (pac) are present at the termini of the genome as well as
at the junction between the long and the short segments (52).
3.3.3 HSV-1 entry.
Several viral envelope glycoproteins are implicated in the HSV-1 entry process,
including: gB, gC, gD, and the heterodimer gH/gL (5). The initial interaction between
the virus and the host membrane occurs via binding of gC and/or gB to heparan
sulfate proteoglycans (HSPGs; (5)). It is suggested that the enrichment of HSPGs at
cellular protrusions (filopodia) may promote the initial attachment of HSV-1 to the
host cell (5). The subsequent process of penetration depends on the cell type and the
mode of entry (5) and can occur via direct fusion of the HSV-1 envelope with the
plasma membrane (5) or via fusion with the membrane of an intracellular vesicle,
after endosomal or phagosomal uptake of the virus (40, 60, 126–128). Both fusions
with the plasma membrane and endocytic uptake can be pH-dependent or pH-
independent (5). Although it was shown that the expression of receptors, nectin-1
and paired immunoglobulin-like type 2 receptor α (PILRα), correlates with endocytic
uptake or virus-cell membrane fusion, respectively, another report showed that the
same receptor can also mediate different modes of entry, depending on the cell (5).
Nevertheless, fusion with both the cellular and vesicular membrane (after endocytic
uptake), requires a multi-glycoprotein complex (gB, gD, and gH/gL; (5)) and one of
the following cellular receptors: nectin-1 or -2 (in neurons, keratinocytes and epithelial
cells), herpesvirus entry mediator (HVEM, in fibroblasts and ocular cell types), or 3-O
sulfated heparan sulfate (3-O HS, in corneal fibroblasts; (124)). Binding of gD to one
of these receptors leads to a conformational change of gD and further triggers gB to
insert its fusion loops into the target cell membrane, allowing membrane fusion to
take place (124). Fusion of the HSV-1 envelope with the cell membrane leads to the
release of the nucleocapsid and tegument proteins into the host cytoplasm (5). For
transport towards the nuclear membrane HSV-1 nucleocapsids bind dynein to shuttle
along microtubules (160). As mentioned above, HSV-1 can enter the cell by receptor-
mediated fusion between virus- and cell-membrane or receptor-mediated endocytosis
(5). In neurons, HSV-1 entry seems to occur via direct fusion at the plasma
membrane (5). The HSV-1 capsids are then transported retrogradely along sensory
axons towards the nucleus in the neuronal cell body (8, 52). It was shown that HSV-1
capsids are cotransported to the neuronal nucleus with the tegument proteins VP1/2
(pUL36) and pUL37, which might support binding of capsids to dynein (8). Other
tegument proteins including VP11/12, VP13/14, VP16, and VP22 were found
predominantly lost prior to the onset of retrograde transport (8). However dissociation
of HSV-1 VP16 and VP11/12 was not complete in all neurons, which is proposed to
explain the establishment of an acute feedback loop in some neurons (8). After
reaching the nuclear membrane, HSV-1 uncoating occurs at the nuclear pore
complex (NPC), leading to the release of the viral genome through the NPC into the
nuclear space (136). It is suggested that the viral DNA leaves the capsid through the
capsid portal, which is composed of pUL6 proteins (136). The portal proteins may
also be implicated in mediating the proper orientation of the capsid and the NPC for
release of the HSV-1 genome (136). The interaction of HSV-1 capsid with the NPC
may occur via the inner tegument protein pUL25 (associated to the capsid) and one
subunit of the NPC, CAN/Nup214 (136). In addition, the tegument protein pUL36,
cellular Nup358 and importin beta, as well as the RanGTP/RanGDP cycle (for energy
supply) seems to be involved in translocation of the viral genome into the nucleus
(136). It is believed that the interaction with the NPC results in destabilization of the
viral capsid, allowing the viral genome to leave the capsid due to pressure built up
during the process of viral genome packaging (136). It is suggested that polarized
DNA ejection into the nucleus occurs, in which one of the HSV-1 immediate early
genes access the nucleus first (136). Transcription of this gene could act as a force
pulling the genome out of the capsid (136). The internalized linear HSV-1 genome
becomes circularized in the nucleus (59) and further serves as a template for both,
viral gene expression and DNA replication (52).
3.3.4 HSV-1 transcription and translation
The production of HSV-1 proteins is regulated by temporal expression of the viral
genes, subdivided into three different stages: immediate early (IE), early (E), and late
(L; (171)). While IE and E genes encode for proteins required for the regulation of
HSV-1 gene expression and DNA replication, L genes encode for proteins required
for virus assembly and egress (170). L genes can be further divided into two classes,
leaky-late and true late (7). The leaky-late genes are expressed at very low levels at
early times after infection and become intensely upregulated at late times; in contrast,
true late genes are expressed exclusively after the onset of viral DNA replication (7).
The mechanism that restricts late gene activation after DNA replication has not yet
been determined, although at least two general possibilities have been considered.
First, the restriction may be related to DNA structure, or possibly DNA modifications
that are altered immediately post replication. Alternatively, binding of viral or cellular
proteins to repressor elements within late promoters may inhibit late gene
expression, with subsequent displacement or titration of the repressors being
accomplished by DNA replication.
All HSV-1 genes are transcribed by the host RNA polymerase II (52). Each viral
promoter has a TATA box homology upstream of the start site of transcription (52). It
was shown that initiation of HSV-1 gene expression requires demethylation of
histones, which are associated with the viral DNA after entering the nucleus, by
lysine-specific demethylase 1 (LSD1, (145). Further, VP16 together with LSD1 and
the cellular factors Oct1 and HCFC1 mediate initial transcription of IE genes (145). At
the same time, a repressor complex composed of LSD1, histone deacetylase
(HDAC) 1 or 2, RE-1 silencing transcription factor (REST), and corepressor of REST
(CoREST) prevent premature transcription of HSV-1 E and L genes (145). With the
onset of IE gene transcription, ICP0 inactivates the repressor complex, allowing
transcription of E and L genes (145). In addition, the cellular transcriptional activator
Sp1 and the HSV-1 IE protein ICP4 are involved in activating transcription of E and L
genes (90, 156), while at the same time ICP4 represses transcription from several IE
genes (17, 66, 103). ICP22, ICP27, and UL13 might also be implicated in
transcriptional regulation, possibly via modification of RNA polymerase II activity
(110). For example, ICP27 was found to directly interact with RNA polymerase II,
which is suggested to prevent the expression of intron-containing cellular genes,
while allowing the expression of intron-less viral genes (7). In this context, ICP27 has
also a central function in shutting down the cellular mRNA splicing apparatus, via
SRPK1 mediated inhibition of serine/arginine-rich splicing factors (SRSFs), which are
required for splicesome assembly (153). To support viral mRNA stability and nuclear
export, HSV-1 mRNAs become both 3’-polyadenylated and 5′-capped by host
proteins (7). In addition, ICP27 was shown to be involved in polyadenylation and
nucleocytoplasmic export of viral mRNAs (114).
HSV-1 protein synthesis is carried out by the host translation machinery (52).
However, with some interference by HSV-1 proteins. For example, it was shown that
binding of ICP0 to the elongation factor EF-1δ or hyperphosphorylation of EF-1δ by
the HSV-1 protein kinase UL13 supports translation of viral mRNAs (88).
3.3.5 HSV-1 DNA replication and encapsidation.
Seven proteins encoded by HSV-1 were shown to be essential to promote viral DNA
synthesis in cell culture: the origin-binding protein UL9, the ss DNA binding protein
ICP8, the DNA polymerase (UL30/UL42), and the helicase/primase complex
(UL5/UL8/UL52; (192)). The helicase-primase complex has DNA-dependent ATPase
and helicase activity (29, 44, 92, 157) and the ability to synthesize primers (44, 157)
in order to initiate viral replication. The HSV-1 ICP8 protein has a strong affinity to ss
DNA (100) which supports an extended, single strand conformation of the HSV-1
DNA template (147) so that purine and pyrimidine bases of the template can base-
pair readily with incoming nucleotides. In addition, ICP8 is involved in the recruitment
and stimulation of replication factors and the expression of late virus genes (192),
and ICP8 together with UL5 promote unwinding of the HSV-1 origin of DNA
replication (33, 184, 186, 200). In addition to the minimal factors necessary for HSV-1
DNA replication, several accessory factors involved in nucleotide biosynthesis are
supplied by the virus, including thymidine kinase, ribonucleotide reductase,
deoxyuridine triphosphatase, and uracil-DNA-glycolsylase (192).
It was suggested that the formation of HSV-1 RCs starts adjacent to promyelocytic
leukemia nuclear bodies (PML NBs; (111)). With the onset of HSV-1 gene expression
PML NBs become disrupted (47). The disruption of these nuclear entities prevents
their antiviral activity (47). At the same time, several PML proteins involved in
transcriptional regulation or DNA replication and repair become associated with HSV-
1 RCs including HDAC, Rb, p53, the MRN complex, ATM, ATR, RPA, Chk2, Rad52,
and Brca1 (115–117, 171, 176, 194). In addition, a multitude of other DNA damage
sensing and repair factors were found within HSV-1 RCs or associated with ICP8,
especially proteins of the cellular homologous recombination machinery (115–117,
171, 176, 194, 196). The basic model for HSV-1 replication is a rolling-circle
mechanism which leads to the formation of larger-than-unit length concatemers (19,
78, 79, 81). Additionally, complex, branched structures of HSV-1 replication
intermediates were observed (192). There is raising evidence that cellular
recombination and repair proteins play a central role in multiple steps of HSV-1 DNA
replication (105, 195). The function of several of these proteins is described in more
detail below. Further support for efficient HSV-1 DNA replication may come from
several chromatin remodeling factors (BRG1, BRM, hSNF2H, BAF155, mSin3a, and
histone deacetylase 2) identified associated with HSV-1 RCs (171). These proteins
may play a role in maintaining a nucleosome-free viral DNA, essential for virus
replication (171). Although regulation of virus genes by cellular transcription factors
seems to be reasonable, not all transcriptional regulators localized in HSV-1 RCs are
involved in transcriptional regulation of virus genes. For example, the transcription
factors Sp1 and Sp2 rather enhance OriS-dependent HSV-1 DNA replication than
support virus transcription (1). In contrast, cellular transcriptional regulators Daxx and
Sp100 are components of HSV-1 RCs and participate in the interferon mediated
intrinsic antiviral response against HSV-1 (35, 48, 63). Recruitment of these factors
into HSV-1 RCs may impede their antiviral activity via interferon response.
The products of HSV-1 DNA replication are larger-than-unit length concatemers
(192). Both packaging signals pac1 and pac2 lie within the a repeats of the HSV-1
genome (Fig. 2B; (52)). The tripartite terminase as well as UL32 and UL28 recognize
the genomic ends in concatemers and endonucleolytically cleave these into precise
genomic lengths, adjacent to the pac signals in the DR region of the genome (11,
52). One single genome is then inserted into the capsid through the portal, supported
by the ATPase-activity of the terminase (11). The inserted DNA replaces the inner
scaffold proteins, which are degraded or expelled during DNA packaging (11).
3.3.6 HSV-1 egress.
There are different hypotheses concerning the mechanism of HSV-1 egress. A
widespread view is that the newly synthesized capsids, together with some tegument
proteins bud into the perinuclear lumen, mediated by a virus encoded budding
machinery (including UL34 and UL31) located at the inner nuclear membrane (11,
52). In a second step, the immature primary enveloped virions fuse with the outer
nuclear membrane and release the capsid into the cytoplasm. The capsid then buds
into membranes of the late trans-Golgi compartment or endosome, thereby acquiring
the final envelope (52). An alternative pathway describes the nuclear exit of naked
capsids via impaired nuclear pores (134). In a third alternative mechanism, after
budding into the perinuclear lumen (from the cytoplasm), the virion follows the
intraluminal transport via the endoplasmatic reticulum (ER) and the Golgi apparatus
(134). Regardless of the mechanism of envelopment, virions exit the cell by
exocytosis (52, 134). In case of HSV-1 replication within neurons, the nucleocapsid
and envelop proteins are transported separately to axon termini and secondary
envelopment is suggested to occur at the site of virion egress (52).
3.3.7 HSV-1 latency.
Virus replication in epithelial cells and virion release at the site of host entry can lead
to the spread of HSV-1 into neurons of the trigeminal ganglia via axon termini. Upon
entry, virions can travel via retrograde axonal transport to the cell bodies where
lifelong latency is established. The mechanisms that control productive or latent
infection are not fully understood, however a hallmark of HSV-1 latent infection is that
transcription of latency-associated transcripts (LATs) are the only viral products
synthesized in large quantities from latent HSV-1 episomes (52). A primary LAT
transcript of ~8.5kb is processed into a ~2kB intron (49) and several microRNAs
(175). While the function of the LAT intron is not clear, several of the microRNAs are
involved in repression of viral mediators of lytic infection, including ICP0 and ICP4
(175). The structure of the LAT intron closely resembles cellular long non-coding
RNAs (lncRNAs), and it may therefore be involved in epigenetic regulation, similar to
the function of cellular lncRNAs (198). In the host, reactivation of the virus can be
induced by unknown causes. A recent study showed that the treatment of axon
termini of latently infected neurons with the mTOR kinase inhibitor rapamycin
stimulated lytic replication of HSV-1 (93). Since mTOR signaling pathways in neurons
have been shown to integrate a variety of extracellular signals into neurons (193),
these results indicate that environmental stimuli may be sufficient to induce
reactivation of HSV-1 from latency. In line with this concept, mTOR activity was
shown to regulate the translational repressor eIF4E-binding protein (4E-BP), which is
involved in the regulation of expression of latent HSV-1 genomes (93).
3.4 Viruses and the cellular DNA damage sensing and repair
machinery.
There is rising evidence that viruses which replicate in the host cell nucleus interfere
with nuclear components and pathways, in order to facilitate their own propagation
(82, 107, 130, 174, 187). DNA-damage response (DDR) pathways in particular may
play central roles in virus infection (82, 107, 130, 174, 187). The host cell responds to
incoming viral genomes during the first few hours of infection, by activating a DNA
damage response (DDR; (187, 189)). This response is facilitated by the presence of
free ss DNA and/or ds DNA ends as well as unusual secondary structures of viral
genomes (e.g. the hairpins of the AAV2 ITRs, see above and ref. (52)) and/or
extraordinary replication intermediates (e.g. branched structures of the HSV-1
genome, see above and ref. (192)). In addition, similar to replication of the host cell
DNA, replication of virus DNA, once initiated, may not proceed to completion without
interruptions at both leading- and lagging-strand synthesis (34), resulting in the
initiation of DDR signaling. Several studies have demonstrated that these cellular
proteins of the DNA damage sensing and repair machinery can have positive and/or
negative effects on the viral life cycle, depending on the virus and its replication
strategy (82, 107, 130, 174, 187). For instance, DDR-mediated covalent linkage of Ad
DNA would inhibit packaging; therefore, Ad inactivates specific DDR proteins by
degradation or mislocalization (DNA-PK, DNA ligase IV, and the Mre11 complex; (12,
27, 152)). In contrast, HSV-1 uses the DNA damage sensing and repair machinery to
promote covalent linkage of its genome during replication (discussed in more detail
below and ref. (192)). In addition, the DDR pathway can be a tool for the viruses in
general, to gain control over the cell cycle and to allow viral genome replication, while
preventing premature apoptosis of infected cells (82, 107, 130, 174, 187).
Furthermore, DNA-damage induced protein complexes may protect viral DNA from
nuclease-dependent degradation (82, 107, 130, 174, 187). Therefore, viruses have
evolved strategies to manipulate the DNA damage sensing and repair machinery in a
way that detrimental factors become unplugged while beneficial factors become
hijacked, leading to a dramatic remodeling process in the host nucleus which is
described below.
3.4.1 The main players of the cellular DNA damage sensing and repair machinery.
Cells activate a complex signaling network that includes kinase regulation,
transcriptional induction and redistribution of a multitude of factors in response to
DNA damage or stalled replication forks (61). Depending on the extent of DNA
damage, cell cycle progression is stopped (99), to enable DNA repair, or apoptosis is
induced via induction and activation of Bax (65, 143). The three main kinases,
mediating signaling transmission after recognizing DNA damage or stalled replication
forks are PI3 kinase-like kinases (PIKKs), specifically ataxia telangiectasia mutated
(ATM), ATM and Rad3-related kinase (ATR), and DNA-dependent protein kinase
(DNA-PK; (166)). These three kinases are recruited to sites of DNA damage and play
a crucial role in DDR by transmitting and amplifying the signal (166).
3.4.2 The ATR pathway and stalled replication forks.
DNA damage pathways contribute to proper replication of cellular DNA by stabilizing
transiently stalled replication forks, regulating replication after DNA repair restart, or
facilitating fork movement on difficult-to-replicate templates (83). At replication forks,
progression of the DNA polymerases is uncoupled from the helicase activity, leading
to the formation of ss DNA gaps, which become immediately coated by the cellular ss
DNA-binding protein replication protein A (RPA) and which are further recognized by
the ATR-ATRIP (ATR interacting protein) complex (53, 83). The subsequently
induced DDR is crucial to modulate DNA replication dynamics in order to prevent
DNA damage during replication (83). ATR signaling via checkpoint kinase 1 (Chk1)
leads to the activation and recruitment of the repair machinery as well as checkpoint
activation, mediating a cell cycle arrest (53, 83). Therefore, Chk1 acts as a signaling
transmitter to signal DNA damage to the rest of the nucleus. The adaptor protein
claspin is crucial for bringing ATR and Chk1 together (39). Additional proteins
implicated in the conserved ATR checkpoint pathway are: the RAD17–RFC complex
(RAD17, RFC2, RFC3, RFC4, RFC5), the 9-1-1 complex (RAD9, RAD1, HUS1) and
the ATR activator protein TopBP1 (53). However, the mechanism by which TOPBP1
activates ATR is poorly defined. If DNA repair is not necessary, the MCM helicase
complex, the WRN (Werner syndrome, RecQ helicase-like), and BLM helicases are
able to remodel perturbed replication fork structures or difficult-to-replicate secondary
structures to aid progression of the polymerase complex in response to ATR
signaling (83).
Besides replication stress, ATR is also activated in response to many types of DNA
damage, including DSBs, base adducts, or crosslinks, however a single DNA
structure might be always responsible for activation of ATR kinase activity (39).
3.4.3 ATM and DNA-PK in homologous recombination (HR) and non-homologous
end joining (NHEJ) after recognition of DNA double strand breaks.
In contrast to ATR, DNA-PK is not able to arrest the replication process following
replication stress (108) but plays an essential role in DNA ds break repair (159). DNA
ds breaks can arise from endogenous sources, including reactive oxygen species
(ROS), cellular nucleases, and collapsed replication forks, but also from exogenous
sources such as ionizing radiation and chemicals (159). Two main pathways are
involved in repairing DNA ds breaks: homologous recombination (HR) and non-
homologous end joining (159). Several DNA repair factors are common to both
pathways, including the MRN (Mre11/Rad50/Nbs1) complex, BRCA1, H2AX, PARP-
1, and RAD18 (159). The MRN complex acts as main sensor of ds breaks (99) to
induce not only HR or NHEJ, but also for example cell-cycle arrest (99). Cellular DNA
damage repair via HR can only occur in S or G2 phase of the cell cycle when sister
chromatids are available (159). NHEJ remains active throughout the cell cycle,
indicating that NHEJ competes for ds breaks in S and G2 phase of the cell cycle
(159). The core machinery of HR is built by  CtIP, RPA, EXO1, BRCA 1 and 2,
PALB2, Rad51, Rad52, and Rad54 , while the core repair machinery of NHEJ is
composed of DNA-PK (Ku70/Ku80/DNA-PKcs), Artemis, Lig4, XRCC4, 53BP1, and
Fig 3. ATR mediated DDR signaling at stalled replication forks. At stalled replication forks ss 
DNA gaps become immediately coated with RPA and are further recognized by the ATR-
ATRIP complex. Recruitment of TOPBP1 by the 9-1-1 complex leads to activation of ATR ki-
nase activity. The adaptor protein claspin  then supports ATR mediated acntivation of Chk1 
which transmitts the DNA damage signal to the rest of the nucleus. Finally this ATR mediated 
signaling at a DNA lesions or stalled replication forks can coordinate cell cycle, repair, and 
replication. Figure adapted from: Nature Reviews Molecular Cell Biology 9, 616-627 (August 
2008) | doi:10.1038/nrm2450. 
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Fig 4. ATM and DNA-PK in HR (A) and NHEJ (B). The MRN complex plays an important role in 
sensing DNA ds breaks in both HR and NHEJ. ATM is further responsible to recruit CtIP to sites 
of DNA damage. The core repair machinery of HR is finally composed of CtIP, RPA, EXO1, BRCA 
1 and 2, PALB2, Rad51, Rad52, and Rad54 (A), while the core repair machinery of NHEJ is com-
posed of DNA-PK (Ku70/Ku80/DNA-PKcs), Artemis, Lig4, XRCC4, 53BP1 and XLF. Figure 
adapted from: Nature Reviews Cancer 12, 587-598 (September 2012) | doi:10.1038/nrc3342. 
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XLF (26, 34). In HR, WRN and BLM were found to stimulate endonuclease activity of
EXO1 at ssDNA–dsDNA junction as well as the incision of a nucleotide at a nick
(154) and 5′→3′ ds DNA exonuclease activity (131), respectively. ATM plays not only
a central role in HR by recruiting CtIP to sites of DNA damage (34), several proteins
involved in initial DDR signaling are targets for phosphorylation of both ATM and
DNA-PKcs. For example, activation of Chk2 by ATM after ds breaks is well described
(4, 37, 87), but also DNA-PK was reported to induce activation of Chk2 (104, 173). In
addition, p53 was shown to be a target of both DNA-PK (102, 180, 183) and ATM
(14). Due to this overlap it seems to be likely that initial DNA-PK mediated signaling
influences HR and that ATM signaling contributes to NHEJ. However, it is important
to mention that besides ATM and DNA-PK, ATR signaling can also become activated
in response to the formation of ss DNA gaps on DNA double strand ends or repair
intermediates (53) and may therefore also contribute to HR or NHEJ events.
3.4.4 HSV-1 and the cellular DNA damage sensing and repair machinery.
HSV-1 induces the activation of a cellular DNA ds break response pathway including
ATM, the MRN complex, Chk2, p53, RPA, and Rad51 (25, 105, 158, 196). It is
suggested that the MRN complex in particular is required for the formation and
stability of the concatemers and complex branched structures observed during HSV-
1 genome replication (105). Several proteins found in HSV-1 RCs belong to the
cellular HR machinery. It is suggested that recombination events play a central role in
HSV-1 replication, by promoting inversion of two segments of the HSV-1 genome
upon replication and the formation of HSV-1 concatemers (195). However, not all
components of the HR machinery have a significant role in HSV-1 replication. The
WRN complex was shown to have only a modest influence on HSV-1 recombination
events (171). In contrast to several HR proteins which might support HSV-1
replication, proteins of the NHEJ seem to have inhibitory function in HSV-1 replication
(135, 171). Although Ku70 was found as component of HSV-1 RCs, HSV-1
replication in absence of Ku70 was shown to be significantly increased (171). It is
unclear whether any specific HSV-1 proteins counteract Ku70 activity. In addition,
another NHEJ protein, DNA-PKcs, was shown to reduce replication efficiency of
HSV-1 in cell culture experiments (135). Therefore, it is not surprising that HSV-1
targets DNA-PKcs for degradation, using the E3 ubiquitin ligase function of the virus
protein ICP0 (101, 135). It was suggested that the NHEJ pathway in general may
have an inhibitory function on HSV-1 replication, for example by blocking
homologous recombination events of the ds DNA genome of HSV-1 (171). However
more recent results showed that knockdown of another central element of NHEJ,
DNA ligaseIV/XRCC4, reduced HSV-1 replication severely (120). It is proposed that
DNA ligase IV/XRCC4 contributes to the initial formation of end-to-end ligation of the
incoming viral genomes, forming circular viral molecules for replication (120). All
together, these data indicate that the NHEJ machinery may be useful for HSV-1
replication, however, in a strictly time dependent manner.
While ATM and ATM-targets were observed to be activated during HSV-1 infection,
ATR and ATR-targets were not. This has been proposed to be a result of disruption
of the ATR/ATRIP protein complex by the HSV-1 IE protein ICP0 (197). However,
later studies showed that although not active, both ATR and ATRIP were recruited
into HSV-1 RCs (116, 176). It was also shown that proteins of the ATR pathway (in
absence of ATR kinase activity) including ATR, RPA, TopBP1, clapsin, or CINP play
a beneficial role in HSV-1 gene expression and virus production (115). By supporting
gene expression rather than mediating a DDR, it seems that HSV-1 uses cellular
proteins of the ATR pathway outside of their host context.
Although an ATR-mediated DDR was not observed during HSV-1 infection, several
proteins related to stalled replication forks were found associated to HSV-1 RCs,
including WRN, Rad51, BRCA1 Rad17, Rad9, or HUS1 (115, 196). The appearance
of stalled replication forks during HSV-1 genome replication is very likely, due to
described nicks and gaps (57, 89). Similar to their cellular function (83), these
proteins might support also stabilization of the viral replication forks and restart of
interrupted replication. Therefore, in absence of these cellular factors, the integrity of
viral replication forks or replication intermediates may not be ensured. It is proposed
that such a mechanism is involved also in the establishment of HSV-1 latency in
neurons (105). Indeed, it was shown that in neurons, HSV-1 failed to initiate both a
DDR and the formation of viral replication centers (105). However, although viral
infection of neuroblastoma cells did not induce a DDR, treatment of these cells with
cellular DNA damage inducers facilitated HSV-1 promoter activity and viral protein
expression (177). This observation also implicates a mechanism by which HSV-1
genes, in a quiescent or latent state, may become active to facilitate productive
infection through activation of the cellular DNA damage sensing and repair machinery
in neuronal cells (177).
3.4.5 AAV2 and the cellular DNA damage sensing and repair machinery.
In addition to helper virus proteins, the fate of AAV2 replication depends also on
cellular proteins. Recently, cellular proteins have been identified that interact with
AAV2 Rep 78/68 during Ad or HSV-1 supported AAV2 replication (123, 128). With
both helper viruses, one of the main groups of cellular proteins belongs to the cellular
DNA damage sensing and repair machinery (123, 128). The function of these
proteins in AAV2 replication is reviewed in detail below (3.6).
3.4.6 DDR induced by AAV2 in absence of a helper virus.
Early studies have shown that infection with wtAAV2 or UV light-inactivated AAV2
(UV-AAV2) inhibits multiplication of the cells in culture and that the perturbation of the
cell cycle leads to the accumulation of cells in late S and/or G2 phases, independent
on viral gene expression and replication (199). It is likely that the ss AAV2 DNA and
its hairpin shaped ITRs are the primary signals for a virus-induced cell cycle arrest.
Further examination revealed that AAV2 DNA triggers a DDR that resembles the
response of an aberrant cellular DNA replication fork (85). The signaling was shown
to be strictly dependent on ATR and Chk1 functions in presence of BML, Rad9, and
TopBP1 (85). Moreover, DNA polymerase delta, RPA, and the Rad9/Rad1/Hus1
complex but not ATM and NBS1 have been found accumulated in AAV2 DNA foci
(85). The hypothetical model of Jurvansuu et al. suggests primary recognition of
AAV2 DNA by the ss DNA binding proteins Rad51 and RPA (85). RPA further
enables binding of both ATR/ATRIP and 9-1-1 protein complexes to AAV2 DNA (85).
ATR phosphorylates Rad17, 9-1-1 and Chk1 and recruits other proteins, which leads
to the induction of a cell cycle arrest (85). Additional studies revealed that p53 plays
also an essential role in the induction of the AAV2 induced cell cycle arrest, as cells
deficient in p53 were shown to proceed into lethal mitosis, independent of the
presence or absence of AAV2 Rep proteins (84, 142). By inducing cell death in cells
defective for p53, AAV2 was shown to inhibit tumor growth in mice (142). Therefore
AAV2 is suggested a very promising tool to deliver DNA of unusual structure into
cells in order to trigger a DNA damage response that selectively eliminates tumor
cells lacking p53 activity (142).
Despite the AAV2 DNA, the AAV2 replication proteins Rep 78 and Rep 68, but not
Rep 52 and Rep 40, have been shown to induce a cell cycle arrest in G1 and G2
phase of the cell cycle, mediated by elevated levels of the CDK inhibitor p21 and
reduced levels of cyclin E-, A- and B1-associated kinase activity (150). Expression of
Rep 78 has been shown to interfere also with S-phase progression, mediated by
accumulation of hypophosphorylated retinoblastoma protein (Rb; (150)). The
antiproliferative effect of Rep 78/68 on cells was also linked to the inhibition of
Cdc25A (22). In addition, a potential Rep 78/68-induced damage of the cellular
chromatin is suggested to activate a cellular DDR (22); however further studies
supporting this hypothesis are necessary.
3.4.7 The role of DNA damage sensing and repair proteins in AAV2 vector
transduction.
The DNA sensing and repair machinery is not only affecting wtAAV2 replication, but
also important steps in rAAV2 vector transduction, including conversion of the ss
AAV2 vector genome into ds DNA, formation of stable ds circular monomers or large
concatemers (circular and/or linear), and efficient transgene expression in target cells
(2). Inhibitory effects of the MRN complex (32, 152) and ATM (38, 149) on rAAV2
transduction were also observed. The inhibitory effect of ATM was shown to correlate
with reduced circularization of rAAV2 genomes (149). Another study showed that
ATM together with Ku86 is linked to rAAV2 processing, resulting in reduced amounts
of stable episomal rAAV2 vectors and, therefore, inefficient long-term rAAV2 vector
gene expression (38). However, when using a self-complementary recombinant
AAV2 (scAAV2) vector, the MRN complex and ATM together with RecQ and DNA-PK
were shown to support efficient transduction (38), indicating that the inhibitory effect
of ATM and Ku86 affects second-strand synthesis or the stabilization of ss AAV2
vectors.
The inhibitory effect of DDR factors on AAV2 vector transduction might also include
several other steps of AAV2 infection and is suggested to belong to the cell’s intrinsic
antiviral response (46, 47, 106, 169). In this regard, one of the functions of the helper
virus might be to overcome these cellular barriers. One example for this hypothesis is
the Ad mediated degradation of the MRN complex discussed below (152).
Of note: A chapter on viral and cellular components of AAV2 replication
compartments completes the introduction of this thesis. However, as this topic is
presented here in the form of a manuscript that includes its own references, it has
been placed after chapter 3.5, which lists the references for chapters 3.1-3.4.
3.5 References (chapters 3.1-3.4)
1. A T Nguyen-Huynh, and P. A. Schaffer. 1998. Cellular transcription factors
enhance herpes simplex virus type 1 oriS-dependent DNA replication. J Virol
72:3635–3645.
2. Adachi, K., and H. Nakai (ed.). 2011. The Role of DNA Repair Pathways in
Adeno-Associated Virus Infection and Viral Genome Replication / Recombination
/ Integration. DNA Repair and Human Health. InTech, New York, NY.
3. Aghi, M., and R. L. Martuza. 2005. Oncolytic viral therapies – the clinical
experience. Oncogene 24:7802–7816.
4. Ahn, J. Y., J. K. Schwarz, H. Piwnica-Worms, and C. E. Canman. 2000.
Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for
efficient activation of Chk2 in response to ionizing radiation. Cancer Res
60:5934–5936.
5. Akhtar, J., and D. Shukla. 2009. Viral entry mechanisms: cellular and viral
mediators of herpes simplex virus entry. FEBS J 276:7228–7236.
6. Alazard-Dany, N., A. Nicolas, A. Ploquin, R. Strasser, A. Greco, A. L.
Epstein, C. Fraefel, A. Salvetti, and P. O'Hare. 2009. Definition of Herpes
Simplex Virus Type 1 Helper Activities for Adeno-Associated Virus Early
Replication Events. PLoS Pathog 5:e1000340.
7. Anders, D., J. Kerry, and G. Pari (ed.). 2007. Human Herpesviruses: Biology,
Therapy, and Immunoprophylaxis. Chapter 19. DNA synthesis and late viral gene
expression. Cambridge University Press, Cambridge, New York.
8. Antinone, S. E., and G. A. Smith. 2010. Retrograde Axon Transport of Herpes
Simplex Virus and Pseudorabies Virus: a Live-Cell Comparative Analysis. J Virol
84:1504–1512.
9. Asokan, A., J. B. Hamra, L. Govindasamy, M. Agbandje-McKenna, and R. J.
Samulski. 2006. Adeno-associated virus type 2 contains an integrin alpha5beta1
binding domain essential for viral cell entry. J Virol 80:8961–8969.
10. Atchison RW, Casto BC, and Hammon WM. 1965. Adenovirus-Associated
Defective Virus Particles Adenovirus-Associated Defective Virus Particles.
Science 149:754–756.
11. Baines, J. D. 2011. Herpes simplex virus capsid assembly and DNA packaging:
a present and future antiviral drug target. Trends in Microbiology 19:606–613.
12. Baker, A., K. J. Rohleder, L. A. Hanakahi, and G. Ketner. 2007. Adenovirus
E4 34k and E1b 55k Oncoproteins Target Host DNA Ligase IV for Proteasomal
Degradation. J Virol 81:7034–7040.
13. Baltimore, D. 1971. Expression of animal virus genomes. Bacteriol Rev 35:235–
241.
14. Banin, S., L. Moyal, S. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I.
Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced
phosphorylation of p53 by ATM in response to DNA damage. Science (New
York, N.Y 281:1674–1677.
15. Bartlett, J. S., R. Wilcher, and R. J. Samulski. 2000. Infectious Entry Pathway
of Adeno-Associated Virus and Adeno-Associated Virus Vectors. J Virol
74:2777–2785.
16. Batchu, R. B., M. A. Shammas, J. Y. Wang, R. J. Shmookler Reis, and N. C.
Munshi. 2002. Interaction of adeno-associated virus Rep78 with SV40 T antigen:
implications in Rep protein expression leading to the inhibition of SV40-mediated
cell proliferation. Intervirology 45:115–118.
17. Beard, P., S. Faber, K. Wilcox, and L. Pizer. 1983. Herpes simplex virus
immediate early infected-cell polypeptide 4 binds to DNA and promotes
transcription. Proc Natl Acad Sci U S A 11:4016–4020.
18. Becerra, S. P., J. A. Rose, M. Hardy, B. M. Baroudy, and C. W. Anderson.
1985. Direct mapping of adeno-associated virus capsid proteins B and C: a
possible ACG initiation codon. Proc. Natl. Acad. Sci. U.S.A. 82:7919–7923.
19. Ben-Porat, T., and S. A. Tokazewski. 1977. Replication of herpesvirus DNA. II.
Sedimentation characteristics of newly synthesized DNA. Virology 79:292–301.
20. Berns, K. I., and R. A. Bohenzky. 1987. Adeno-associated viruses. an update.
Advances in virus research 32:243–306.
21. Berns, K. I., and R. M. Linden. 1995. The cryptic life style of adeno-associated
virus. Bioessays 17:237–245.
22. Berthet, C., K. Raj, P. Saudan, and P. Beard. 2005. How adeno-associated
virus Rep78 protein arrests cells completely in S phase. Proceedings of the
National Academy of Sciences of the United States of America 102:13634–
13639.
23. Bjorklund, A., D. Kirik, C. Rosenblad, B. Georgievska, C. Lundberg, and R.
J. Mandel. 2000. Towards a neuroprotective gene therapy for Parkinson's
disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of
GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res 886:82–
98.
24. Bohenzky, R. A., R. B. LeFebvre, and K. I. Berns. 1988. Sequence and
symmetry requirements within the internal palindromic sequences of the adeno-
associated virus terminal repeat. Virology 166:316–327.
25. Boutell, C., and R. D. Everett. 2004. Herpes simplex virus type 1 infection
induces the stabilization of p53 in a USP7- and ATM-independent manner. J
Virol 78:8068–8077.
26. Bouwman, P., and J. Jonkers. 2012. The effects of deregulated DNA damage
signalling on cancer chemotherapy response and resistance. Nat Rev Cancer
12:587–598.
27. Boyer, J., K. Rohleder, and G. Ketner. 1999. Adenovirus E4 34k and E4 11k
inhibit double strand break repair and are physically associated with the cellular
DNA-dependent protein kinase. Virology 263:307–312.
28. Brister, J. R., and N. Muzyczka. 2000. Mechanism of Rep-mediated adeno-
associated virus origin nicking. J Virol 74:7762–7771.
29. Calder, J. M., and N. D. Stow. 1990. Herpes simplex virus helicase-primase: the
UL8 protein is not required for DNA-dependent ATPase and DNA helicase
activities. Nucleic Acids Res 18:3573–3578.
30. Cao, M., H. Zhu, S. Bandyopadhyay, H. You, and P. L. Hermonat. 2011. HPV-
16 E1, E2 and E6 each complement the Ad5 helper gene set, increasing rAAV2
and wt AAV2 production. Gene Ther 19:418–424.
31. Cataldi, M. P., and D. M. McCarty. 2010. Differential effects of DNA double-
strand break repair pathways on single-strand and self-complementary adeno-
associated virus vector genomes. J Virol 84:8673–8682.
32. Cervelli, T., J. A. Palacios, L. Zentilin, M. Mano, R. A. Schwartz, M. D.
Weitzman, and M. Giacca. 2008. Processing of recombinant AAV genomes
occurs in specific nuclear structures that overlap with foci of DNA-damage-
response proteins. Journal of cell science 121:349–357.
33. Challberg, M. D. 1986. A method for identifying the viral genes required for
herpesvirus DNA replication. Proc Natl Acad Sci U S A 83:9094–9098.
34. Chapman, J. R., M. R. Taylor, and S. J. Boulton. 2012. Playing the End Game:
DNA Double-Strand Break Repair Pathway Choice. Molecular Cell 47:497–510.
35. Chee, A. V., P. Lopez, P. P. Pandolfi, and B. Roizman. 2003. Promyelocytic
Leukemia Protein Mediates Interferon-Based Anti-Herpes Simplex Virus 1
Effects. J Virol 77:7101–7105.
36. Chejanovsky, N., and B. J. Carter. 1989. Mutagenesis of an AUG codon in the
adeno-associated virus rep gene: effects on viral DNA replication. Virology
173:120–128.
37. Chen, Y., and Y. Sanchez. 2004. Chk1 in the DNA damage response.
conserved roles from yeasts to mammals. DNA repair 3:1025–1032.
38. Choi, V. W., D. M. McCarty, and R. J. Samulski. 2006. Host Cell DNA Repair
Pathways in Adeno-Associated Viral Genome Processing. J Virol 80:10346–
10356.
39. Cimprich, K. A., and D. Cortez. 2008. ATR: an essential regulator of genome
integrity. Nat Rev Mol Cell Biol 9:616–627.
40. Clement, C., V. Tiwari, P. M. Scanlan, T. Valyi-Nagy, B. Y. J. T. Yue, and D.
Shukla. 2006. A novel role for phagocytosis-like uptake in herpes simplex virus
entry. J Cell Biol 174:1009–1021.
41. Costello, E., P. Saudan, E. Winocour, L. Pizer, and P. Beard. 1997. High
mobility group chromosomal protein 1 binds to the adeno-associated virus
replication protein (Rep) and promotes Rep-mediated site-specific cleavage of
DNA, ATPase activity and transcriptional repression. EMBO J 16:5943–5954.
42. Cotmore, S. F., and P. Tattersall. 1996. 28 Parvovirus DNA Replication. Cold
Spring Harbor Monograph Archive; Volume 31 (1996): DNA Replication in
Eukaryotic Cells.
43. Daya, S., N. Cortez, and K. I. Berns. 2009. Adeno-associated virus site-specific
integration is mediated by proteins of the nonhomologous end-joining pathway. J
Virol 83:11655–11664.
44. Dodson, M. S., and I. R. Lehman. 1991. Association of DNA helicase and
primase activities with a subassembly of the herpes simplex virus 1 helicase-
primase composed of the UL5 and UL52 gene products. Proc Natl Acad Sci U S
A 88:1105–1109.
45. Duan, D., Z. Yan, Y. Yue, W. Ding, and J. F. Engelhardt. 2001. Enhancement
of muscle gene delivery with pseudotyped adeno-associated virus type 5
correlates with myoblast differentiation. J Virol 75:7662–7671.
46. Everett, R. D., J. Murray, A. Orr, and C. M. Preston. 2007. Herpes simplex
virus type 1 genomes are associated with ND10 nuclear substructures in
quiescently infected human fibroblasts. J Virol 81:10991–11004.
47. Everett, R. D., S. Rechter, P. Papior, N. Tavalai, T. Stamminger, and A. Orr.
2006. PML Contributes to a Cellular Mechanism of Repression of Herpes
Simplex Virus Type 1 Infection That Is Inactivated by ICP0. J Virol 80:7995–
8005.
48. Everett, R. D., D. F. Young, R. E. Randall, and A. Orr. 2008. STAT-1- and IRF-
3-Dependent Pathways Are Not Essential for Repression of ICP0-Null Mutant
Herpes Simplex Virus Type 1 in Human Fibroblasts. J Virol 82:8871–8881.
49. Farrell, M. J., A. T. Dobson, and L. T. Feldman. 1991. Herpes simplex virus
latency-associated transcript is a stable intron. Proc Natl Acad Sci U S A 88:790–
794.
50. Ferrari, F. K., T. Samulski, T. Shenk, and R. J. Samulski. 1996. Second-
strand synthesis is a rate-limiting step for efficient transduction by recombinant
adeno-associated virus vectors. J Virol 70:3227–3234.
51. Fisher, K. J., G. P. Gao, M. D. Weitzman, R. DeMatteo, J. F. Burda, and J. M.
Wilson. 1996. Transduction with recombinant adeno-associated virus for gene
therapy is limited by leading-strand synthesis. J Virol 70:520–532.
52. Flint, S. J. (ed.). 2004. Principles of virology. Molecular biology, pathogenesis,
and control of animal viruses, 2nd ed. ASM Press, Washington, D.C.
53. Flynn, R. L., and L. Zou. 2011. ATR: a master conductor of cellular responses
to DNA replication stress. Trends in Biochemical Sciences 36:133–140.
54. Forterre, P. 2006. The origin of viruses and their possible roles in major
evolutionary transitions. Virus Res. 117:5–16.
55. Fraefel, C., A. G. Bittermann, H. Bueler, I. Heid, T. Bachi, and M.
Ackermann. 2004. Spatial and temporal organization of adeno-associated virus
DNA replication in live cells. J Virol 78:389–398.
56. Francois, A., M. Guilbaud, R. Awedikian, G. Chadeuf, P. Moullier, and A.
Salvetti. 2005. The cellular TATA binding protein is required for rep-dependent
replication of a minimal adeno-associated virus type 2 p5 element. J Virol
79:11082–11094.
57. Frenkel, N., and B. Roizman. 1971. Herpes vimplex virus: genome size and
redundancy studied by renaturation kinetics. J Virol 8:591–593.
58. Gao, G., L. Vandenberghe, and Wilson J. 2005. New recombinant serotypes of
AAV2 vectors. Gene Ther 5:285–297.
59. Garber, D. A., S. M. Beverley, and D. M. Coen. 1993. Demonstration of
circularization of herpes simplex virus DNA following infection using pulsed field
gel electrophoresis. Virology 197:459–462.
60. Gianni, T., G. Campadelli-Fiume, and L. Menotti. 2004. Entry of Herpes
Simplex Virus Mediated by Chimeric Forms of Nectin1 Retargeted to Endosomes
or to Lipid Rafts Occurs through Acidic Endosomes. J Virol 78:12268–12276.
61. Giglia-Mari, G., A. Zotter, and W. Vermeulen. 2011. DNA damage response.
Cold Spring Harbor perspectives in biology 3:a000745.
62. Girod, A., C. E. Wobus, Z. Zadori, M. Ried, K. Leike, P. Tijssen, J. A.
Kleinschmidt, and M. Hallek. 2002. The VP1 capsid protein of adeno-
associated virus type 2 is carrying a phospholipase A2 domain required for virus
infectivity. J Gen Virol 83:973–978.
63. Glass, M., and R. D. Everett. 2013. Components of Promyelocytic Leukemia
Nuclear Bodies (ND10) Act Cooperatively To Repress Herpesvirus Infection. J
Virol 87:2174–2185.
64. Glauser, D. L., O. Saydam, N. A. Balsiger, I. Heid, R. M. Linden, M.
Ackermann, and C. Fraefel. 2005. Four-dimensional visualization of the
simultaneous activity of alternative adeno-associated virus replication origins. J
Virol 79:12218–12230.
65. Gong, B., Q. Chen, B. Endlich, S. Mazumder, and A. Almasan. 1999. Ionizing
radiation-induced, Bax-mediated cell death is dependent on activation of cysteine
and serine proteases. Cell Growth Differ 10:491–502.
66. Gu, B., R. Kuddus, and N. A. DeLuca. 1995. Repression of activator-mediated
transcription by herpes simplex virus ICP4 via a mechanism involving
interactions with the basal transcription factors TATA-binding protein and TFIIB.
Mol Cell Biol 15:3618–3626.
67. H Lechevalier. 1972. Dmitri Iosifovich Ivanovski (1864-1920). Bacteriol Rev.
36:135–145.
68. Hamilton, H., J. Gomos, K. I. Berns, and E. Falck-Pedersen. 2004. Adeno-
Associated Virus Site-Specific Integration and AAVS1 Disruption. J Virol
78:7874–7882.
69. Hefferon, K. L. 2006. Recent advances in DNA virus replication 2006. Research
Signpost, Trivandrum, Kerala, India.
70. Heilbronn, R., M. Engstler, S. Weger, A. Krahn, C. Schetter, and M. Boshart.
2003. ssDNA-dependent colocalization of adeno-associated virus Rep and
herpes simplex virus ICP8 in nuclear replication domains. Nucleic acids research
31:6206–6213.
71. Hermonat, P. L. e. a. 1998. The adeno-associated virus Rep78 major regulatory
protein binds the cellular TATA-binding protein in vitro and in vivo. Virology.:120–
127.
72. Hermonat, P. L., M. A. Labow, R. Wright, K. I. Berns, and N. Muzyczka. 1984.
Genetics of adeno-associated virus: isolation and preliminary characterization of
adeno-associated virus type 2 mutants. J Virol 51:329–339.
73. Holscher, C., J. A. Kleinschmidt, and A. Burkle. 1995. Holscher, C 1995High-
level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is
sufficient for infectious-particle formation by a rep-negative AAV mutant. J Virol
69:6880–6885.
74. Homa, and Brown. 1997. Capsid assembly and DNA packaging in herpes
simplex virus. Rev Med Virol 7:107–122.
75. Hunter, L. A., and R. J. Samulski. 1992. Colocalization of adeno-associated
virus Rep and capsid proteins in the nuclei of infected cells. J Virol 66:317–324.
76. Hüser, D., A. Gogol-Döring, T. Lutter, S. Weger, K. Winter, E.-M. Hammer, T.
Cathomen, K. Reinert, R. Heilbronn, and B. R. Cullen. 2010. Integration
Preferences of Wildtype AAV-2 for Consensus Rep-Binding Sites at Numerous
Loci in the Human Genome. PLoS Pathog 6:e1000985.
77. International Committee on Taxonomy of Viruses., and A. M. King. 2012.
Virus taxonomy : classification and nomenclature of viruses : ninth report of the
International Committee on Taxonomy of Viruses. Academic Press, London.
78. Jacob, R. J., L. S. Morse, and B. Roizman. 1979. Anatomy of herpes simplex
virus DNA. XII. Accumulation of head-to-tail concatemers in nuclei of infected
cells and their role in the generation of the four isomeric arrangements of viral
DNA. J Virol 29:448–457.
79. Jacob, R. J., and B. Roizman. 1977. Anatomy of herpes simplex virus DNA VIII.
Properties of the replicating DNA. J Virol 23:394–411.
80. Janik, J. E., M. M. Huston, and J. A. Rose. 1981. Locations of adenovirus
genes required for the replication of adenovirus-associated virus. Proc. Natl.
Acad. Sci. U.S.A. 78:1925–1929.
81. Jean, J. H., M. L. Blankenship, and T. Ben-Porat. 1977. Replication of
herpesvirus DNA. I. Electron microscopic analysis of replicative structures.
Virology 79:281–291.
82. Jiang, M., and M. J. Imperiale. 2012. Design stars: how small DNA viruses
remodel the host nucleus. Future Virology 7:445–459.
83. Jones, R. M., and E. Petermann. 2012. Replication fork dynamics and the DNA
damage response. Biochem. J. 443:13–26.
84. Jurvansuu, J., M. Fragkos, C. Ingemarsdotter, and P. Beard. 2007. Chk1
instability is coupled to mitotic cell death of p53-deficient cells in response to
virus-induced DNA damage signaling. J Mol Biol 372:397–406.
85. Jurvansuu, J., K. Raj, A. Stasiak, and P. Beard. 2004. Viral Transport of DNA
Damage That Mimics a Stalled Replication Fork. J Virol 79:569–580.
86. Kashiwakura, Y., K. Tamayose, K. Iwabuchi, Y. Hirai, T. Shimada, K.
Matsumoto, T. Nakamura, M. Watanabe, K. Oshimi, and H. Daida. 2005.
Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus
type 2 infection. J Virol 79:609–614.
87. Kastan, M. B., and D. S. Lim. 2000. The many substrates and functions of ATM.
Nature reviews 1:179–186.
88. Kawaguchi, Y., R. Bruni, and B. Roizman. 1997. Interaction of herpes simplex
virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects
translational machinery. J Virol 71:1019–1024.
89. Kieff, E. D., S. L. Bachenheimer, and B. Roizman. 1971. Size, composition,
and structure of the deoxyribonucleic acid of herpes simplex virus subtypes 1
and 2. J Virol 8:125–132.
90. Kim, D.-B., S. Zabierowski, and N. A. DeLuca. 2002. The Initiator Element in a
Herpes Simplex Virus Type 1 Late-Gene Promoter Enhances Activation by ICP4,
Resulting in Abundant Late-Gene Expression. J Virol 76:1548–1558.
91. King, J. A. 2001. DNA helicase-mediated packaging of adeno-associated virus
type 2 genomes into preformed capsids. The EMBO Journal 20:3282–3291.
92. Klinedinst, D. K., and M. D. Challberg. 1994. Helicase-primase complex of
herpes simplex virus type 1: a mutation in the UL52 subunit abolishes primase
activity. J Virol 68:3693–3701.
93. Kobayashi, M., A. C. Wilson, M. V. Chao, and I. Mohr. 2012. Control of viral
latency in neurons by axonal mTOR signaling and the 4E-BP translation
repressor. Genes & Development 26:1527–1532.
94. Kotin, R. M., J. C. Menninger, D. C. Ward, and K. I. Berns. 1991. Mapping and
direct visualization of a region-specific viral DNA integration site on chromosome
19q13-qter. Genomics 10:831–834.
95. Kotin, R., M. Siniscalco, R. Samulski, X. Zhu, L. Hunter, C. Laughlin, S.
McLaughlin, N. Muzyczka, M. Rocchi, and K. I. Berns. 1990. Site-specific
integration by adeno-associated virus. Proc Natl Acad Sci U S A 87:2211–2215.
96. Kyostio, S. R., R. S. Wonderling, and R. A. Owens. 1995. Negative regulation
of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep
binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J
Virol 69:6787–6796.
97. Lackner, D. F., and N. Muzyczka. 2002. Studies of the mechanism of
transactivation of the adeno-associated virus p19 promoter by Rep protein. J
Virol 76:8225–8235.
98. Lafferty, W. E., R. W. Coombs, J. Benedetti, C. Critchlow, and L. Corey.
1987. Recurrences after Oral and Genital Herpes Simplex Virus Infection. N Engl
J Med 316:1444–1449.
99. Lavin, M. F., and S. Kozlov. 2007. ATM activation and DNA damage response.
Cell Cycle 6:931–942.
100. Lee, C. K., and D. M. Knipe. 1985. An immunoassay for the study of DNA-
binding activities of herpes simplex virus protein ICP8. J Virol 54:731–738.
101. Lees-Miller, S. P., M. C. Long, M. A. Kilvert, V. Lam, S. A. Rice, and C. A.
Spencer. 1996. Attenuation of DNA-dependent protein kinase activity and its
catalytic subunit by the herpes simplex virus type 1 transactivator ICP0. J Virol
70:7471–7477.
102. Lees-Miller, S. P., K. Sakaguchi, S. J. Ullrich, E. Appella, and C. W.
Anderson. 1992. Human DNA-activated protein kinase phosphorylates serines
15 and 37 in the amino-terminal transactivation domain of human p53. Molecular
and cellular biology 12:5041–5049.
103. Leopardi, R., N. Michael, and B. Roizman. 1995. Repression of the herpes
simplex virus 1 alpha 4 gene by its gene product (ICP4) within the context of the
viral genome is conditioned by the distance and stereoaxial alignment of the
ICP4 DNA binding site relative to the TATA box. J Virol 69:3042–3048.
104. Li, J., and D. F. Stern. 2005. Regulation of CHK2 by DNA-dependent protein
kinase. The Journal of biological chemistry 280:12041–12050.
105. Lilley, C. E., C. T. Carson, A. R. Muotri, F. H. Gage, and M. D. Weitzman.
2005. DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc Natl
Acad Sci U S A 102:5844–5849.
106. Lilley, C. E., M. S. Chaurushiya, C. Boutell, R. D. Everett, M. D. Weitzman,
and J. D. Baines. 2011. The Intrinsic Antiviral Defense to Incoming HSV-1
Genomes Includes Specific DNA Repair Proteins and Is Counteracted by the
Viral Protein ICP0. PLoS Pathog 7:e1002084.
107. Lilley, C. E., R. A. Schwartz, and M. D. Weitzman. 2007. Using or abusing:
viruses and the cellular DNA damage response. Trends in Microbiology 15:119–
126.
108. Liu, S., S. O. Opiyo, K. Manthey, J. G. Glanzer, A. K. Ashley, C. Amerin, K.
Troksa, M. Shrivastav, J. A. Nickoloff, and G. G. Oakley. 2012. Distinct roles
for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in
response to replication stress. Nucleic Acids Research 40:10780–10794.
109. Loeffler, F. A., and P. Frosch. 1898. Berichte der Kommission zur
Erforschung der Maul- und Klauenseuche bei dem Institut für
Infektionskrankheiten in Berlin. Cbl. Bakt. I. Abt., Orig:371–391.
110. Long, M. C., V. Leong, P. A. Schaffer, C. A. Spencer, and S. A. Rice. 1999.
ICP22 and the UL13 protein kinase are both required for herpes simplex virus-
induced modification of the large subunit of RNA polymerase II. J Virol 73:5593–
5604.
111. Maul, G. G., A. M. Ishov, and R. D. Everett. 1996. Nuclear domain 10 as
preexisting potential replication start sites of herpes simplex virus type-1.
Virology 217:67–75.
112. Mayor H.D., Jamison R.M., Jordan L.E., and Melnick J.L. 1965. Structure
and Composition of a Small Particle Prepared from a Simian Adenovirus. J
Bacteriol. 90:235–242.
113. McCarty, D. M., S. M. Young, and R. J. Samulski. 2004. Integration of
Adeno-Associated Virus (AAV) and Recombinant AAV Vectors. Annu. Rev.
Genet. 38:819–845.
114. McGregor, F., A. Phelan, J. Dunlop, and J. B. Clements. 1996. Regulation
of herpes simplex virus poly (A) site usage and the action of immediate-early
protein IE63 in the early-late switch. J Virol 70:1931–1940.
115. Mohni, K. N., A. R. Dee, S. Smith, A. J. Schumacher, and S. K. Weller.
2012. Efficient Herpes Simplex Virus 1 Replication Requires Cellular ATR
Pathway Proteins. J Virol 87:531–542.
116. Mohni, K. N., C. M. Livingston, D. Cortez, and S. K. Weller. 2010. ATR and
ATRIP are recruited to herpes simplex virus type 1 replication compartments
even though ATR signaling is disabled. J Virol 84:12152–12164.
117. Mohni, K. N., A. S. Mastrocola, P. Bai, S. K. Weller, and C. D. Heinen.
2011. DNA Mismatch Repair Proteins Are Required for Efficient Herpes Simplex
Virus 1 Replication. J Virol 85:12241–12253.
118. Mouw, M. B., and D. J. Pintel. 2000. Adeno-associated virus RNAs appear in
a temporal order and their splicing is stimulated during coinfection with
adenovirus. J Virol 74:9878–9888.
119. Muralidhar, S., S. P. Becerra, and J. A. Rose. 1994. Site-directed
mutagenesis of adeno-associated virus type 2 structural protein initiation codons:
effects on regulation of synthesis and biological activity. J Virol 68:170–176.
120. Muylaert, I., and P. Elias. 2007. Knockdown of DNA Ligase IV/XRCC4 by
RNA Interference Inhibits Herpes Simplex Virus Type I DNA Replication. Journal
of Biological Chemistry 282:10865–10872.
121. Muzyczka, N., and Berns K.I (ed.). 2001. Parvoviridae. The viruses and their
replication. Fields Virology, Fourth ed., (D.M. Knipe and P.M. Howley, eds),
Philadelphia.
122. Nash, K., W. Chen, W. F. McDonald, X. Zhou, and N. Muzyczka. 2007.
Purification of Host Cell Enzymes Involved in Adeno-Associated Virus DNA
Replication. J Virol 81:5777–5787.
123. Nash, K., W. Chen, M. Salganik, and N. Muzyczka. 2008. Identification of
Cellular Proteins That Interact with the Adeno-Associated Virus Rep Protein. J
Virol 83:454–469.
124. Navaratnarajah, C. K., T. S. Miest, A. Carfi, and R. Cattaneo. 2012.
Targeted entry of enveloped viruses: measles and herpes simplex virus I.
Current Opinion in Virology 2:43–49.
125. Newcomb, W. W., B. L. Trus, F. P. Booy, A. C. Steven, J. S. Wall, and J. C.
Brown. 1993. Structure of the herpes simplex virus capsid. Molecular
composition of the pentons and the triplexes. J Mol Biol 232:499–511.
126. Nicola, A. V., A. M. McEvoy, and S. E. Straus. 2003. Roles for Endocytosis
and Low pH in Herpes Simplex Virus Entry into HeLa and Chinese Hamster
Ovary Cells. J Virol 77:5324–5332.
127. Nicola, A. V., and S. E. Straus. 2004. Cellular and Viral Requirements for
Rapid Endocytic Entry of Herpes Simplex Virus. J Virol 78:7508–7517.
128. Nicolas, A., N. Alazard-Dany, C. Biollay, L. Arata, N. Jolinon, L. Kuhn, M.
Ferro, S. K. Weller, A. L. Epstein, A. Salvetti, and A. Greco. 2012.
Identification of Rep-Associated Factors in Hsv-1-Induced Aav-2 Replication
Compartments. J Virol.
129. Nicolas, A., N. Jolinon, N. Alazard-Dany, V. Barateau, A. L. Epstein, A.
Greco, H. Büning, and A. Salvetti. 2012. Factors influencing helper-
independent adeno-associated virus replication. Virology 432:1–9.
130. Nikitin, P. A., and M. A. Luftig. 2011. At a crossroads: human DNA tumor
viruses and the host DNA damage response. Future Virology 6:813–830.
131. Nimonkar, A. V., A. Z. Ozsoy, J. Genschel, P. Modrich, and S. C.
Kowalczykowski. 2008. Human exonuclease 1 and BLM helicase interact to
resect DNA and initiate DNA repair. Proceedings of the National Academy of
Sciences 105:16906–16911.
132. Ni, T. H., W. F. McDonald, I. Zolotukhin, T. Melendy, S. Waga, B. Stillman,
and N. Muzyczka. 1998. Cellular proteins required for adeno-associated virus
DNA replication in the absence of adenovirus coinfection. J Virol 72:2777–2787.
133. Nony, P., J. Tessier, G. Chadeuf, P. Ward, A. Giraud, M. Dugast, R. M.
Linden, P. Moullier, and A. Salvetti. 2001. Novel cis-acting replication element
in the adeno-associated virus type 2 genome is involved in amplification of
integrated rep-cap sequences. J Virol 75:9991–9994.
134. Oliveira, A. P. de, and C. Fraefel. 2010. Herpes Simplex Virus Type
1/Adeno-Associated Virus Hybrid Vectors~!2009-12-12~!2010-01-13~!2010-06-
17~! TOVJ 4:109–122.
135. Parkinson, J., S. P. Lees-Miller, and R. D. Everett. 1999. Herpes simplex
virus type 1 immediate-early protein vmw110 induces the proteasome-dependent
degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol
73:650–657.
136. Pellequer, J.-L., P. Parot, I. Liashkovich, W. Hafezi, J. M. Kühn, H.
Oberleithner, and V. Shahin. 2011. Nuclear delivery mechanism of herpes
simplex virus type 1 genome. J. Mol. Recognit. 24:414–421.
137. Pereira D.J., and McCarty DM Muzyczka N. 1997. The adeno-associated
virus (AAV) Rep protein acts as both a repressor and an activator to regulate
AAV transcription during a productive infection. J Virol 71:1079–1088.
138. Philpott, N. J. 2002. A p5 integration efficiency element mediates Rep-
dependent integration into AAVS1 at chromosome 19. Proceedings of the
National Academy of Sciences 99:12381–12385.
139. Prasad, C., C. Meyers, D.-J. Zhan, H. You, M. Chiriva-Internati, J. L.
Mehta, Y. Liu, and P. L. Hermonat. 2003. The adeno-associated virus major
regulatory protein Rep78-c-Jun-DNA motif complex modulates AP-1 activity.
Virology 314:423–431.
140. Qing, K., C. Mah, J. Hansen, S. Zhou, V. Dwarki, and A. Srivastava. 1999.
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-
associated virus 2. Nat Med 5:71–77.
141. Qiu J., and Pintel D. 2008. Processing of adeno-associated virus RNA. Front
Biosci. 1:3101–3115.
142. Raj, K., P. Ogston, and P. Beard. 2001. Virus-mediated killing of cells that
lack p53 activity. Nature 412:914–917.
143. Ray, S., and A. Almasan. 2003. Apoptosis induction in prostate cancer cells
and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-
related apoptosis-inducing ligand and CPT-11. Cancer Res 63:4713–4723.
144. Richardson, W. D., and H. Westphal. 1981. A cascade of adenovirus early
functions is required for expression of adeno-associated virus. Cell 27:133–141.
145. Roizman, B. 2011. The Checkpoints of Viral Gene Expression in Productive
and Latent Infection: the Role of the HDAC/CoREST/LSD1/REST Repressor
Complex. J Virol 85:7474–7482.
146. Russell, D. W., I. E. Alexander, and A. D. Miller. 1995. DNA synthesis and
topoisomerase inhibitors increase transduction by adeno-associated virus
vectors. Proc Natl Acad Sci U S A 92:5719–5723.
147. Ruyechan, W. T., and A. C. Weir. 1984. Interaction with nucleic acids and
stimulation of the viral DNA polymerase by the herpes simplex virus type 1 major
DNA-binding protein. J Virol 52:727–733.
148. Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein,
and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV)
into human chromosome 19. EMBO J 10:3941–3950.
149. Sanlioglu, S., M. M. Monick, G. Luleci, G. W. Hunninghake, and J. F.
Engelhardt. 2001. Rate limiting steps of AAV transduction and implications for
human gene therapy. Curr Gene Ther 1:137–147.
150. Saudan, P., J. Vlach, and P. Beard. 2000. Inhibition of S-phase progression
by adeno-associated virus Rep78 protein is mediated by hypophosphorylated
pRb. The EMBO journal 19:4351–4361.
151. Schatz, D. G., and P. C. Swanson. 2011. V(D)J Recombination: Mechanisms
of Initiation. Annu. Rev. Genet. 45:167–202.
152. Schwartz, R. A., J. A. Palacios, G. D. Cassell, S. Adam, M. Giacca, and M.
D. Weitzman. 2007. The Mre11/Rad50/Nbs1 Complex Limits Adeno-Associated
Virus Transduction and Replication. J Virol 81:12936–12945.
153. Sciabica, K. S., Q. J. Dai, and R. M. Sandri-Goldin. 2003. ICP27 interacts
with SRPK1 to mediate HSV splicing inhibition by altering SR protein
phosphorylation. EMBO J 22:1608–1619.
154. Sharma, S. 2003. The Exonucleolytic and Endonucleolytic Cleavage Activities
of Human Exonuclease 1 Are Stimulated by an Interaction with the Carboxyl-
terminal Region of the Werner Syndrome Protein. Journal of Biological Chemistry
278:23487–23496.
155. Sheldrick, P., and N. Berthelot. 1975. Inverted repetitions in the
chromosome of herpes simplex virus. Cold Spring Harbor symposia on
quantitative biology 39 Pt 2:667–678.
156. Shepard, A. A., P. Tolentino, and N. A. DeLuca. 1990. trans-dominant
inhibition of herpes simplex virus transcriptional regulatory protein ICP4 by
heterodimer formation. J Virol 64:3916–3926.
157. Sherman, G., J. Gottlieb, and M. D. Challberg. 1992. The UL8 subunit of the
herpes simplex virus helicase-primase complex is required for efficient primer
utilization. J Virol 66:4884–4892.
158. Shirata, N., A. Kudoh, T. Daikoku, Y. Tatsumi, M. Fujita, T. Kiyono, Y.
Sugaya, H. Isomura, K. Ishizaki, and T. Tsurumi. 2005. Activation of ataxia
telangiectasia-mutated DNA damage checkpoint signal transduction elicited by
herpes simplex virus infection. The Journal of biological chemistry 280:30336–
30341.
159. Shrivastav, M., L. P. de Haro, and J. A. Nickoloff. 2008. Regulation of DNA
double-strand break repair pathway choice. Cell Res 18:134–147.
160. Sodeik, B. 1997. Microtubule-mediated Transport of Incoming Herpes
Simplex Virus 1Capsids to the Nucleus. The Journal of Cell Biology 136:1007–
1021.
161. Song, S., Y. Lu, Y. K. Choi, Y. Han, Q. Tang, G. Zhao, K. I. Berns, and T. R.
Flotte. 2004. DNA-dependent PK inhibits adeno-associated virus DNA
integration. Proceedings of the National Academy of Sciences of the United
States of America 101:2112–2116.
162. Sonntag, F., K. Schmidt, and J. A. Kleinschmidt. 2010. A viral assembly
factor promotes AAV2 capsid formation in the nucleolus. Proceedings of the
National Academy of Sciences 107:10220–10225.
163. Stanberry, L. R. 2006. Neonatal herpes in premature infants: a special
problem. Pediatrics 118:2543–2544.
164. Stracker, T. H., G. D. Cassell, P. Ward, Y.-M. Loo, B. van Breukelen, S. D.
Carrington-Lawrence, R. K. Hamatake, P. C. van der Vliet, S. K. Weller, T.
Melendy, and M. D. Weitzman. 2004. The Rep Protein of Adeno-Associated
Virus Type 2 Interacts with Single-Stranded DNA-Binding Proteins That Enhance
Viral Replication. J Virol 78:441–453.
165. Summerford, C., and R. J. Samulski. 1998. Membrane-associated heparan
sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J
Virol 72:1438–1445.
166. Summers, K. C., F. Shen, E. A. Sierra Potchanant, E. A. Phipps, R. J.
Hickey, and L. H. Malkas. 2011. Phosphorylation: The Molecular Switch of
Double-Strand Break Repair. International Journal of Proteomics 2011:1–8.
167. Surosky, R. T., M. Urabe, S. G. Godwin, S. A. McQuiston, G. J. Kurtzman,
K. Ozawa, and G. Natsoulis. 1997. Adeno-associated virus Rep proteins target
DNA sequences to a unique locus in the human genome. J Virol 71:7951–7959.
168. Tattersall, P., and D. C. Ward. 1976. Rolling hairpin model for replication of
parvovirus and linear chromosomal DNA. Nature 263:106–109.
169. Tavalai, N., P. Papior, S. Rechter, M. Leis, and T. Stamminger. 2006.
Evidence for a role of the cellular ND10 protein PML in mediating intrinsic
immunity against human cytomegalovirus infections. J Virol 80:8006–8018.
170. Taylor, T. J., M. A. Brockman, E. E. McNamee, and D. M. Knipe. 2002.
Herpes simplex virus. Front Biosci 7:d752-64.
171. Taylor, T. J., and D. M. Knipe. 2004. Proteomics of herpes simplex virus
replication compartments. association of cellular DNA replication, repair,
recombination, and chromatin remodeling proteins with ICP8. J Virol 78:5856–
5866.
172. Tessier, J., G. Chadeuf, P. Nony, H. Avet-Loiseau, P. Moullier, and A.
Salvetti. 2001. Characterization of adenovirus-induced inverted terminal repeat-
independent amplification of integrated adeno-associated virus rep-cap
sequences. J Virol 75:375–383.
173. Tomimatsu, N., B. Mukherjee, and S. Burma. 2009. Distinct roles of ATR
and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells.
EMBO reports 10:629–635.
174. Turnell, A. S., and R. J. Grand. 2012. DNA viruses and the cellular DNA-
damage response. Journal of General Virology 93:2076–2097.
175. Umbach, J. L., M. F. Kramer, I. Jurak, H. W. Karnowski, D. M. Coen, and
B. R. Cullen. 2008. MicroRNAs expressed by herpes simplex virus 1 during
latent infection regulate viral mRNAs. Nature.
176. Vogel, R., M. Seyffert, R. Strasser, A. P. de Oliveira, C. Dresch, D. L.
Glauser, N. Jolinon, A. Salvetti, M. D. Weitzman, M. Ackermann, and C.
Fraefel. 2011. Adeno-Associated Virus Type 2 Modulates the Host DNA
Damage Response Induced by Herpes Simplex Virus 1 during Coinfection. J
Virol 86:143–155.
177. Volcy, K., and N. W. Fraser. 2013. DNA damage promotes herpes simplex
virus-1 protein expression in a neuroblastoma cell line. J. Neurovirol. 19:57–64.
178. Walz, C., A. Deprez, T. Dupressoir, M. Durst, M. Rabreau, and J. R.
Schlehofer. 1997. Interaction of human papillomavirus type 16 and adeno-
associated virus type 2 co-infecting human cervical epithelium. J Gen Virol 78 (Pt
6):1441–1452.
179. Wanga, J., Faustb S.M., and Rabinowitz E.J. 2011. The next step in gene
delivery: Molecular engineering of adeno-associated virus serotypes. J Mol Cell
Cardiol:793–802.
180. Wang, S., M. Guo, H. Ouyang, X. Li, C. Cordon-Cardo, A. Kurimasa, D. J.
Chen, Z. Fuks, C. C. Ling, and G. C. Li. 2000. The catalytic subunit of DNA-
dependent protein kinase selectively regulates p53-dependent apoptosis but not
cell-cycle arrest. Proceedings of the National Academy of Sciences of the United
States of America 97:1584–1588.
181. Wang, X. S., S. Ponnazhagan, and A. Srivastava. 1995. Rescue and
replication signals of the adeno-associated virus 2 genome. J Mol Biol 250:573–
580.
182. Wang, X. S., and A. Srivastava. 1997. A novel terminal resolution-like site in
the adeno-associated virus type 2 genome. J Virol 71:1140–1146.
183. Wang, Y., and W. Eckhart. 1992. Phosphorylation sites in the amino-terminal
region of mouse p53. Proceedings of the National Academy of Sciences of the
United States of America 89:4231–4235.
184. Ward, P., M. Falkenberg, P. Elias, M. Weitzman, and R. M. Linden. 2001.
Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a
herpes simplex virus type 1 replication complex in a reconstituted system. J Virol.
75:10250–10258.
185. Warrington, K., JR, O. Gorbatyuk, J. Harrison, S. Opie, S. Zolotukhin, and
N. Muzyczka. 2004. Adeno-Associated Virus Type 2 VP2 Capsid Protein Is
Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus†. J
Virol 78:6595–6609.
186. Weindler, F. W., and R. Heilbronn. 1991. A subset of herpes simplex virus
replication genes provides helper functions for productive adeno-associated virus
replication. Journal of virology 65:2476–2483.
187. Weitzman, M. D., C. T. Carson, R. A. Schwartz, and C. E. Lilley. 2004.
Interactions of viruses with the cellular DNA repair machinery. DNA Repair
(Amst) 3:1165–1173.
188. Weitzman, M. D., K. J. Fisher, and J. M. Wilson. 1996. Recruitment of wild-
type and recombinant adeno-associated virus into adenovirus replication centers.
J Virol 70:1845–1854.
189. Weitzman, M. D., C. E. Lilley, and M. S. Chaurushiya. 2010. Genomes in
conflict. maintaining genome integrity during virus infection. Annual review of
microbiology 64:61–81.
190. Weitzman, M. D., and R. M. Linden. 2011. Adeno-Associated Virus Biology,
p. 1–23. In R. O. Snyder and P. Moullier (ed.), Adeno-Associated Virus. Humana
Press. Methods in molecular biology. Humana Press, Totowa, NJ.
191. Weitzman, M. D., S. M. Young, T. Cathomen, and R. J. Samulski. 1991.
Targeted Integration by Adeno-Associated Virus. EMBO J 12:201–220.
192. Weller, S. K., and D. M. Coen. 2012. Herpes Simplex Viruses: Mechanisms
of DNA Replication. Cold Spring Harbor Perspectives in Biology 4:a013011.
193. Weston, M. C., H. Chen, and J. W. Swann. 2012. Multiple Roles for
Mammalian Target of Rapamycin Signaling in Both Glutamatergic and
GABAergic Synaptic Transmission. Journal of Neuroscience 32:11441–11452.
194. Wilcock, D., and D. P. Lane. 1991. Localization of p53, retinoblastoma and
host replication proteins at sites of viral replication in herpes-infected cells.
Nature 349:429–431.
195. Wilkinson, D. E., and S. K. Weller. 2003. The role of DNA recombination in
herpes simplex virus DNA replication. IUBMB life 55:451–458.
196. Wilkinson, D. E., and S. K. Weller. 2004. Recruitment of cellular
recombination and repair proteins to sites of herpes simplex virus type 1 DNA
replication is dependent on the composition of viral proteins within prereplicative
sites and correlates with the induction of the DNA damage response. Journal of
virology 78:4783–4796.
197. Wilkinson, D. E., and S. K. Weller. 2006. Herpes simplex virus type I disrupts
the ATR-dependent DNA-damage response during lytic infection. Journal of cell
science 119:2695–2703.
198. Wilson, A. C., and I. Mohr. 2012. A cultured affair: HSV latency and
reactivation in neurons. Trends in Microbiology 20:604–611.
199. Winocour, E., M. F. Callaham, and E. Huberman. 1988. Perturbation of the
cell cycle by adeno-associated virus. Virology 167:393–399.
200. Wu, C. A., N. J. Nelson, D. J. McGeoch, and M. D. Challberg. 1988.
Identification of herpes simplex virus type 1 genes required for origin-dependent
DNA synthesis. J Virol 62:435–443.
201. Xiao, P.-J., and R. J. Samulski. 2012. Cytoplasmic trafficking, endosomal
escape, and perinuclear accumulation of adeno-associated virus type 2 particles
are facilitated by microtubule network. J Virol 86:10462–10473.
202. Xiao, W., N. Chirmule, S. C. Berta, B. McCullough, G. Gao, and J. M.
Wilson. 1999. Gene therapy vectors based on adeno-associated virus type 1. J
Virol 73:3994–4003.
203. Xiao, W., K. H. Warrington, P. Hearing, J. Hughes, and N. Muzyczka. 2002.
Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2.
Journal of Virology 76:11505–11517.
204. Yakobson, B., T. A. Hrynko, M. J. Peak, and E. Winocour. 1989.
Replication of adeno-associated virus in cells irradiated with UV light at 254 nm.
J Virol 63:1023–1030.
205. Yakobson, B., T. Koch, and E. Winocour. 1987. Replication of adeno-
associated virus in synchronized cells without the addition of a helper virus. J
Virol 61:972–981.
206. Yalkinoglu, A. O., R. Heilbronn, A. Burkle, J. R. Schlehofer, and H. Zur
Hausen. 1988. DNA amplification of adeno-associated virus as a response to
cellular genotoxic stress. Cancer Res 48:3123–3129.
207. Young, R. C. 2010. Incidence, Recurrence, and Outcomes of Herpes Simplex
Virus Eye Disease in Olmsted County, Minnesota, 1976-2007The Effect of Oral
Antiviral ProphylaxisEpidemiology of HSV and Oral Antivirals. Arch Ophthalmol.
128:1178–1183.
208. Zaitlin, M. (1998). The Discovery of the Causal Agent of the Tobacco Mosaic
Virus Disease, p. 105–110. In S. D. Kung and S. F. Yang (ed.), Discoveries in
plant biology. World Scientific Publ. Co. World Scientific Publ. Co., Singapore
[u.a.].
209. Zhou, Z. H., B. V. Prasad, J. Jakana, F. J. Rixon, and W. Chiu. 1994.
Protein subunit structures in the herpes simplex virus A-capsid determined from
400 kV spot-scan electron cryomicroscopy. J Mol Biol 242:456–469.
3.6 Viral and cellular components of AAV2 replication
compartments.
I have written a review article for submission to the Open Virology Journal, which
analyzes and discusses the known interactions of helpervirus and cellular proteins
with AAV2 Rep proteins or AAV2 RCs. I include this manuscript here as part of the
Introduction of my thesis. My own contribution includes: literature search and analysis
and writing of the manuscript. I received editorial help from the following co-authors:
Michael Seyffert, Bruna de Andrade Pereira, and Cornel Fraefel.
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ADENO-ASSOCIATED VIRUS - BIOLOGICAL PRO-
PERTIES 
 AAV2 is one of the most promising vectors for human 
gene therapy [1]. The apparent lack of pathogenicity and low 
immunogenicity together with the capability to infect both 
dividing and non-dividing cells constitute perfect 
characteristics for a transgene delivery vector. AAV2 is a 
small, icosahedral and non-enveloped particle, which has a 
size of about 20-22 nm in diameter. Its genome consists of a 
linear single-stranded DNA with a size of 4.7kb and encodes 
two open reading frames (ORF), rep and cap. The rep ORF 
is regulated by two promoters (p5 and p19) which in 
cooperation with a common splicing site encode four Rep 
proteins termed Rep40, Rep52, Rep68 and Rep78, named 
according to their apparent molecular weight. The two large 
Rep proteins Rep68 and Rep78 are required for AAV2 DNA 
replication, self-regulation of transcription, site-specific 
integration as well as for inhibition of helpervirus 
replication, whereas the smaller Rep40 and Rep52 are 
believed to be required for packaging [2-4]. The cap ORF is 
controlled by the p40 promoter and encodes the three 
structural proteins VP1, VP2 and VP3 [5,6]. Moreover, a 
nested alternative ORF of the cap gene has been shown 
recently to encode a protein, designated assembly-activating 
protein (AAP), which is believed to be required for AAV2 
capsid assembly in the nucleolus [7]. 
 AAV2 belongs to the family of the Parvoviridae and the 
genus Dependovirus, as its replication depends on the 
simultaneous infection with a helper virus, such as Ad, HSV-
1, or papillomavirus [8-12]. In absence of a helper virus 
however, AAV2 establishes a latent infection, either by 
maintaining its genome in an episomal state [13] or 
integrating it into a well-defined locus termed AAVS1 on 
human chromosome 19 (Ch19) at position 19q13.4 [14-18]. 
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Upon infection with a helpervirus, AAV2 is rescued from 
latency and enters a lytic life cycle in which the viral DNA is 
replicated and progeny virus is produced. 
 The AAV2 DNA has a unique structure. Its two ends are 
characterized by 145 nt palindromic sequences termed 
inverted terminal repeats (ITR) which fold into hairpins. Just 
as unique as the AAV2 DNA structure is the rolling-hairpin 
mechanism of AAV2 DNA replication: the end of the 3’-ITR 
acts as the essential primer for second-strand synthesis, a 
process termed self-priming. The following asymmetric 
leading-strand DNA synthesis resembles a rolling-circle 
model of DNA replication, resulting in a closed-end 
intermediate at the 3’-ITR. This structure is resolved by the 
so called terminal resolution step, which involves a site- and 
strand-specific endonuclease cut performed by Rep68/78 at 
the so called terminal resolution site (TRS; [19-21]). The 
following unwinding of the remaining 3’-ITR allows to 
complete the replication process. 
ADENOVIRUS AND HERPES SIMPLEX VIRUS TYPE 
1 - BIOLOGICAL PROPERTIES 
 Adenovirus is the best characterized helper virus for 
AAV2. Adenoviruses are non-enveloped, double-stranded 
DNA viruses. Their capsid is characterized by a well-defined 
icosahedral structure consisting of three major proteins, 
hexon (II), penton base (III) and long knobbed projection 
termed fiber (IV), which is required to bind to the cell 
surface adenoviral receptor (CAR). The linear 26-45 kb 
dsDNA has inverted terminal repeats (ITRs) at each end, 
where a terminal protein (TP) is covalently attached to it 
[22]. The genome encodes four early transcription cassettes 
termed E1 (E1A and E1B), E2, E3 and E4, and five late gene 
products designated L1 to L5 which result from a series of 
splicing events of the major late (ML) transcript and 
constitute the structural proteins. 
 The adenovirus life cycle can be divided into two phases. 
The early phase is determined as the entry of the particle into 
the cell and the trafficking of the viral genome to the nucleus 
where expression of the early genes occurs. The second, or 
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late, phase includes the virus DNA replication and the 
expression of late genes, followed by virus assembly and 
egress from the nucleus and the cell. 
 HSV-1 is another well characterized and efficient helper 
virus for AAV2 replication. It is a widespread human 
pathogen which has also both a lytic and a latent phase. It 
infects mainly mucosal tissue and neurons. The viral particle 
is composed of three structural compartments, (i) the viral 
envelope, (ii) the tegument consisting of a distinct set of 
viral proteins and (iii) the capsid which encloses the viral 
genome. The HSV-1 genome is a double-stranded DNA of 
152 kbp which encodes at least 84 proteins. 
 HSV-1 can enter the cell both by fusion at the cell 
membrane or endocytosis and fusion with the endosomal 
membrane. The capsid is transported along microtubules to 
the nuclear pores, where the HSV-1 DNA, along with 
specific HSV-1 tegument proteins such as VP16 and the 
virion host shut-off protein, enters the nucleus. VP16 then 
transactivates the expression of the viral immediate early 
(IE) genes via the cellular RNA polymerase II [23]. The IE 
proteins have regulatory functions and activate the 
expression of the early (E) genes. Many of the E gene 
products are enzymes involved in DNA metabolism and their 
synthesis initiates the replication of the HSV-1 genome. The 
IE gene products and the replication of the HSV-1 DNA then 
activate expression of the late (L) genes, which encode 
structural components of the virion. HSV-1 can also 
establish latent infections, primarily in sensory neurons. 
During latency, HSV-1 gene expression is limited to the 
latency-associated transcripts (LATs) and no viral proteins 
are synthesized [24]. The mechanisms that control 
productive or latent infection of HSV-1 are not fully 
understood. 
THE NUCLEAR REPLICATION COMPARTMENTS 
OF DNA VIRUSES 
Viral RCs Develop Adjacent to PML Bodies 
 Similar to many other DNA viruses including Ad and 
HSV-1, AAV2 DNA replication takes place in so called viral 
replication compartments (RCs) or replication centers in the 
host cell nucleus [25-29]. The cell nucleus is a highly 
structured and compartmentalized space, containing not only 
the genome but also a multitude of proteins organized in 
subnuclear organelles [30]. Several of these nuclear bodies 
including clastosomes, nuclear speckles, nucleoli, or 
promyelocytic leukemia (PML) bodies contain proteins 
involved in central cellular processes such as proteolysis, 
transcription, apoptosis, or DNA-damage sensing and repair 
[31]. It seems to be a general feature of nuclear replicating 
DNA viruses that incoming viral genomes initially associate 
with PML bodies (also termed as ND10 nuclear bodies) and 
that the viral replication centers mature juxtaposed to these 
nuclear subcompartments [32-34]. PML bodies are 
functionally complex, containing proteins not only involved 
in DNA replication, transcription, or epigenetic silencing but 
also in the host defense mechanisms against viral infection 
[35]. It seems that viruses have evolved strategies to exploit 
PML bodies in order to initiate viral gene transcription and 
viral DNA replication [32,36-39]. For that reason, the often 
observed initial association of incoming viral genomes with 
PML bodies [32-34] might be a consequence of the cellular 
front line defense against viruses, however efficiently 
hijacked by the virus. During Ad supported AAV2 
replication, AAV2 DNA has been found associated also with 
PML bodies [25], similar to cells infected with Ad alone 
[37,38], and AAV2 RCs mature juxtapose to PML bodies 
[25]. With the onset of infection, several replication and 
repair proteins, normally localized to PML bodies, have been 
found associated with Ad supported AAV2 RCs (discussed 
below). The HSV-1 ICP0 protein can efficiently disrupt 
PML bodies [40], and indeed, HSV-1-supported AAV2 RCs 
did not co-exist with PML bodies [25]. Nevertheless, integral 
cellular PML bodies might have an effect on initial AAV2 
gene expression as well as the composition of cellular 
proteins in AAV2 RCs, as similar to Ad coinfection, several 
cellular replication and repair factors of PML bodies 
accumulate also in HSV-1 supported AAV2 RCs (discussed 
below). 
Spatial and Temporal Organization of RCs 
 Viral RCs are composed of a multitude of cellular 
proteins. These factors may alter depending on the necessity 
of the different viruses but also depending on the different 
functions of viral RCs, which may change spatially and 
temporally over the course of replication. In HSV-1 infected 
cells, besides viral DNA and RNA metabolism, capsid 
assembly and genome packaging is also localized to viral 
RCs [41-43]. By contrast, Ad DNA replication and assembly 
is suggested to occur in distinct nuclear compartments [44]. 
AAV2 capsid assembly has been observed to occur also 
dislocated from viral RCs in nucleoli [45]. However, the site 
of genome packaging into pre-assembled capsids remains to 
be identified. 
 In the host cell, high transcriptional activity in G1 phase 
[46] is separated in a time dependent manner from genome 
replication in S-phase of the cell cycle. In contrast, viruses 
have to create an environment which enables high 
transcriptional activity of viral genes as well as the 
production of viral DNA for progeny virions in parallel. 
Therefore, viral RCs have to be well structured 
microenvironments not only in a temporal but also in a 
spatial manner. For example, Ad RCs are surrounded by 
ring-like structures called peripheral replicative zones, where 
Ad DNA replication transcription and pre-mRNA processing 
occurs [47,48]. The defined pattern of VP5, ICP4, and ICP8 
within HSV-1 RCs [41] also indicates a complex 
organization. In contrast, besides the well described vast 
growth dynamics of AAV2 RCs [25], not much is known 
about their spatial and temporal organization. The 
identification of factors associated with AAV2 RCs, as well 
as the definition of their localization may help to better 
understand the organization of helper supported AAV2 
replication. 
HSV-1 & AD HELPER VIRUS PROTEINS INVOLVED 
IN AAV2 REPLICATION 
 In addition to multiple cellular proteins, a defined set of 
helper virus proteins are involved in AAV2 replication. The 
best studied helper virus proteins for AAV2 replication are 
provided by Ad and HSV-1. In case of Ad, these helper 
factors include E1A, E1B55K, E2A, E4orf6, and the VA 
RNA [49-51]. The Ad E1A protein not only promotes 
transcription of the early Ad genes, but also transcription of 
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the AAV2 Rep ORF [52]. E1B55K and E4orf6 form a 
heterodimer that supports AAV2 mRNA export from the 
nucleus [53], and the VA RNAs play a central role in AAV2 
infection by maintaining protein translation [54]. The DNA-
binding protein E2A supports multiple steps of the AAV2 
life cycle including regulation of AAV2 gene expression, 
viral mRNA processing and export, and viral DNA 
replication [55,56]. 
 The minimal set of HSV-1 helper proteins required for 
AAV2 replication includes the helicase-primase complex 
encoded by UL5, UL8, and UL52 and the major DNA 
binding protein ICP8 (UL29; [57-59]). All of these proteins 
are also mandatory for HSV-1 replication [60]. In addition, 
the HSV-1 origin binding protein (UL9), the viral DNA 
polymerase (UL30) and the ds DNA binding protein UL42 
have been found to support AAV2 replication [57,58]. It has 
been shown that the UL5 helicase activity is necessary for 
efficient AAV2 DNA replication, whereas the primase-
activity of UL52 is redundant [61]. Although not much is 
known about the detailed function of ICP8 in AAV2 
replication, it seems that it is linked to the interaction with 
AAV2 Rep78, in an AAV2-ss DNA dependent manner 
[58,59,62]. 
 The minimal set of HSV-1 helper proteins (UL5, UL8, 
UL29, UL52) together with two other HSV-1 proteins, the 
viral DNA polymerase (UL30) and the ds DNA binding 
protein UL42, along with AAV2 Rep68 have been shown to 
be also sufficient to initiate replication of duplex DNA, 
containing the AAV2 origins of DNA replication, in an in 
vitro replication system [59]. 
CELLULAR PROTEINS ASSOCIATED WITH HSV-1 
OR AD SUPPORTED AAV2 RCs 
 While helper virus proteins involved in AAV2 replication 
are well studied [63], not much is known about the role of 
host proteins recruited to AAV2 RCs. Nevertheless, these 
proteins are likely implicated in several steps of the AAV2 
life cycle including AAV2 DNA replication, gene expression 
and posttranscriptional modification. The recruitment of host 
cell proteins into AAV2 RCs may alter, depending on the 
type of helper virus. However, it is likely that AAV2 might 
also recruit a set of indispensable cellular proteins, 
independent of the type of helper virus. 
 In order to identify host proteins associated with AAV2 
replication, co-immunoprecipitation (co-IP) assays of AAV2 
Rep78 and immunofluorescence analysis in presence or 
absence of a helper virus have been performed (Tables 1 and 
2; [64-73]). However, the majority of proteins were 
identified only by mass spectrometry of Rep78-associated 
complexes [64,68], and many of these interactions remain to 
be validated. Nevertheless, our aim was to analyze these 
cellular proteins concerning similarities and differences. We 
used the string database (http://string-db.org/) to reconstitute 
possible interaction networks between identified cellular 
proteins associated with AAV2 RCs in presence of Ad 
(Table 1, Fig. 1) or HSV-1 (Table 2, Fig. 2). The database 
lists confident known and predicted direct (physical) and 
indirect (functional) interactions between cellular proteins, 
based on experimental validations. 
 Based on the string database, the two main groups of 
cellular proteins of HSV-1 supported AAV2 RCs include 
DNA replication and repair proteins, and RNA splicing 
factors (Fig. 2). Similar to HSV-1 coinfection, a governing 
group of proteins associated with Ad supported AAV2 RCs 
belong to the cellular DNA replication and repair machinery 
(Fig. 1). In addition, a multitude of transcriptional regulators 
as well as RNA splicing factors and a noticeable network of 
mRNA and protein trafficking factors were identified in 
AAV2 and Ad coinfected cells (Fig. 1). Besides these main 
groups, also proteins involved in nuclear organization, 
translation, protein degradation, cytoplasmic signaling, and 
many more were identified in AAV2 Rep78 co-IP assays of 
cells coinfected with AAV2 and either HSV-1 or Ad as the 
helpervirus. In the following, we discuss a selection of these 
proteins in more detail including their potential functions in 
different steps of the AAV2 life cycle. 
PROTEINS INVOLVED IN AAV2 DNA AND RNA 
METABOLISM 
Cellular Proteins Promoting Initial AAV2 Second-Strand 
Synthesis and AAV2 DNA Replication 
 Due to the ss nature of the AAV2 genome, AAV2 
replication initially requires DNA second-strand synthesis 
before viral genes can be expressed and viral DNA 
replication can occur. The formation of ds genomes is a 
critical step for wtAAV2 to initiate productive infection, but 
also for rAAV2 vectors, as this step is of importance for 
successful expression of transgene sequences [74]. Second-
strand synthesis is believed to be mediated through the host 
replication machinery, but helper virus proteins might be 
involved as well [75]. 
 Prior to polymerase-mediated displacement of the 
parental DNA strand, a pre-replication complex is formed, 
which loads the whole DNA replication machinery onto the 
DNA [76]. The MCM proteins 2-7 are essential components 
of this complex [76]. Several of these proteins were found in 
both Ad and HSV-1 supported AAV2 RCs (Tables 1 and 2, 
Fig. 3) and have been also found to be required to replicate 
AAV2 DNA from a ssDNA template in an in vitro 
replication assay [77,78]. Upon initial second-strand 
synthesis MCM might participate in the formation of a 
replication complex on the 3’ end of the incoming ss AAV2 
DNA template. The complementary self-annealing sequence 
of the AAV2 ITR provides a base-paired 3’ hydroxyl group 
for initial unidirectional DNA synthesis [75]. Because AAV2 
provides its own DNA primer, viral DNA replication 
exclusively uses leading-strand DNA synthesis and not 
lagging-strand synthesis. Although both helper viruses, Ad 
and HSV-1, express their own polymerase, AAV2 seems to 
use only the HSV-1 polymerase [57], while the Ad DNA 
polymerase has not been found to be involved in AAV2 
DNA replication [49-51,79]. In contrast to AAV2 
replication, Ad DNA synthesis uses a protein priming 
mechanism in which the viral polymerase (AdPol) 
recognizes and binds to the viral preterminal protein (pTP); 
the pTP-dCMP complex then serves as the primer for 
subsequent elongation catalyzed by AdPol via a strand 
displacement mechanism. Since the AdPol needs to form a 
stable heterodimer with pTP to initiate its DNA replication 
via a protein priming mechanism, and AAV2 replication 
uses a DNA primer to initiate viral DNA replication, it is not 
surprising that the Ad polymerase does not contribute to 
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AAV2 DNA replication. HSV-1 replication is initiated by 
binding of the UL9 protein and unwinding of the HSV-1 ori 
[80]. Subsequently, the viral polymerase catalyzes DNA 
synthesis at the leading-strand and lagging-strand. At the 
eukaryotic replication fork, DNA polymerase delta (POLD) 
together with PCNA is suggested to build the lagging-strand 
replisome, and polymerase epsilon together with PCNA the 
leading-strand replisome [81]. However, PCNA together 
with POLD1 was found associated with AAV2-Rep78 
during coinfection with Ad (Table 1, Fig. 1) and therefore 
might be the essential polymerase for leading-strand 
synthesis of the viral DNA. In addition, chromatin 
immunoprecipitation (ChIP) studies revealed that DNA 
POLD, but not polymerase alpha and epsilon, directly binds 
to UV inactivated AAV2 genomes, independent of the 
presence of a helper virus [82]. Collectively, these findings 
are in line with the observation that upon SV40 infection, 
POLD is also responsible for leading-strand synthesis of the 
viral DNA [83]. Interestingly, PCNA and POLD1 were also  
 
found in HSV-1 supported AAV2 RCs (Table 2, Fig. 2), 
although the HSV-1 polymerase complex has been shown to 
be sufficient to promote productive AAV2 infection [57,58]. 
Second-strand synthesis of the ssAAV2 genome leads to the 
formation of a duplex DNA molecule that is covalently 
closed at one end by the hairpin structure of the ITR initially 
used as a DNA primer. In order to complete replication, in a 
next step called terminal resolution, the remaining hairpin 
has to be resolved and replicated to yield a linear ds DNA 
[75]. For this, the AAV2 Rep protein binds to the RBS motif 
in order to promote cleavage of one strand at the unique 
TRS. The regenerated 3’hydroxyl group within the ITR then 
provides the basis for the replication through the viral ITR 
[75]. In a last step called reinitiation, a double-hairpinned 
intermediate is formed by denaturation and reannealing of 
the linear ITR [75]. This last step initiates a new round of 
strand displacement synthesis, generating a ss AAV2 
genome that can be packaged into a capsid [75]. 
 
 
Fig. (1). Cellular proteins associated with Ad supported AAV2 RCs. The String database (http://string-db.org/) was used to reconstitute the 
interaction networks between identified cellular proteins associated with Ad supported AAV2 RCs and/or the AAV2 Rep78 protein. The 
database lists confident known and predicted direct (physical) and indirect (functional) interactions between cellular proteins based on 
experimental validations. Four functional categories, mRNA processing (blue), DNA replication (red), transcription (yellow), and DNA 
damage sensing and repair (green) are highlighted. 
88    The Open Virology Journal, 2013, Volume 7 Vogel et al. 
 
 
 
 
 
 
Table 1. Proteins Identified in Rep78-Associated Complexes and/or AAV2 RCs During Ad Supported AAV2 Replication 
 
Protein Name 
Gene Name/  
Abbreviation  
Alternative Names/ 
Abbreviations  
UniProt ID  Reference  
ATP-binding cassette subfamily D member 3  ABCD3  (PMP70, PXMP1)  P28288  [64]  
ATP-binding cassette subfamily E member 1  ABCE1  (RLI, RNASEL1, RNS4I)  P61221  [64]  
A-kinase anchor protein 12  AKAP12  (AKAP250)  Q02952  [64]  
ADP-ribosylation factor 1  ARF1   P84077  [64]  
Coatomer ADP-ribosylation factor 4  ARF4  (ARF2)  P18085  [64]  
Serine-protein kinase ATM  ATM  (A-T mutated)  Q13315  [65-66]  
Sodium/potassium-transporting ATPase   ATP1A1   P05023  [64]  
SERCA2A  ATP2A2  (ATP2B)  P16615  [64]  
ATP synthase subunit alpha, mitochondrial  ATP5A1  (ATP5AL2, ATPM )  P25705  [64]  
ATP synthase subunit beta, mitochondrial  ATP5B  (ATPMB, ATPSB)  P06576  [64]  
ATP synthase subunit gamma, mitochondrial  ATP5C1  (ATP5CL1, ATPG)  P36542  [64]  
ELG protein variant (fragment)  C17orf85  (ELG)  Q53F19  [64]  
Calcium-dependent protein kinase type II   CAMK2D   Q4G1A8  [64]  
Calcium-dependent protein kinase type II   CAMK2G   Q8WU40  [64]  
Coatomer subunit   COPA  (HEPCOP)  P53621  [64]  
Aspartyl-tRNA synthetase  DARS  DARS  Q53T60  [64]  
Dolichyl-diphosphooligosaccharide transferase  DDOST  (KIAA0115, OST48)  P39656  [64]  
DEAH (Asp-Glu-Ala-His) box polypeptide 9  DHX9   Q6PJK6  [64]  
DNA methyltransferase 1-associated protein 1  DMAP1  (KIAA1425)  Q9NPF5  [64]  
14-3-3 Dedicator of cytokinesis protein 7  DOCK7   A4FU72  [64]  
Dynein heavy chain, cytosolic  DYNC1H1   Q6P2H7  [64]  
Transcription factor E2F1  E2F1  (RBBP3)  Q01094  [69]  
Elongation factor 1-  EEF1G   Q53YD7  [64]  
Elongation factor 2  EEF2   Q6PK56  [64]  
Eukaryotic initiation factor 4A-I  EIF4A1  (DDX2A, eIF4FA1 )  P60842  [64]  
RNA-binding protein FUS  FUS  (TLS)  P35637  [64]  
Histone H2A.x  H2AFX  (H2AX, H2a/x)  P16104  [65]  
Histone deacetylase 2 variant (fragment)  HDAC2  (HD2)  Q92769  [64]  
HINT4 (histidine triad protein 3)  HINT3   Q9NQE9  [64]  
Histone H1.2  HIST1H1C  (H1F2)  P16403  [64]  
Heterogenous nuclear ribonucleoprotein U  HNRNPU  (hnRNPU, SAFA, U21.1)  Q00839  [64]  
Heat shock cognate 71 kDa protein  HSPA8  (HSC70, HSP73, HSPA10)  P11142  [64]  
Stress-70 protein, mitochondrial  HSPA9  (GRP75, HSPA9B, mt-HSP70)  P38646  [64]  
Interleukin enhancer-binding factor 3  ILF3  (DRBF, MPHOSPH4, NF90)  Q12906  [64]  
Importin-7  IPO7  (RANBP7)  O95373  [64]  
Insulin receptor substrate 4  IRS4  (py160, pp160)  O14654  [64]  
BTB/POZ domain-containing protein KCTD5  KCTD5   Q9NXV2  [73]  
KH-type splicing regulatory protein  KHSRP  (FUBP2)  Q92945  [64]  
Kinesin 1 heavy chain  KIF5B   Q6P164  [64]  
Kinesin light chain 2  KLC2   Q9H0B6  [64]  
BC002942 protein  LMF2  (TMEM112B, TMEM153)  Q9BU23  [64]  
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Abbreviation  
Alternative Names/ 
Abbreviations  
UniProt ID  Reference  
Lysozyme C precursor  LYZ  (LZM)  P61626  [64]  
DNA replication licensing factor MCM3  MCM2  (BM28, CCNL1, CDCL1, KIAA0030)  P49736  [64]  
DNA replication licensing factor MCM5  MCM5  (CDC46)  P33992  [64]  
DNA replication licensing factor MCM6  MCM6  (p105MCM)  Q14566  [64]  
DNA replication licensing factor MCM7  MCM7  (CDC47)  P33993  [64]  
Myosin light polypeptide 6  MYL6  (MYL6, LC17, MLC3)  P60660  [64]  
Nibrin  NBN  (NBS1, P95)  O60934  [66]  
Nucleolin  NCL   P19338  [64]  
Nucleophosmin  NPM1  (Nucleolar phosphoprotein B23)  P06748  [64],[70]  
Nucleoporin 85  NUP85  (NUP75, PCNT1)  Q9BW27  [64]  
Poly-[ADP-ribose] polymerase 1  PARP1  (ADPRT, PPOL)  P09874  [64]  
Proliferating cell nuclear antigen  PCNA   P12004  [64]  
Prohibitin-2  PHB2  (BAP, REA)  Q99623  [64]  
DNA polymerase delta catalytic subunit  POLD1   P28340  [64]  
Protein phosphatase 1 regulatory subunit 26  PPP1R26  (KIAA0649)  Q5T8A7  [64]  
DNA-dependent protein kinase  PRKDC  (HYRC1, DNA-PKcs)  P78527  [64-66]  
U4/U6 small nuclear ribonucleoprotein Prp4  PRPF4   Q6IAP9  [64]  
26S protease regulatory subunit 7  PSMC2   Q75L23  [64]  
Proteasome non-ATPase regulatory subunit 2  PSMD2  (TRAP2)  Q13200  [64]  
DNA repair protein RAD50  RAD50   Q92878  [64]  
GTP-binding nuclear protein RAN  RAN  (ARA24)  P62826  [64]  
E3 SUMO-protein ligase RanBP2  RANBP2  (NUP358)  P49792  [64]  
Reticulocalbin-1 precursor  RCN1   Q15293  [64]  
Telomere-associated protein RIF1  RIF1   Q5UIP0  [64]  
Replication protein A 70 kDa DNA-binding subunit  RPA1  (REPA1, RPA70)  P27694  [64]  
32-kDa replication protein A  RPA2  (REPA2, RPA32, RPA34)  P15927  [64-65]  
60S ribosomal protein L11  RPL11   P62913  [64]  
60S ribosomal protein L13  RPL13  (BBC1)  P26373  [64]  
60S ribosomal protein L23  RPL23  (RPL23 A)  P62829  [64]  
60S ribosomal protein L7  RPL7  (RPL7 A)  P18124  [64]  
RPS4X protein  RPS4X   Q96IR1  [64]  
RPS9 protein  RPS9   A5D904  [64]  
RuvB-like 1  Ruvbl1  (INO80H, NMP238, TIP49, TIP49A)  Q9Y265  [64]  
Splicing factor 3B subunit 4  SF3B4  SAP49  Q15427  [64]  
Mitochondrial 2-oxoglutarate/malate carrier protein  SLC25A11  (SLC20A4, OGCP)  Q02978  [64]  
Phosphate carrier protein, mitochondrial  SLC25A3  (PHC, PTP)  Q00325  [64]  
SLC25A5 protein  SLC25A5  (SLC25A5)  Q6NVC0  [64]  
ADP/ATP translocase 3  SLC25A6  (ANT3)  P12236  [64]  
Structural maintenance of chromosomes protein 1A  SMC1A  (DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1)  Q14683  [65]  
Structural maintenance of chromosome 2  SMC2  (CAPE, SMC2L1)  O95347  [64]  
SNW domain-containing protein 1  SNW1   Q0D2M5  [64]  
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 Besides the MCM complex and the processive complex 
(containing PCNA and DNA polymerase), several other 
proteins are found in the cellular replisome complex 
including Claspin, And1, and RFC [84]. A combination of 
PCNA, POLD1, the helicase complex MCM, and RFC, 
together with AAV2 Rep have been shown to be required 
and sufficient to reconstitute efficient AAV2 DNA 
replication in an in vitro replication system [77,78] and all of 
these proteins were also found in both Ad and HSV-1 
supported AAV2 RCs, except for RFC, which was found in 
AAV2 RCs only in cells coinfected with HSV-1. Rep78 and 
Rep 68 proteins have been shown to have site-specific DNA 
helicase and endonuclease activities required to carry out 
both terminal resolution and reinitiation in an in vitro assay 
[85-87]. Although AAV2 encodes its own helicase provided 
by Rep, the cellular helicase complex MCM seems to play a 
central role in AAV2 replication and may not only be  
 
 
involved in formation of the pre-initiation complex. Nash  
et al. suggested that a complex composed of Rep and MCM 
might bind to the 5 hairpin after reinitiation of the ITR and 
unwind the displaced strand from the template, while POLD-
PCNA extends the 3 primer on the template strand [64]. 
Similar to eukaryotic DNA replication [84], the resulting ss 
DNA loop of the displaced strand may become coated with 
the host ss DNA binding protein RPA (composed of the 
subunits RPA70, RPA32, and RPA14), which is also found 
in both Ad and HSV-1 supported AAV2 RCs (Tables 1 and 
2, Fig. 3). However, the observed phosphorylation in 
infected cells might change the function of RPA32 from 
DNA replication protein towards DNA damage signaling 
protein (discussed in more detail below). Premature 
activation of the DNA replication complex in G1 phase of 
the cell cycle has been shown to be regulated by binding of 
retinoblastoma protein (Rb) or prohibitin to MCM proteins  
 
(Table 1) contd….. 
Protein Name  
Gene Name/  
Abbreviation  
Alternative Names/ 
Abbreviations  
UniProt ID  Reference  
Transcription factor Sp1  SP1  (TSFP1)  P08047  [71]  
Spectrin  chain, brain 2  SPTBN2   A4QPE4  [64]  
Splicing coactivator subunit SRm300  SRRM2   Q05BI2  [64]  
Splicing factor, arginine/serine-rich 1  SRSF1  (ASF, SF2, SF2P33)  Q07955  [64]  
Splicing factor, arginine/serine-rich 2  SRSF2   Q01130  [64]  
Splicing factor, arginine/serine-rich 4  SRSF4  (SRP75)  Q08170  [64]  
Lupus La protein  SSB   P05455  [64]  
Stomatin-like protein 2, mitochondrial  STOML2  (SLP2)  Q9UJZ1  [64]  
RNA polymerase II coactivator p15 (PC4)  SUB1  (PC4, RPO2TC1)  P53999  [64]  
Arginine/serine-rich-splicing factor 14  SUGP2  (KIAA0365, SFRS14)  Q8IX01  [64]  
Transcription elongation factor SPT6  SUPT6H  (KIAA0162, SPT6H)  Q7KZ85  [64]  
p53  TP53  (p53)  P04637  [72]  
Transcription intermediary factor 1-  TRIM24  (RNF82, TIF1, TIF1A)  O15164  [64]  
Elongation factor Tu, mitochondrial  TUFM  (P43, EFTU )  P49411  [64]  
Splicing factor U2AF 35-kDa subunit  U2AF1  (U2AF35, U2AFBP)  Q01081  [64]  
Ubiquitin-activating enzyme E1  UBA1  (A1S9T, UBE1)  P22314  [64]  
Ubiquitin-protein ligase EDD1  UBR5  (EDD, EDD1, HYD, KIAA0896)  O95071  [64]  
U3 snRNA-associated protein 14 A  UTP14A  (SDCCAG16)  Q9BVJ6  [64]  
Voltage-dependent anion channel protein 2  VDAC2  (VDAC2)  P45880  [64]  
Wolframin  WFS1  (WFS1)  O76024  [64]  
X-ray repair cross-complementing protein 5  XRCC5  (G22P2, CTC85, CTCBF, Ku80, Ku86, TLAA)  P13010  [64-65]  
X-ray repair cross-complementing protein 6  XRCC6  (G22P1, CTC75, CTCBF, TLAA, Ku70)  P12956  [64-65]  
Nuclease sensitive element-binding protein 1  YBX1   Q6PKI6  [64]  
14-3-3 Protein   YWHAE   P62258  [64]  
14-3-3 Protein   YWHAQ   P27348  [64]  
14-3-3 Protein /  YWHAZ   P63104  [64]  
Zinc finger CCHC domain-containing protein 3  ZCCHC3   Q3B7J3  [64]  
Bold: Abbreviation used in the text.  
Red: Similar or homologous cellular proteins identified in Rep78-associated complexes in both Ad and HSV-1 supported AAV2 replication. 
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 [88,89]. Dissociation of prohibitin from MCM is suggested 
to be regulated by cell cycle regulated kinases and licenses 
DNA replication in S phase of the cell cycle [89]. Prohibitin 
(both, PHB and PHB2) was found associated with Rep in 
both Ad and HSV-1 supported AAV2 replication (Tables 1 
and 2, Fig. 3; [64,68]). Prohibitin may have an inhibitory 
effect on regulation of AAV2 DNA replication; however, a 
direct impact has not yet been investigated. In addition to its 
role in preventing the activity of replisomes [89], prohibitin 
might also be involved in transcriptional regulation of viral 
genes (see below). Cyclin-dependent kinases (CDKs) and 
germinin are other MCM inhibitors [90]. Binding of both 
proteins results in the displacement of MCM from replicated 
DNA at fork termination in late S-phase and prevents  
re-replication of the cellular genome [90]. In cells coinfected 
with AAV2 and HSV-1, germinin was found recruited to 
AAV2 RCs (Table 2, Fig. 2; R. Vogel unpublished data). It 
is possible that a spatial and/or temporal regulation of the 
activity of the MCM complex by several regulators, 
including prohibitin and germinin, might also play a central 
role in the AAV2 life cycle. Spatial or temporal inhibition of 
AAV2 DNA replication within AAV2 RCs may be 
important to promote vast transcription of AAV2 genes from 
ds replication intermediates. 
 Immunofluorescence analysis revealed a more even 
distribution of MCM in the nucleus of cells coinfected with 
AAV2 and HSV-1 although it was also associated with Rep 
to a certain degree [68]. Similarly, besides significant 
overlap with Ad supported AAV2 RCs, MCM5 and MCM7 
were also detected outside of AAV2 RCs [64]. It is 
suggested that during HSV-1-induced AAV2 DNA 
replication Ku proteins may substitute for MCM function in 
strand displacement activity [68], similar to their partial 
substitution of MCM in an in vitro AAV2 replication assay 
[64]. In addition, the essential HSV-1 helicase primase 
complex (UL5/8/52) is proposed to substitute for helicase 
activity of MCM upon strand displacement [68]. However, 
dislocation of MCM from AAV2 RCs might also be a 
consequence of a complex spatial and/or temporal regulation 
which might influence AAV2 DNA replication in coinfected 
cells. 
The Role of Cellular DNA Damage Sensing and Repair 
Proteins in AAV2 DNA Replication 
 It is likely that the structure of incoming viral DNA as 
well as viral replication intermediates play a central role in 
the recruitment of cellular proteins into viral replication 
compartments. Both incoming Ad and HSV-1 DNA are  
 
 
Fig. (2). Cellular proteins associated with HSV-1 supported AAV2 RCs. The String database (http://string-db.org/) was used to reconstitute 
the interaction networks between identified cellular proteins (as described in Figure 1) associated with HSV-1 supported AAV2 RCs and/or 
the AAV2 Rep78 protein. Four functional categories, mRNA processing (blue), DNA replication (red), transcription (yellow), and DNA 
damage sensing and repair (green) are highlighted. 
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Table 2. Proteins Identified in Rep78-Associated Complexes and/or AAV2 RCs during HSV-1 Supported AAV2 Replication 
 
Protein Name 
Gene Name  
(Abbreviation)  
Alternative Names  UniProt ID  Reference  
Serine-protein kinase ATM  ATM  (A-T mutated)  Q13315  [67]  
Ataxia telangiectasia and Rad3-related protein  ATR  (FRP1)  Q13535  [67]  
ATP-binding cassette sub-family E member 1  ABCE1  (RLI, RNASEL1, RNASELI, RNS4I, OK/SW-cl.40)  P61221  [68]  
Acyl-CoA dehydrogenase family member 9, 
mitochondrial  
ACAD9   Q9H845  [68]  
Annexin A5  ANXA5  (ANX5, ENX2, PP4)  P08758  [68]  
ADP-ribosylation factor-like protein 8B  ARL8B  (ARL10C, GIE1)  Q9NVJ2  [68]  
ATP synthase subunit O, mitochondrial  ATP5O  (ATPO, OSCP)  P48047  [68]  
Serine/threonine-protein kinase Chk2  CHEK2  (CDS1, Chk2, RAD53)  O96017  [67]  
Calcium-binding mitochondrial carrier protein 
Aralar1  
SLC25A12  (CMC1, ARALAR1) O75746  [68]  
Probable ATP-dependent RNA helicase DDX17  DDX17  
(DEAD box protein p72, 17, RNA-dependent helicase 
p72)  
Q92841  [68]  
Elongation factor 1-alpha 1  EEF1A1  (EF1A, LENG7)  P68104  [68]  
Protein flightless-1 homolog  FLII  (FLIL)  Q13045  [68]  
Germinin  GMNN   O75496 
Vogel 
unpublished data 
Histone H2A.x  H2AFX  (H2AX, H2a/x)  P16104  [67]  
Liver histone H1e   (H1E) A3R0T7  [68]  
Histone H4  HIST1H4A  (H4FA)  P62805  [68]  
Heterogeneous nuclear ribonucleoprotein A3  HNRNPA3  (hnRNPA3)  P51991  [68]  
Heterogeneous nuclear ribonucleoprotein A/B  HNRNPAB  (hnRNPAB)  Q53F64  [68]  
Heterogeneous nuclear ribonucleoproteins C1/C2  HNRNPC  (hnRNPC)  P07910  [68]  
Heterogeneous nuclear ribonucleoprotein D0  HNRNPD  (AUF1, hnRNP D)  Q14103  [68]  
Heterogeneous nuclear ribonucleoprotein H  HNRNPH1  (hnRPH1)  P31943  [68]  
Heterogeneous nuclear ribonucleoprotein M  HNRNPM  (hnRPM, NAGR1)  P52272  [68]  
Heat shock cognate 71 kDa protein  HSPA8  (HSC70, HSP73, HSPA10)  P11142  [68]  
Keratin, type I cytoskeletal 13  KRT13   A8K2H9  [68]  
Prelamin-A/C (Lamin-A/C)  LMNA  (LMN1)  P02545  [68]  
Lamin-B1  LMNB1  (LMN2, LMNB)  P20700  [68]  
Lamin-B2  LMNB2  (LMN2)  Q03252  [68]  
LIM domain only protein 7  LMO7  (FBX20,FBXO20, KIAA0858)  Q8WWI1  [68]  
DNA replication licensing factor MCM7  MCM7  (CDC47)  P33993  [68]  
Myosin phosphatase Rho-interacting protein  MPRIP  KIAA0864, MRIP, RHOIP3  Q6WCQ1  [68]  
Double-strand break repair protein MRE11A  MRE11A  (HNGS1, MRE11)  P49959  [68]  
DNA mismatch repair protein Msh2  MSH2  (MSH2)  P43246  [68]  
DNA mismatch repair protein Msh3  MSH3  (DUC1, DUG, MRP1)  P20585  [68]  
DNA mismatch repair protein Msh6  MSH6  (GTBP, p160)  P52701  [68]  
Myosin-10  MYH10   P35580  [68]  
Myosin regulatory light chain 12A  MYL12A  (MLCB, MRLC3, RLC)  P19105  [68]  
Myosin regulatory light chain 12B  MYL12B  (MRLC2, MYLC2B)  O14950  [68]  
Myosin light chain kinase 2, skeletal/cardiac 
muscle  
MYLK2   Q9H1R3  [68]  
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linear ds molecules that seem to elicit an immediate DDR 
after entry into the nucleus [91-95]. The incoming AAV2 
DNA is of ss nature, with a complex secondary structure. 
Therefore, it is not surprising that besides RPA several other 
ssDNA binding proteins including SSBP1, NPM1, RuvBL, 
and hnRNPU (Tables 1 and 2, Figs. 1, 2) were found 
associated with AAV2 RCs (discussed in more detail below). 
In addition, in absence of a helper virus, AAV2 DNA has 
been shown to elicit a DDR mediated by ATR [82], which is 
characteristic of the presence of ss DNA ends [96]. 
 There is rising evidence that besides cellular replication 
factors, also proteins of the DNA sensing and repair 
machinery play central roles in replication of DNA viruses 
[91-95]. Three studies have intensively investigated DDR 
(Table 2) cond…… 
Protein Name 
Gene Name  
(Abbreviation)  
Alternative Names  UniProt ID  Reference  
Nibrin  NBN  (NBS1, P95)  O60934  [67-68]  
Nuclear pore complex protein Nup153  NUP153   P49790  [68]  
Poly [ADP-ribose] polymerase 1  PARP1  (ADPRT, PPOL)  P09874  [68]  
Proliferating cell nuclear antigen  PCNA   P12004  [68]  
Prohibitin  PHB   P35232  [68]  
D-3-phosphoglycerate dehydrogenase  PHGDH  (PGDH3)  O43175  [68]  
DNA polymerase delta catalytic subunit  POLD1   P28340  [68]  
DNA-dependent protein kinase catalytic subunit  PRKDC  (HYRC, HYRC1, DNA-PKcs)  P78527  [67]  
DNA repair protein RAD50  RAD50   Q92878  [68]  
RNA-binding protein 14  RBM14  (SIP)  Q96PK6  [68]  
Replication factor C subunit 2  RFC2  (RFC40)  P35250  [68]  
Replication factor C subunit 3  RFC3   P40938  [68]  
Replication protein A 70 kDa DNA-binding 
subunit  
RPA1  (REPA1, RPA70)  P27694  [68]  
Replication protein A 32 kDa subunit  RPA2  (REPA2, RPA32, RPA34)  P15927  [67-68]  
60S ribosomal protein L11  RPL11   P62913  [68]  
60S ribosomal protein L13  RPL13  (BBC1 OK/SW-cl.46)  P26373  [68]  
40S ribosomal protein S10  RPS10   P46783  [68]  
40S ribosomal protein S18  RPS18   P62269  [68]  
RPS4X protein  RPS4X   P62701  [68]  
RuvB-like 2  Ruvbl2  (INO80J, TIP48, TIP49B, CGI-46)  Q9Y230  [68]  
Splicing factor, proline- and glutamine-rich  SFPQ  (hPOMp100, SFP)  P23246  [68]  
ADP/ATP translocase 3  SLC25A6  (ANT3, CDABP0051, ADT3)  P12236  [68]  
Structural maintenance of chromosomes protein 
1A  
SMC1A  (DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1)  Q14683  [68]  
Spectrin alpha chain, non-erythrocytic 1  SPTAN1  (NEAS, SPTA2)  Q13813  [68]  
Spectrin beta chain, non-erythrocytic 1  SPTBN1  (SPTB2)  Q01082  [68]  
Single-stranded DNA-binding protein, 
mitochondrial  
SSBP1  (PWP1-interacting protein 17, Mt-SSB)  Q04837  [68]  
p53  TP53  (p53)  P04637  [67]  
Tropomodulin-3  TMOD3   Q9NYL9  [68]  
Class IVb beta tubulin    Q8IWP6  [68]  
Elongation factor Tu, mitochondrial  TUFM  (EF-Tu, P43)  P49411  [68]  
Vimentin  VIM   P08670  [68]  
X-ray repair cross-complementing protein 5  XRCC5  (G22P2, CTC85, CTCBF, Ku80, Ku86, TLAA)  P13010  [67-68]  
X-ray repair cross-complementing protein 6  XRCC6  (G22P1, CTC75, CTCBF, TLAA, Ku70)  P12956  [67-68]  
Bold: Abbreviation used in the text.  
Red: Similar or homologous cellular proteins identified in Rep78-associated complexes in both Ad and HSV-1 supported AAV2 replication. 
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factors of Ad or HSV-1 supported AAV2 RCs [65-67].  
The main kinase, required for activation of a robust  
DNA-damage response in AAV2 and Ad coinfected cells has 
been shown to be DNA-PK [65,66]. In cells coinfected with 
AAV2 and HSV-1, both ATM and DNA-PK seem to 
mediate signaling to downstream targets including p53 and 
Chk2, while signaling to RPA32 appears to be mediated by 
DNA-PK alone [67]. The DNA-PK complex colocalized 
with both HSV-1 and Ad supported AAV2 RCs [65,67], 
however, late upon coinfection with HSV-1, DNA-PKcs was 
degraded [67]. This might be the reason why DNA-PK was 
not found associated with AAV2 Rep protein in co-IP 
experiments [68]. Not only the AAV2 genome structure with 
its cis-acting replication element CARE, the ITRs, and the 
single-stranded nature, but also the AAV2 Rep proteins have 
been shown to evoke a cellular DDR and a cell cycle arrest 
in S phase [97,98]. The interference of AAV2 with the 
cellular DDR and repair machinery may not only allow 
control of cell cycle progression, but also promote second-
strand synthesis of the AAV2 genome [74,99]. Cells exposed 
to a variety of genotoxic agents (e.g. HU or IR) have been 
shown to support significant helper-independent AAV2 rep 
expression and even DNA replication, although at very low 
levels [100-103]. 
 Proteins of the DDR and repair machinery also influence 
rAAV2 vector fate [104-112]. It is suggested that the T-
shaped hairpin structure within the AAV ITR and/or ss 
DNA-ds DNA junctions in the stem of the hairpin, may 
recruit DNA repair factors of the homologous recombination 
machinery [113]. While some proteins promote the 
formation of stable ds rAAV2 genomes, others decrease 
rAAV2 vector transduction efficiency [104-112]. In addition, 
genotoxic treatment has been shown to affect also integration 
rates or rAAV2 genomes; although these events occur at 
very low frequencies due to the absence of AAV2 rep 
expression [114,115]. 
 
Fig. (3). Cellular proteins and homologous proteins found in both Ad and HSV-1 supported AAV2 RCs. The String database (http://string-
db.org/) was used to reconstitute the interaction networks between identified cellular proteins or homologous proteins (as described in Fig. 1) 
which were found associated with both Ad and HSV-1 supported AAV2 RCs and/or the AAV2 Rep78 protein. Three functional categories, 
DNA replication (red), transcription (yellow), and DNA damage sensing and repair (green) are highlighted. 
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 Not only in absence of a helper virus, but also upon 
helper virus supported AAV2 replication, the accumulation 
of AAV2 replication intermediates harboring a covalently 
closed hairpin and a free DNA end is very likely to further 
activate and attract cellular components of the DDR 
signaling and repair machinery. Therefore, it is conceivably 
that the composition of cellular proteins in AAV2 RCs may 
change, depending on the prevalent structure of the AAV2 
DNA during infection and replication. 
The Role of the MRN Complex (and its Components) in 
AAV2 DNA Replication 
 Proteins of the MRN complex (composed of MRE11, 
NBS1, and RAD50) are among the first to appear at the site 
of DNA lesion [116]. MRN mediates downstream signaling 
to key proteins involved in sensing, signaling, and effector 
responses to DNA ds breaks [116]. In absence of a helper 
virus, the MRN complex has been shown to be recruited also 
to incoming AAV2 DNA [82,104,107]. The consequence of 
this recruitment on recombinant AAV2 transduction is still 
under debate. 
 An inhibitory effect of the MRN complex on 
transduction efficiency of recombinant AAV2 vectors due to 
binding of the MRN complex to AAV-ITRs has previously 
been reported [1,104,106,107,117]. However, upon infection 
with self-complementary recombinant AAV2 (scAAV) 
vectors, the MRE11 and NBS1 proteins of the MRN 
complex have been shown to be required for the formation of 
double-stranded circular episomes, the predominant form of 
AAV2 persisting in human tissue [107]. The MRN complex, 
although with opposite determination, is also a critical 
element for both helper viruses HSV-1 and Ad [118-125]. 
The interaction with MRN is one example how Ad and 
HSV-1 adopt very different ways to interfere with the host 
DDR. The disruption of the NHEJ machinery by 
E1b55K/E4orf6 mediated degradation of the MRN complex 
is absolutely required to prevent Ad genome 
concatemerization, which would prohibit viral genome 
packaging into virions [119,126,127]. In addition, Ad 
interference with these central elements of the DDR and 
repair system also prevents apoptosis during infection 
[118,119,128]. In contrast, the MRN complex is required for 
full activation of the ATM-mediated DDR pathway, which is 
suggested to support recombination dependent HSV-1 
replication and the formation and stabilization of HSV-1 
DNA concatemers and complex branched replication 
products [124,125]. Interestingly, in Ad supported AAV2 
replication, the function of MRN for AAV2 replication 
seems to be linked to its effect on the helper virus. Ad 
mediated inhibition of the MRN complex has been shown to 
support AAV2 replication [117], and only the RAD50 and 
the NBS1 proteins of the MRN complex were detected in Ad 
supported AAV2 RCs (Table 1, Fig. 1). In contrast, all 
components of the MRN complex (NBS1, MRE11, and 
RAD50) where found recruited to HSV-1 supported AAV2 
RCs (Table 2, Fig. 2; [67,68]) and so far, there is no 
indication of an inhibitory effect of the MRN complex on 
HSV-1 supported AAV2 replication. It is suggested that the 
utilization of the HSV-1 polymerase for AAV2 replication 
may bypass the inhibitory effects of MRN on second-strand 
synthesis and replication of AAV2 DNA under these helper 
virus conditions [117]. It remains to be investigated whether 
the MRN complex may even enhance HSV-1 supported 
AAV2 replication, as it enhances HSV-1 replication 
[124,125]. 
 Independent of its function in the MRN complex, 
phosphorylated NBS1 is involved in the activation of the S-
phase checkpoint [129]. In cells coinfected with AAV2 and 
HSV-1, abundant NBS1 was localized to AAV2 RCs [67], 
and it may be involved in the induction of a cell cycle arrest 
in these cells. Although NBS1 levels decrease with the onset 
of infection [66], a potential role in S-phase checkpoint 
activation remains to be determined in cells coinfected with 
AAV2 and Ad as the helpervirus. 
 In contrast to cells coinfected with AAV2 and Ad, but in 
line with the observed inhibitory effect of the MRN complex 
on rAAV2 vector transduction, cells deficient in the MRN 
target ATM, exhibit increased rAAV2 transduction 
efficiency [1]. It is suggested that ATM inhibits single-to 
double-strand conversion of rAAV2 vectors [1]. 
The Role of DDR Signaling via ATM and DNA-PK in 
AAV2 DNA Replication 
 Although the MRN complex is not functional in cells 
coinfected with AAV2 and Ad, ATM and DNA-PK, two 
main kinases in DDR [130] mediate downstream signaling to 
SMC1, Chk1, Chk2, H2AX, XRCC4, and RPA [65,66]. 
While H2AX, ATM and SMC1 were found in a pan-nuclear 
pattern, DNA-PK (DNA-PKcs, Ku70, and Ku86) and 
RPA32 accumulate within Ad supported AAV2 RCs (Table 
1, Fig. 1; [65,66]). ATM, DNA-PKcs, Chk2, RPA32 and 
H2AX are phosphorylated and all but H2AX are recruited to 
HSV-1 supported AAV2 RCs (Table 2, Fig. 2; [67,68]). 
Since all proteins of the MRN complex are also associated 
with HSV-1 supported AAV2 RCs, it is not clear whether 
activation of ATM and DNA-PK signaling in these cells 
requires a functional MRN complex or not. Although the 
significance of DNA-PK in the AAV2 lytic cycle remains 
unclear, the activation of the ATM pathway appears to be 
beneficial for Ad supported AAV2 genome replication [66]. 
ATM signaling in cells coinfected with AAV2 and Ad may 
affect SMC1 and SMC2, two central components of 
condensin and cohesion complexes [131], which were found 
to be associated with Rep proteins in HSV-1 and Ad 
supported AAV2 replication (Tables 1 and 2, Fig. 3). Both 
proteins possess DNA ATPase activity and are required for 
the correct segregation of replicated chromosomes and many 
other events linked to chromatin dynamics and regulation of 
gene expression [131]. In addition, the cohesin complex 
works as a downstream effector in the ATM mediated DDR 
to control the S-phase checkpoint [132]. It is possible that 
these factors have also multiple functions in the AAV2 life 
cycle including checkpoint activation and viral gene 
expression. 
 Both ATM and DNA-PK are phosphatidylinositol  
3-kinase-related kinases which possess serine/threonine 
kinase function [133]. 14-3-3 proteins (YWHA) bind to 
ATM and DNA-PK targets containing phospho-serine or 
phospho-threonine groups and regulate the function of these 
proteins implicated for example in cell cycle progression or 
apoptosis [134]. 14-3-3 proteins , , and / were found 
associated with Rep proteins in cells coinfected with AAV2 
and Ad (Table 1, Fig. 1). Although interaction of viral 
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proteins with 14-3-3 proteins has been described for different  
viruses [135,136], it has not yet been described for HSV-1 or 
Ad. It is possible that the interaction of AAV2 Rep with 14-
3-3 proteins in cells coinfected with Ad is part of the AAV2 
mediated hijacking of cellular factors and might influence 
cell cycle regulation and/or apoptosis in coinfected cells. 
The Multifunctional RPA Protein and AAV2 Replication 
 An important downstream target of the DDR is the 
cellular ss DNA binding protein RPA [137]. Besides its role 
in DNA replication, RPA is essential also for DNA 
recombination and repair processes [138]. In this case, the N-
terminus of the 32-kDa subunit of human RPA becomes 
hyperphosphorylated by kinases of the cellular DDR (e.g. 
DNA-PK; [138]), which is suggested to cause a change in 
RPA conformation that down-regulates activity in DNA 
replication but does not affect DNA repair processes [138]. 
RPA was found in both, Ad and HSV-1 supported AAV2 
RCs (Tables 1 and 2, Fig. 3) and DNA-PK-dependent 
phosphorylation of RPA32 has been observed also during 
both Ad and HSV-1 supported AAV2 replication [65-67]. It 
is not clear if non-phosphorylated and phosphorylated RPA 
coexist in AAV2 RCs. But it is possible that temporal 
phosphorylation of RPA may occur upon AAV2 replication 
which might influence its function. It is tempting to 
speculate that in contrast to non-phosphorylated RPA, 
phosphorylated RPA can participate in DDR signaling upon 
AAV2 replication and not directly promote the process of 
AAV2 strand displacement replication in vivo [77]. A similar 
phenomenon has been observed in cells infected with SV40 
[139]. Although RPA maintained SV40 DNA replication in 
vitro, it has not been found to be involved in replication of 
SV40 DNA in vivo; more precisely, RPA is phosphorylated 
in vivo and therefore not able to localize to SV40 RCs [139]. 
Non-Homologous End Joining (NHEJ) and Homologous 
Recombination (HR) 
 While components of the non-homologous end joining 
(NHEJ) machinery have been shown to have both inhibitory 
(e.g. Ku70; [140]) and supportive (e.g. DNA 
ligaseIV/XRCC4; [141]) effects on HSV-1 replication, 
NHEJ proteins are not beneficial for Ad infection in general 
[118,119,126-128]. The impact of NHEJ proteins on AAV2 
replication is less well understood. Besides the MRN 
complex and LigaseIV/XRCC4, the central element in NHEJ 
is the DNA-PK complex [130]. In both, Ad and HSV-1 
supported AAV2 replication, DNA-PK was activated and 
recruited into AAV2 RCs (Tables 1 and 2, Fig. 3 [65,67]). In 
addition, signaling to XRCC4 was observed when Ad was 
the helpervirus [65]. It is suggested that DNA-PK induces 
the phosphorylation of histone 1 (H1) at DNA ds breaks in 
order to reduce its affinity for DNA and thereby support 
access of DNA ligaseIV/XRCC4 to broken DNA ends [142]. 
Histone 1 (H1F2 or H1E) was also detected associated with 
both Ad and HSV-1 supported AAV2 RCs (Tables 1 and 2, 
Fig. 3) and may therefore be involved in regulating the 
access of DNA repair factors to AAV2 DNA. However, 
another report showed that not the catalytic subunit (cs) of 
DNA-PK, but Ku70 and Ku80 are required to recruit 
ligaseIV/XRCC4 to sites of ds breaks and promote end-
joining events [143]. It has been shown that Ku proteins 
directly interact with the AAV2 ITR hairpins [111]. 
Therefore, both Ku binding to AAV2 DNA [111] as well as 
the association of DNA-PKcs with Rep78 [64,144] may 
recruit the DNA-PK complex to AAV2 RCs. However, the 
role of DNA-PK and other factors of the NHEJ machinery in 
AAV2 replication is still under debate. In one report, rAAV2 
replication in the presence of HSV-1 or Ad helper functions 
has been shown to be decreased in absence of DNA-PK 
[111] while another report showed enhanced wtAAV2 
genome replication in absence of DNA-PK activity when Ad 
was used as the helper virus [66]. In the latter case, it has 
been suggested that loss of DNA-PK could lead to reduced 
circularization of the AAV2 genome which might promote 
AAV2 DNA replication events [66]. Indeed, DNA-PK has 
been shown to support the formation of stable ds rAAV2 
vector genomes including circular monomers and 
concatemers [108,112]. Besides DNA-PKcs, the following 
repair proteins have been shown to also support rAAV2 
recombination events: the MRN complex, ATM, Artemis, 
BLM, and WRN [105-110,112]. There is evidence that the 
hairpins at AAV-ITRs are targeted by the cellular DNA 
repair machinery, including DNA-PK [111] and Artemis 
[109] similar to DNA hairpin structures in mammalian cells 
emerging during the V(D)J recombination or NHEJ [145]; 
this may support viral genome recombination [109], self-
circularization [108,112], concatemerization [146], and 
genomic integration [3] of the rAAV2 genomes. The impact 
of these proteins on helper virus supported AAV2 replication 
is not clear. Artemis and ATM are involved in both HR and 
NHEJ events, depending on the cell-cycle phase [147]. 
While ATM was found associated with both Ad and HSV-1 
supported AAV2 replication (see above, Tables 1 and 2,  
Fig. 3), Artemis as well as BLM and WRN, two proteins of 
the RecQ helicases complex involved in HR events and 
stabilization of replicating DNA [148], were not found 
associated with AAV2 RCs. This is consistent with Ad 
infection, where BLM is degraded [149], but in contrast to 
HSV-1 infection, where BML is recruited into viral RCs 
[140]. 
 Independent of its role in NHEJ events, there is 
preliminary evidence that DNA-PKcs may mediate also 
modification of the large Rep proteins upon AAV2 and Ad 
coinfection [66]. The group of J.P. Trempe showed that 
phosphorylation of the AAV2 Rep proteins alters their 
interactions with the AAV2 ITRs [150]; thus DNA-PK may 
play an essential role in regulating Rep mediated processes 
of viral DNA replication [65,66], including terminal 
resolution. 
The Role of NHEJ in AAV2 Integration Events 
 Although the data is inconsistent, the NHEJ pathway 
seems to influence AAV2 integration events. In cell culture 
experiments, DNA-PKcs has been shown to enhance 
integration of both ss rAAV2 and ds rAAV2 vectors [106]. 
Another report showed that the NHEJ factor ligase IV in 
particular supports integration of incoming ss AAV2 vector 
genomes [151]. Another factor implicated in V(D)J 
recombination events is the high mobility group protein 1 
(HMG1; [152]). Although not identified in presence of Ad 
and HSV-1, this protein has been shown to bind to Rep78 
and enhance RBS binding and nicking activities of Rep as 
well as site-specific integration of the AAV2 genome in 
absence of a helper virus [153]. Although these data suggest 
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a positive influence of NHEJ mechanisms on AAV2 
integration in cell culture, rAAV2 genome integration has 
been shown to be strongly enhanced in DNA-PKcs-deficient 
SCID mice [154]. 
The ATR Pathway 
 The MRN complex and BLM as well as several factors 
of the ATR dependent DDR including ATR, TopBP1, Brca1, 
Rad17, RPA, Chk1, and Rad51 have been found recruited to 
AAV2 DNA in absence of a helper virus [82,104]. The 
group of P. Beard showed that ATR, Chk1, and BML are 
involved in an AAV2 DNA induced cell cycle arrest in G2 
phase, likely by mimicking an aberrant cellular DNA 
replication fork [82]. Besides the MRN complex, RPA, and 
ATR, none of the other proteins (BLM, TopBP1, Brca1, 
Rad17, and Rad51) recruited to AAV2 DNA in absence of a 
helper virus were found associated with helper virus 
supported AAV2 RCs. Moreover, for both helper viruses, 
Ad5 and HSV-1, it has been shown that ATR signaling via 
Chk1 is inhibited in infected cells [67,118,155]. However, 
factors of the ATR pathway might still have an impact on 
viral replication, as it has been shown that ATR, RPA, 
TopBP1, clapsin, and CINP play a beneficial role in HSV-1 
gene expression and virus production even in absence of 
ATR kinase activity [155,156]. The absence and/or 
obstruction of several proteins of the ATR pathway in 
presence of a helper virus implies the extensive influence of 
the helper virus on the cellular environment to promote 
AAV2 replication. 
PARP 
 Another multifunctional cellular repair protein found 
associated with AAV2 RCs in presence of both Ad and 
HSV-1 is poly(ADP-ribose) polymerase-1 (PARP-1). This 
nuclear enzyme mediates poly-ADP-ribosylation 
(PARylation) of cellular proteins involved in several 
different processes including replication, recombination, 
repair, and cell death [157]. The addition of poly-ADP-
ribosyl polymers is implicated in the recruitment of DNA 
damage repair factors to sites of single- and double-strand 
breaks [157]. In addition, PARP supports DNA stability by 
protecting DNA ends from nucleases [157]. A recent report 
showed that upon HSV-1 infection, PARP1/2 is involved in 
increasing total protein PARylation levels [158], which may 
occur in the context of DDR activation by HSV-1 [158]. 
There is one report, showing that the HSV-1 ICP4 protein is 
PARylated upon infection [159]; however, which effect this 
modification as well as the overall upregulation of protein 
PARylation has on HSV-1 infection remains to be 
investigated. Due to its presence in both Ad and HSV-1 
supported AAV2 RCs (Tables 1 and 2, Fig. 3), it is very 
likely that PARP might also affect the function of viral 
proteins and/or cellular repair and replication factors in 
AAV2 RCs. In addition, PARP-1 may also be involved in 
the integration of the AAV2 genome into the host 
chromosome, similar to its role in HIV integration [160]. 
RUVBL1 and RUVBL2 
 The RuvB-like proteins (RUVBL1 and RUVBL2), also 
termed pontin and reptin, are members of the family of 
ATPases and are associated with diverse cellular activities 
including regulation of cell proliferation, apoptosis,  
 
transcription and DNA repair [161]. Both, pontin and reptin 
were found associated with Ad and HSV-1 supported AAV2 
RCs (Tables 1 and 2, Fig. 3). In AAV2 replication, these 
proteins may be exploited to regulate cell cycle progression 
or apoptosis. In addition, similar to the AAV2 Rep proteins 
[75], pontin and reptin both possess ATPase and helicase 
activity [161] which might also support AAV2 DNA 
replication. 
NUP85 and NUP153 
 The roles of nucleoporins in DNA repair are less well 
described. Two nucleoporins were found associated with 
AAV2 RCs, NUP85 and NUP153 (Tables 1 and 2, Fig. 3). In 
yeast, nucleoporins have been shown to be involved in 
sequestration of active sites of DNA repair to the nuclear 
periphery [162,163]. In human cells, there is evidence that 
NUP153 is essential for proper activation of the DNA 
damage checkpoints and that it promotes NHEJ over HR 
events [164]. NUP153 may also be involved in supporting 
NHEJ events in AAV2 infection. In addition, it is tempting 
to speculate that similar to their role in spatial organization 
of DNA repair centers in yeast [162,163], nucleoporins may 
play a role in spatial organization of AAV2 replication 
compartments. 
Mismatch Repair Proteins 
 Another group of DNA repair proteins found in HSV-1 
supported AAV2 RCs belong to the family of mismatch 
repair (MMR) factors. In general, MMR factors are required 
to maintain DNA integrity [165]. These proteins are highly 
conserved from prokaryotes to humans and are involved in 
the recognition of DNA loop or base-base mismatches, 
resulting from insertion/deletion or DNA polymerase 
proofreading errors, respectively [165]. Two mismatch repair 
complexes composed of MSH2 and 3 (MutS), and MSH2 
and 6 (MutS) are involved in the recognition of DNA 
mismatches. MMR factors are also involved in DDR 
signaling and the control of HR [165]. Similar to HSV-1 
infected cells, where MSH2 and 6 have been found 
associated with the HSV-1 ICP8 protein [140], AAV2 Rep 
was found associated with MSH2, MSH3, and MSH6 (Table 
2, Fig. 2; [68]) and the localization of these proteins to HSV-
1 supported AAV2 RCs was confirmed by 
immunofluorescence experiments [68]. It is possible that 
MSH proteins localize only to HSV-1 but not to Ad 
supported AAV2 RCs because they bind to the HSV-1 ICP8 
protein, which has been shown to both interact with MSH 
proteins [140] and localize to AAV2 RCs in coinfected cells 
[68]. Upon HSV-1 infection, MMR proteins have been 
shown to be not only recruited to viral RCs, but also to be 
required for efficient HSV-1 replication [156]. It is 
suggested that besides their proofreading role in viral DNA 
replication, MMR proteins may play a role in IE gene 
expression prior to HSV-1 DNA replication [156]. The 
expression of HSV-1 IE genes is necessary to promote 
efficient AAV2 replication. In contrast, proteins of the 
cellular mismatch repair machinery have not been found 
associated with Ad RCs and do not seem to be involved in 
efficient virus replication, which may also explain their 
absence in AAV2 and Ad coinfection. The precise function 
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of MMR proteins for HSV-1 supported AAV2 replication 
remains to be elucidated. 
B23/Nucleophosmin 
 In addition to cellular proteins directly involved in DNA- 
RNA- or protein-metabolism, some unexpected cellular 
factors were found associated with AAV2 Rep proteins. For 
instance B23/nucleophosmin (NPM; Table 1, Fig. 1; 
[64,70]), which is a multifunctional protein involved in 
duplication of centrosomes [166,167] and protein shuttling 
[168]. Although it is unclear which of the several functions 
of NPM may be involved in AAV2 amplification, it has been 
shown that nucleophosmin participates in Rep-mediated 
nicking at the AAV2 TRS [70]. Moreover, it is suggested 
that nucleophosmin has a role also in virion assembly via 
formation of Rep-Cap-NPM complexes [70]. 
Transcriptional Regulation 
 The AAV2 transcripts are generated from three different 
promoters (p5, p19, and p40) and all pre-mRNAs are 
generated by the cellular RNA polymerase II complex. 
Although none of the subunits of the TATA-box dependent 
transcription initiation complex (formed by TFII, TBP, and 
Pol II) were identified associated with AAV2 RCs in 
presence of a helper virus, at least TAF1 (a subunit of TFII; 
[144]) and TBP [169] were found associated with AAV2 
Rep in absence of a helper virus. It is possible that these 
cellular initiation complex factors are also involved in the 
initiation of AAV2 transcription, similar to their role in 
HSV-1 [170] and Ad [171] infection. In addition, it has been 
shown that the TATA box in cis and the TBP in trans are 
involved in Rep-dependent replication from the minimal 
replication origin present within the AAV2 p5 promoter 
region [172]. 
 Transcriptional activity is not only dependent on the 
formation of the initiation complex, but is tightly regulated 
by transcription factors and coactivators [173]. Several 
transcriptional regulator proteins including Sp1, E2F, p53, 
and PHB2 as well as transcriptional coactivators including 
SUB1 and FLII were found in Ad and HSV-1 supported 
AAV2 RCs (Tables 1 and 2, Figs. 1, 2; [64,72,100,169, 
174]). It is worth mentioning that many more proteins 
involved in transcription (string data base) were found in Ad 
supported AAV2 RCs (E2F, PHB2, RuvBL1, SSB, SNW1, 
Sp1, SuB1, SUPT6H, p53, TRIM24, HDAC2, DMAP1, 
DHX9, YBX1; Table 1, Fig. 1) compared to HSV-1 
supported AAV2 RCs (PHB, RuvBL2, FLII, hnRNPD, 
germinin, p53; Table 2, Fig. 2). The proteins found in Ad 
coinfection cover diverse steps of cellular transcription 
including regulation (E2F or PHB2, string data base), 
elongation (SUPT6H, string data base), and termination 
(SSB, string data base), while transcription proteins found in 
presence of HSV-1 coinfection are mainly regulators of 
initiation (string data base). Interestingly, in absence of a 
helper virus, several more cellular transcriptional regulators 
were found associated with AAV2 Rep including JUN, 
HMG1, and topors [153,175,176]. It is possible that certain 
helper virus proteins can substitute for cellular proteins 
involved in regulation, elongation, and termination of AAV2 
transcripts in coinfected cells. For example the HSV-1 ICP4 
protein, which is involved in several steps of HSV-1 
transcription, including elongation [177], might also be 
involved in elongation of AAV2 transcripts. For other helper 
virus proteins, namely the Ad E1A and DBP [52,56,178] as 
well as the HSV-1 ICP0 protein [57], a positive impact on 
rep gene expression has been shown previously. 
Histones and Histone-Modulating Proteins 
 As mentioned above, prohibitin is another cellular 
protein that is recruited into both Ad and HSV-1 supported 
AAV2 RCs (Tables 1 and 2, Fig. 3). Prohibitin is a potential 
tumor suppressor protein [179]. Similar to Rb, prohibitin 
mediates suppression of the E2F transcription factor [179]. 
Prohibitin is recruited into SV40 RCs and represses 
transcription from SV40 promoters together with histone-
deacetylase and N-CoR [180]. Deacetylation of histones 
leads to a tight binding of histones to the DNA [181] and 
therefore transcriptional repression. 
 Upon HSV-1 infection, HDAC2 in a complex with 
CoREST, LSD1 and REST is involved in the temporal 
regulation of HSV-1 gene expression by repression of 
premature transcription of E and L genes [182]. Also upon 
Ad infection, histone-deacetylase has been shown to interact 
with E1A in order to regulate temporal expression of the Ad 
genes [183]. Although not found during AAV2 and HSV-1 
coinfection, HDAC2 was found associated with Ad 
supported AAV2 RCs (Table 1; Fig. 1). As already 
mentioned, E1A has been shown to be required directly for 
the activation of the AAV2 p5 promoter [56]. Therefore, it is 
possible that Ad E1A together with prohibitin and histone-
deacetylase regulates temporal expression of AAV2 genes 
via modification of histones associated with viral DNA. 
 Indeed several histone proteins were found in both Ad 
and HSV-1 supported AAV2 RCs (Tables 1 and 2, Fig. 3). 
This is in line with a report showing that within hours of 
infection ds AAV2 DNA is associated with nucleosome-like 
structures, independent of the presence or absence of a 
helper virus [184]. ds AAV2 DNA associated with 
nucleosomes may be created either by reassociation of 
incoming parental ss DNA or by integration into the cellular 
genome [184]. Similar results have been observed also for 
autonomous parvoviruses, such as minute virus of mice 
(MVM; [185]). Histones have also been found to associate 
with rAAV genomes and induce gene silencing, but 
expression can be rescued by treatment of the cells with 
HDAC inhibitor [186]. 
POSTTRANSCRIPTIONAL MODIFICATION 
Polyadenylation Capping, and Cap Recognition 
 In cells pre-mRNA cap formation and polyadenylation 
are coupled to transcription [187]. Similar to the host RNAs, 
viral RNAs need to be equipped with 5’ Methyl-Gppp caps 
and 3’ poly-adenylated tails or proteins that substitute for 
these functions, in order to allow nuclear export, translation, 
and stability of mRNA. All AAV2 transcripts contain a 
polyadenylation site. Similar to its helper viruses Ad and 
HSV-1, AAV2 polyadenylation and capping may be 
performed by host enzymes. Nevertheless, none of the 6 
cellular proteins necessary for mRNA polyadenylation 
(cleavage and polyadenylation specificity factor (CPSF), 
cleavage stimulation factor (CstF), cleavage factors Im and 
IIm, poly(A) polymerase, and poly(A)-binding protein II 
(PABP [188]), have been identified as associated with 
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AAV2 RCs. However, upon HSV-1 infection it has been 
shown that hnRNPL, a component of the hnRNP complex 
[189], functions as an adaptor protein to recruit proteins 
necessary for viral mRNA polyadenylation and 
nucleocytoplasmic export [190]. Several proteins of the 
hnRNP complex were indeed found associated with AAV2 
RCs when HSV-1 (hnRNPA3, AB, C, D, H1 and M) or Ad 
(hnRNP U) was the helper virus (Tables 1 and 2, Figs. 1, 2). 
These components of the hnRNP complex are involved in 
several functions including polyadenylation, splicing (see 
below), and localization of mRNAs [189]. Similar to their 
role in HSV-1 infection, hnRNPs proteins may be involved 
in polyadenylation and nucleocytoplasmic export of AAV2 
mRNAs [190]. In particular hnRNPH, which has been shown 
to be directly involved in the polyadenylation of cellular 
mRNAs [189], may support polyadenylation of AAV2 
mRNAs in presence of HSV-1. 
 The eukaryotic initiation factor eIF4F recognizes 5 caps 
of mRNAs and mediates initiation of translation via 
recruitment of ribosomes to mRNA [191]. The different 
functions that can be contributed to its subunits include 
recognition of the mRNA 5 cap structure (eIF4E), delivery 
of an RNA helicase to the 5 region (eIF4A), bridging of the 
mRNA and the ribosome (eIF4G), and circularization of the 
mRNA via interaction with PABP [191]. The helicase 
component eIF4A1 was found associated with Ad supported 
AAV2 RCs (Table 1, Fig. 1). 
 Even if not found in cells coinfected with AAV2 and 
HSV-1, eIF4A is also involved in HSV-1 infection, as the 
HSV-1 endoribonuclease vhs binds to eIF4A to promote 
degradation of cellular mRNAs [192,193], while HSV-1 
RNAs are largely spared from vhs-eIF4A mediated 
degradation [194]. Which role aIF4A plays for AAV2 
replication remains to be investigated and might be 
dependent on the type of helper virus. 
 Although not much is known about polyadenylation of 
AAV2 mRNAs, the presence of AAV2 polyadenylation sites 
has been shown to be necessary for Rep supported AAV2 
pre-mRNA splicing in cells coinfected with Ad [195,196]. 
Pre-mRNA Splicing 
 All AAV2 pre-mRNAs contain introns allowing 
alternative RNA processing of the overlapping transcription 
products [195]. Transcription from the p5 and p19 promoters 
generates mRNAs which encode Rep 78 and Rep 52, 
respectively; while spliced mRNAs from these promoters 
encode Rep 68 and Rep 40 [195]. Not only splicing but also 
alternative splicing plays an important role in the generation 
of the two different mRNAs generated from the p40 
promoter, for translation of the AAV2 capsid proteins VP1 
as well as VP2 and VP3 [195]. In addition, the use of two 
different start codons on the 2.3-kb mRNA, gives rise to VP2 
and VP3 [197,198]. As splicing of the nascent AAV2 
transcripts is an essential step in AAV2 replication, it is not 
surprising that one of the main groups of proteins found in 
Ad and HSV-1 supported AAV2 RCs belong to the cellular 
splicing machinery including serine/arginine (SR)-rich 
proteins (SRSFs) and heterogeneous nuclear 
ribonucleoproteins (hnRNPs; [199]). SRSFs are involved in 
recruiting the splicing machinery to pre-mRNAs (also called 
heterogeneous nuclear RNA (hnRNA)), thereby supporting 
splicing together with hnRNA-binding proteins (hnRNPs; 
[199]). However, hnRNPs are also implicated in the 
repression of splicing events by blocking spliceosome 
assembly [199]. Both SRSF and hnRNP binding sites are 
located at exon/intron junctions of pre-RNAs [199]. The 
interplay between SRSF-mediated support and hnRNP-
mediated repression of splicing has been found to influence 
constitutive and alternative splicing events of cellular pre-
mRNAs [199]. It is tempting to speculate that similar to their 
function on cellular pre-mRNAs, SRSFs and/or hnRNPs 
found in AAV2 RCs (Tables 1 and 2, Fig. 1 and 2) regulate 
constitutive splicing of the two Rep pre-mRNAs from the p5 
and p19 promoter [195] as well as alternative splicing of the 
capsid pre-mRNA from the p40 promoter [195]. Besides the 
cellular splicing machinery, the AAV2 Rep78/68 proteins as 
well as helper virus factors are involved in efficient 
processing of nascent AAV2 transcripts [200]. The Ad 
factors E2a, E4, and VA in combination with Rep as well as 
the HSV-1 gene products UL5, UL8, UL52 and UL29 have 
been shown to stimulate splicing of AAV2 RNA [195]. The 
AAV2 Rep proteins and helper virus factors might influence 
the composition and activity of RNA processing factors 
associated with the RNA polymerase II complex upon 
AAV2 gene expression; however, the detailed mechanism of 
Rep and helper virus proteins supported AAV2 mRNA 
splicing is not yet determined. 
 Besides their role in mRNA processing, hnRNPs might 
also be involved in transcriptional regulation, recombination, 
and telomere maintenance [201]. The reported hnRNP 
function in protecting single-stranded telomeric DNA repeats 
from nuclease attacks [201] might also be important for 
maintaining the integrity of ss AAV2 genomes. 
mRNA EXPORT 
 mRNA export is intimately coupled to splicing, via exon 
junction complex mediated escort by the export receptor 
TAP/NXF 1 [202]. However, this factor has not been found 
associated with AAV2 RCs. Besides TAP/NXF 1, 
nucleoporins are other central proteins involved in mRNA 
nuclear export, which were found associated with both Ad 
(Nup85) and HSV-1 (Nup153) supported AAV2 RCs 
(Tables 1 and 2, Fig. 3). Nucleoporins may contribute to the 
export of AAV2 mRNAs in coinfected cells. In addition to 
their function in mRNA export, there is evidence that 
nucleoporins may also play a role in DNA repair (see above). 
Two other proteins, hnRNPA3 and RAN, which were found 
associated with HSV-1 and Ad supported AAV2 RCs, 
respectively, may also be implicated in viral mRNA 
trafficking [203]. 
CYTOPLASMIC PROTEINS 
 Several cytoplasmic and mitochondrial proteins were 
found associated with AAV2 Rep in co-IP experiments in 
both Ad and HSV-1 supported AAV2 replication [64,68]. 
The significance of Rep associated with ribosomal factors 
(RPS and RPL proteins; Tables 1 and 2, Fig. 3) is not clear. 
It is assumed that because of their abundance, ribosomal 
proteins are often found in proteomic screens [64], and 
therefore could likely by a contamination of the purified 
extracts [68]. But associations of Rep with cytoplasmic 
proteins in general is not entirely unexpected, considering 
that Rep68 is detected not only in the nuclear [27,45,85], but 
100    The Open Virology Journal, 2013, Volume 7 Vogel et al. 
also in the cytoplasmic fraction of cells coinfected with 
AAV2 and Ad [85]. In addition, Rep 78/68 proteins have 
been previously shown to interact with another cytoplasmic 
protein, KCTD5, in cells coinfected with AAV2 and Ad 
[73]. KCTD5 has been shown to act as a substrate-specific 
adaptor in multimeric cullin E3 ligase reactions, by 
recruiting proteins for ubiquitination and subsequent 
proteasome-dependent degradation [204]. It is likely that 
although only present in small amounts, AAV2 Rep78/68 
proteins may have also important functions in the regulation 
of cytoplasmic proteins such as KCTD5. 
 Another group of proteins found associated with AAV2 
Rep belong to the cellular myosin network (Tables 1 and 2, 
Fig. 3). For HSV-1, interference with cellular myosin has 
been shown to be implicated in HSV-1 entry processes [205] 
as well as virion egress [206,207]. In addition, alterations in 
the distribution of myosin (and actin) filaments in cells 
infected with HSV-1 have been observed [206-208]. Rep 
association with these factors might influence the 
interference of HSV-1 with the cytoskeleton in coinfected 
cells. 
 Another cytoplasmic protein associated with Rep78 
during both, Ad and HSV-1 supported AAV2 replication is 
ABCE1 (Tables 1 and 2, Fig. 3). In the ATP-binding cassette 
(ABC) multigene family, the ABCE subfamily is involved in 
regulation of protein synthesis [209]. Binding of ABCE1 to 
the eukaryotic initiation factor 2 initiates translation [210]. In 
addition, ABCE1 interferes with the interferon mediated 
cellular response against viruses, via ribonuclease L (RNase 
L) of the 2'-5' oligoadenylate/RNase L (2-5A/RNase L) 
pathway [211]. Several viruses appear to have developed 
strategies to counteract the antiviral activity of the  
2-5A/RNase L pathway including HSV-1 and vaccinia virus 
[212,213]. It is possible that interaction of Rep 78 with 
ABCE1 is implicated in counteracting the 2-5A/RNase L 
activity. On the other hand ABCE1 might support AAV2 
capsid assembly, similar to its role in HIV infection, where 
ABCE1 binds to the HIV-1 Gag and functions as a 
chaperone by promoting ATP-dependent conformational 
changes important for HIV capsid assembly and RNA 
packaging [214]. 
MITOCHONDRIAL PROTEINS 
 As mentioned above, mitochondrial proteins were found 
associated with AAV2 Rep in co-IP experiments including 
ATP5B, ATP5C1, HSPA9, ACAD9, ATP5O, SSBP1, and 
CMC1 (Tables 1 and 2; Figs. 1, 2; [64,68]). It is suggested 
that the interaction of Rep with several mitochondrial 
proteins may be a consequence of AAV2 interference with 
the cells apoptotic pathway [68]. Besides their central role in 
apoptosis, mitochondria are also central elements of the host 
defense against viral infections [215]. Therefore, AAV2 
interference with mitochondrial proteins may also support 
productive viral infection by preventing excessive antiviral 
responses of the host cell. 
CONCLUDING REMARKS 
 Co-IP experiments as well as immunofluorescence 
analysis of cells coinfected with AAV2 and helper virus, 
either Ad or HSV-1, identified numerous cellular proteins 
that interact with Rep78 and/or are recruited into AAV2 
RCs. Clearly additional experiments will be needed to 
confirm these interactions and to investigate the role of most 
of these cellular proteins identified in AAV2 RCs in AAV2 
replication. In this article, we nevertheless suggest potential 
functions in fundamental steps of AAV2 replication. 
 It is conspicuous that irrespective of the type of helper 
virus (Ad or HSV-1), the largest functional categories of 
cellular proteins of AAV2 RCs concern DNA replication and 
repair. In addition several hnRNPs involved in RNA 
metabolism as well as a minor group of cytoplasmic and 
mitochondrial proteins were identified as Rep78 interacting 
partners in presence of either helper virus. By taking a closer 
look at the composition of the functional categories, it is 
apparent that the participation of cellular proteins in AAV2 
DNA and RNA metabolism depends not only on the specific 
replication strategy of AAV2, but also on the available 
helper virus in coinfected cells. Ad and HSV-1 follow very 
different strategies to replicate their genomes. Ad DNA 
replication occurs via a strand displacement mechanism in 
which both strands are synthesized in a continuous fashion 
after protein-primed initiation. In contrast, the basic model 
for HSV-1 replication is a rolling-circle mechanism 
including leading- and lagging-stand synthesis. Due to the 
different modes of replication, it is not surprising that 
proteins involved in AAV2 replication alter depending on 
the type of helper virus. Since AAV2 replication occurs by a 
mechanism distinct from that of both helper viruses, only 
some of the helper virus replication proteins participate in 
AAV2 replication, while others have to be substituted by 
cellular proteins. For example, while Ad supported AAV2 
replication uses central cellular components of the DNA 
replication machinery, such as the MCM complex and 
polymerase delta, HSV-1 supported AAV2 replication uses 
helperviral DNA replication proteins including the HSV-1 
helicase-primase complex (UL5/UL8/UL52) and the HSV-1 
polymerase (UL30; [57-59]). The presence of helper virus 
substitutes of cellular proteins, and vice versa, may allow 
AAV2 to expand the host range. Besides cellular and helper 
virus DNA replication proteins, several factors involved in 
DNA damage sensing and repair seem to be important for 
AAV2 replication. It was shown that cells exposed to 
genotoxic agents (e.g. HU or IR) support efficient helper-
independent AAV2 rep expression and low levels of viral 
DNA replication [100-103]. In addition, for the autonomous 
parvovirus minute virus of mice, the induction of a DNA 
damage response facilitates viral replication [216]. Upon 
coinfection with a helper virus, a defined set of DNA 
damage sensing and repair proteins were found associated 
with AAV2 RCs. Some of these proteins, e.g. MMR 
proteins, were found exclusively in HSV-1 supported AAV2 
RCs. MMR proteins may be implicated in proofreading of 
the viral polymerase and efficient expression of helper virus 
IE genes [155], which in turn would enhance AAV2  
replication. Also, the role of the MRN complex in AAV2 
replication seems to depend on its differential effect on the 
helper virus. Although the effect of many cellular proteins on 
AAV2 replication is indirect and linked to their effect on the 
helper virus, other proteins seem to have a more direct role 
in AAV2 replication. A large number of DNA damage 
sensing and repair proteins were identified associated with 
both Ad and HSV-1 supported AAV2 RCs (e.g. RPA, ATM, 
H2AX, XRCC5/6, and p53). In this context, AAV2 was 
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shown to modulate the interaction of the helper virus with 
the cellular DDR [65-67]. Interestingly, while Ad and HSV-
1 induce and inactivate different pathways of the DDR to 
promote their replication [92,94,95], cellular DDR is more 
similar when coinfected with AAV2. For example, numerous 
proteins involved in NHEJ are recruited into HSV-1 as well 
as Ad supported AAV2 RCs [64-68], while in cells infected 
with Ad alone NHEJ is virtually inactivated. A potential role 
of NHEJ proteins in AAV2 RCs is to maintain integrity of 
the viral genome, by protecting the AAV2 DNA from further 
processing by the AAV2 Rep78 endonuclease activity after 
nicking at the TRS. In addition, NHEJ components seem to 
be involved in circularization of incoming AAV2 genomes 
[108,112], a similar role has been described for retrovirus 
infection [217]. But not only AAV2 modulates the helper 
virus induced DDR. The DDR induced by AAV2 alone is 
completely different from that induced upon coinfection with 
AAV2 and a helper virus. In that sense, the helper viruses 
strongly manipulate the AAV2 induced DDR. For example, 
several proteins of the ATR mediated DDR activated and 
recruited to AAV2 DNA in absence of a helper virus 
[82,104] were not found associated with helper virus 
supported AAV2 RCs. Moreover, in cells coinfected with 
AAV2 and HSV-1, ATR signaling via Chk1 seems to be 
abrogated [67]. 
 When comparing the minimal set of Ad and HSV-1 
helper factors for AAV2 replication, it is conspicuous that 
several of the helper proteins from Ad but none of the helper 
proteins provided by HSV-1 are involved in AAV2 RNA 
metabolism [53,55-59]. Also more cellular proteins involved 
in RNA metabolism were found associated with Ad 
supported AAV2 RCs than with HSV-1 supported AAV2 
RCs. It is possible that other HSV-1 proteins that do not 
belong to the minimal set of helper factors can substitute for 
the cellular RNA metabolism proteins involved AAV2 
replication. 
 As all AAV2 transcripts are spliced [195], it is not 
surprising that several hnRNPs were found associated with 
HSV-1 supported AAV2 RCs. Cellular mRNA splicing 
proteins, including hnRNPs and SRSFs, are even more 
abundant in Ad supported AAV2 RCs. It would be 
interesting to define the precise localization of these proteins 
during AAV2 replication in order to spatially monitor 
transcriptional activity within AAV2 RCs. For some proteins 
of the DDR, such a monitoring within/around AAV2 RCs 
has been performed [65-67] and the data support the idea 
that AAV2 RCs are well-structured and sub-
compartmentalized. In this context, it is suggested that the 
nuclear matrix acts as a scaffold to which different proteins 
are recruited and retained [218]. Further studies are needed 
to determine the importance of such subcompartments for 
AAV2 replication. 
 Besides cellular proteins involved in DNA and RNA 
metabolism, several cytoplasmic and mitochondrial proteins 
were found associated with AAV2 Rep in co-IP experiments 
in both Ad and HSV-1 supported AAV2 replication [64,68]. 
Although the significance of these factors is not known, it 
suggests that additional cellular pathways not directly 
involved in DNA and RNA metabolism are targeted by Rep. 
For example, interaction with cytoplasmic proteins may 
influence AAV2 virion trafficking while interaction with 
mitochondrial proteins may interfere with intrinsic responses 
of the host cell against viral infection [215]. 
 The identification of cellular proteins within helper virus 
supported AAV2 RCs forms the basis for the investigation of 
the functional roles of these proteins in AAV2 infection. The 
identification of cellular inhibitors and enhancers of helper 
virus supported AAV2 replication will contribute to a better 
understanding of the complex mechanisms of interaction 
between AAV2, its helper viruses, and the coinfected cell. 
Moreover, as AAV2 is a widely used vector in biomedical 
applications, the detailed knowledge of the functions of 
cellular proteins in AAV2 gene expression and DNA 
replication may also help to improve vector production and 
transduction efficiency. 
SUMMARY 
 Adeno-associated virus type 2 (AAV2) DNA replication 
takes place in the host cell nucleus in viral replication 
compartments (RCs). These compartments have a defined 
composition of viral and cellular proteins. Co-
immunoprecipitation (co-IP) experiments as well as 
immunofluorescence analysis of cells coinfected with AAV2 
and one of its helper viruses, adenovirus (Ad) or herpes 
simplex virus type 1 (HSV-1), revealed numerous cellular 
proteins that are recruited into AAV2 RCs or interact with 
Rep78. The largest functional categories of cellular proteins 
associated with AAV2 RCs correspond to factors of the 
DNA replication and repair machinery, independent of the 
type of helper virus. In addition, proteins involved in RNA 
metabolism as well as a minor group of cytoplasmic and 
mitochondrial proteins were identified as Rep78 interacting 
partners. Although the majority of cellular proteins 
associated with Ad supported AAV2 RCs was also present in 
HSV-1 supported AAV2 RCs, some proteins were found 
associated with AAV2 RCs only in presence of either Ad or 
HSV-1. The importance of most of the cellular proteins 
identified in AAV2 RCs for AAV2 replication is not known. 
Nevertheless, based on the roles of these proteins in cellular 
processes and in the replication of other viruses, we can 
make some predictions concerning their functions in 
different steps of the AAV2 life cycle. 
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4 Results
4.1 A differential analysis of DNA damage signaling in cells
infected with HSV-1 or coinfected with AAV2 and HSV-1.
Numerous studies revealed that viruses interfere with the cellular DNA damage
sensing and repair machinery (17, 23, 26, 35, 36) and proteins of the DDR pathway
have been shown to significantly influence viral replication (17, 23, 26, 35, 36). I have
performed a detailed analysis of the DDR induced in cells infected with HSV-1 alone
or coinfected with HSV-1 and AAV2, and the results are shown here in the form of a
manuscript that has been published in the Journal of Virology.
My contribution to this publication was as follows: design of the experiments, main
experimental work, including co-immunoprecipitation, Western and
immunofluorescence analyses, confocal microscopy, flow cytometry, and writing of
manuscript. The co-authors contributed to this work by providing reagents, and some
technical and editorial help.
  Published Ahead of Print 19 October 2011. 
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Adeno-Associated Virus Type 2 Modulates the Host DNA Damage
Response Induced by Herpes Simplex Virus 1 during Coinfection
Rebecca Vogel,a Michael Seyffert,a Regina Strasser,a Anna P. de Oliveira,a Christiane Dresch,a Daniel L. Glauser,b Nelly Jolinon,c
Anna Salvetti,c Matthew D. Weitzman,d* Mathias Ackermann,a and Cornel Fraefela
Institute of Virology, University of Zurich, Zurich, Switzerlanda; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdomb;
INSERM U758, Ecole Normale Supérieure de Lyon, Lyon, Francec; and The Salk Institute for Biological Studies, La Jolla, California, USAd
Adeno-associated virus type 2 (AAV2) is a human parvovirus that relies on a helper virus for efficient replication. Herpes sim-
plex virus 1 (HSV-1) supplies helper functions and changes the environment of the cell to promote AAV2 replication. In this
study, we examined the accumulation of cellular replication and repair proteins at viral replication compartments (RCs) and the
influence of replicating AAV2 on HSV-1-induced DNA damage responses (DDR). We observed that the ATM kinase was acti-
vated in cells coinfected with AAV2 and HSV-1. We also found that phosphorylated ATR kinase and its cofactor ATR-interacting
protein were recruited into AAV2 RCs, but ATR signaling was not activated. DNA-PKcs, another main kinase in the DDR, was
degraded during HSV-1 infection in an ICP0-dependent manner, and this degradation was markedly delayed during AAV2 coin-
fection. Furthermore, we detected phosphorylation of DNA-PKcs during AAV2 but not HSV-1 replication. The AAV2-mediated
delay in DNA-PKcs degradation affected signaling through downstream substrates. Overall, our results demonstrate that coin-
fection with HSV-1 and AAV2 provokes a cellular DDRwhich is distinct from that induced by HSV-1 alone.
Adeno-associated virus type 2 (AAV2) is a small, nonenvelopedparvovirus with a single-stranded DNA genome of 4.7 kb
(52). In the absence of a helper virus, AAV2 establishes a latent
infection characterized by site-specific integration of the viral ge-
nome into the AAVS1 site on human chromosome 19 (72). In the
presence of a helper virus, AAV2 can replicate productively in the
host cell nucleus. AAV2DNA replication occurs at discrete sites in
the nucleus, termed replication compartments (RCs). During the
course of infection, several small RCs rapidly expand and fuse to
large structures, which displace the cellular chromatin and fill the
entire cell nucleus (28, 35, 37, 79, 91). AAV2 RCs contain AAV2
proteins, as well as defined helper virus proteins and cellular pro-
teins (3, 35, 63, 65, 75, 79, 90, 91). ReplicatingAAV2has inhibitory
effects on both the host cell (9, 41, 68, 71, 73, 74, 100, 101) and the
helper virus (5, 30, 31, 34, 40, 44, 61, 84, 100).
One of the helper viruses for AAV2 replication is herpes sim-
plex virus 1 (HSV-1) (14). The minimal HSV-1 helper factors for
AAV2 replication from plasmid substrates include the helicase-
primase complex encoded by UL5, UL8, and UL52 and the major
DNA binding protein ICP8 (3) (90). Besides viral helper factors,
the fate of AAV2 replication also depends on cellular proteins.
Recently, cellular proteins have been identified that interact with
AAV2 Rep78/68 in adenovirus (Ad)- or HSV-1-supported AAV2
replication (63, 65). Of these, the largest functional categories corre-
spond to cellular proteins which are involved in DNA metabolism,
including DNA replication, repair, and chromatin modification.
There is accumulating evidence that the DNA damage re-
sponse (DDR) pathways play central roles in viral replication (92).
Control of DDR signaling may be a mechanism to prevent apop-
tosis and/or stop cell cycle progression (92). For example, DNA
damage signaling has been shown to enhance the replication of the
autonomous parvovirus minute virus of mice, perhaps in part by
promoting cell cycle arrest (1). In response to DNA damage, a
complex signaling network is activated that includes kinase regu-
lation, transcriptional induction, and redistribution of a multi-
tude of factors (33, 38). Depending on the extent of DNA damage,
cell cycle progression is stopped to repair DNA breaks or apopto-
sis is induced. Two main pathways are classified for the repair of
DNA double-strand breaks, homologous recombination and
nonhomologous end joining (16, 36, 99). Proteins which are im-
portant for sensing of DNA double-strand breaks include H2AX
and the Mre11/Rad50/Nbs1 (MRN) complex (for a review,
see reference 47). The phosphatidylinositol-3-kinase-like kinases
(PIKKs) ataxia telangiectasiamutated (ATM) and ATM and Rad3
related (ATR) are proximal signaling kinases that have key func-
tions in signaling transduction in homologous recombination
(24, 33, 60, 66, 69). ATM is recruited by the MRN complex (for a
review, see reference 29) and catalytically activated through dimer
dissociation and autophosphorylation at serine 1981 (S1981) (6,
103). Examination of ATR recruitment to sites of DNA damage
revealed that binding of ATR toATR-interacting protein (ATRIP)
leads to colocalization of the ATR-ATRIP complex with replica-
tion protein A (RPA)-coated single-strandedDNA (7). It has been
suggested that interaction of topoisomerase II-binding protein 1
with the ATR-ATRIP complex induces kinase activity of ATR
(59). A third PIKK, DNA-dependent protein kinase (DNA-PK),
belongs to the nonhomologous end-joining machinery and is
composed of the Ku70/Ku80 heterodimer and the catalytic sub-
unit of DNA-PK (DNA-PKcs). Ku70/80 directly recognizes DNA
double-strand breaks and activates DNA-PKcs (for a review, see
reference 15). Activity of DNA-PKcs is proposed to be regulated
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by autophosphorylation at several sites, including S2056 (19, 21).
Investigation of downstream signaling via PIKKs suggests that
checkpoint kinase 1 (Chk1) is mainly a substrate of ATR after the
recognition of single-strand breaks and stalled-replication forks
(22, 32, 53, 80, 83, 105), while Chk2 activation by ATM is more
restricted to double-strand breaks, including those induced by
ionizing radiation (2, 20, 42, 43, 56, 57). However, there is evi-
dence that ATR (85, 87) and DNA-PK (50, 85) can also induce
Chk2 phosphorylation. DNA-PK (49, 86, 88), ATR (46), and
ATM(8) have all been reported to induce phosphorylation of p53.
HSV-1 induces the activation of a cellular DNA double-strand
break response pathway involving the MRN complex, ATM, p53,
RPA (nonphosphorylated), and Rad51 (13, 51, 76, 96), while the
ATR response has been reported to be inhibited (58, 94). Simi-
larly, signaling via DNA-PK is also inhibited by HSV-1 through
ICP0-dependent proteasomal degradation of DNA-PKcs (48, 67).
It has been shown that in the absence of the Ku70 subunit of the
DNA-PK complex, HSV-1 replication is enhanced (81).
AAV2, althoughnot replicating in the absence of a helper virus,
induces a strong DDR mediated by ATR (41). A different DDR is
induced upon coinfection with a helper virus that supports AAV2
replication; for example, during Ad-supported AAV2 replication,
the DDR signaling is mediated primarily by DNA-PK and is inde-
pendent of theMRN complex (25, 75). Furthermore, activation of
ATM, Chk1, Chk2, RPA, and H2AX was also observed (25, 75).
Given that DNA-PK is a key kinase in nonhomologous end join-
ing, it seems that these eventsmay play important roles not only in
the (site-specific) integration of the AAV2 genome (18, 27, 77) but
also in AAV2 genome replication (23). As opposed to Ad and
AAV2 coinfection, the DDR induced by coinfection with HSV-1
and AAV2 has not previously been investigated. Thus, the goals of
the present study were to identify cellular replication and repair
proteins that accumulate at AAV2 RCs when HSV-1 is the helper
virus and to determine the effect of AAV2 on the cellular DDR
signaling pathways induced by HSV-1.
MATERIALS AND METHODS
Cells. DNA-PKcs-positive (expressing one copy of DNA-PKcs) and
DNA-PKcs-negative HCT116 cells were kindly provided by E. Hendrick-
son (University of Minnesota Medical School, Minneapolis) and main-
tained in growthmedium containing Dulbecco’s modified Eagle medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/ml
penicillin G, 100 g/ml streptomycin, and 0.25 g/ml amphotericin B
(1% AB). DNA-PKcs-positive (Fus1) and DNA-PKcs-negative (Fus9)
MO59J cells were kindly provided by T.Melendy (Department of Cellular
and Molecular Biology, Roswell Park Cancer Institute, Buffalo, NY) and
cultured in 50% F10medium–50%DMEM supplemented with 10% FBS,
1% AB, and 250 g/ml G418. AT22 IJE-T yZ5 (expressing ATM) and
AT22 IJE-T pEBS7 (lacking ATM) fibroblast cells were kind gifts from Y.
Shiloh (Department of Molecular Genetics and Biochemistry, Sackler
School ofMedicine, Tel Aviv University, Tel Aviv, Israel). These cells were
maintained in DMEM supplemented with 10% FBS, 1% AB, and 100
g/ml hygromycin B. U2OS GW33 cells were a kind gift from P. Nghiem
(Department of Medicine/Dermatology, University ofWashington, Seat-
tle) and were cultured in DMEM containing 10% FBS, 1%AB, 200g/ml
G418, and 50g/ml hygromycin B. Vero cells weremaintained inDMEM
supplemented with 10% FBS and 1% AB. All cells were maintained at
37°C in a 95% air–5% CO2 atmosphere.
Viruses.HSV-1 strain Fwas kindly provided by B. Roizman (Marjorie
B. Kovler Viral Oncology Laboratories, University of Chicago, Chicago,
IL). rHSV-1 dl1403 (rHSV-1ICP0) was kindly provided by N. D. Stow
(MRCVirologyUnit, University of Glasgow, Glasgow, United Kingdom),
and rHSV-1vEYFP-ICP4 and rHSV-1 vECFP-ICP4 were a kind gift R. D.
Everett (MRC Virology Unit, University of Glasgow, Glasgow, United
Kingdom). Viruses were grown on Vero cells. HSV-1 strain F titers were
determined on Vero cells, and rHSV-1 dl1403 titers were determined on
U2OS cells. AAV2 and Ad2 were kindly provided by H. Buening (Univer-
sity of Cologne, Cologne, Germany) and U. Greber (University of Zurich,
Zurich, Switzerland), respectively. The recombinant AAV2CherryRep
(rAAVCR) genome, containing theAAV2 inverted terminal repeats flank-
ing the rep open reading frames fused at its 5= terminus with the mCherry
coding sequence, has been described previously (3). rAAVCR particles of
AAV serotype 2 were produced by transient transfection of 2935Z with
pDG and pAAVCR and purified on two successive CsCl gradients, and
titers of genome-containing particles were determined by dot blot assay.
rAAV2GFP was kindly provided by M. Linden (King’s College London
School of Medicine, London, United Kingdom).
Antibodies. The following primary antibodies were used: anti-actin
(Santa Cruz Biotechnology SC-10731; dilution for Western blotting
[WB], 1:10,000), anti-ATM (Genetex 70107; dilution for WB, 1:1,000),
anti-ATM-P-S1981 (Rockland Immunochemicals 200-301-400; dilution
for WB, 1:500; dilution for immunofluorescence [IF] assay, 1:50), anti-
ATR (SC-28901; dilution for WB, 1:1,000), anti-ATR-P-S428 (Cell Sig-
naling Technology CST-2853; dilution for WB, 1:500; dilution for IF as-
say, 1:200), anti-ATRIP (Abcam Ab-19531; dilution for WB, 1:2,000;
dilution for IF assay, 1:500), anti-Chk1 (SC-8408; dilution for WB,
1:1,000), anti-Chk1-P-S345 (CST-133D3; dilution forWB, 1:1,000), anti-
Chk2 (SC-5278; dilution for WB, 1:1,000), anti-Chk2-P-T68 (SC-16297;
dilution for WB and immunoprecipitation, 1:250; dilution for IF assay,
1:100), anti-DNA-PKcs (NeoMarkers M5370; dilution for WB, 1:500; di-
lution for IF assay, 1:50; dilution for flow cytometry, 1:250), anti-DNA-
PKcs-P-S2056 (Ab-18192; dilution for WB, 1:2,000; dilution for IF assay,
1:500), anti-HSV-1 ICP8 (Ab-20193; dilution for WB, 1:1,000; dilution
for IF assay, 1:200), anti-H2AX-P-S139 (Millipore 05-636; dilution for
WB, 1:500; dilution for IF assay, 1:50), anti-Nbs1 (Novus Biologicals 100-
143; dilution forWB, 1:1,000), anti-Nbs1-P-S343 (Ab-47272; dilution for
WB, 1:500; dilution for IF assay, 1:100), anti-p53 (Ab-1101; dilution for
WB, 1:1,000), anti-p53-P-S15 (Ab-38497 [purchased in June 2009 and no
longer available]; dilution for WB, 1:500; dilution for IF assay, 1:500),
anti-AAV2 Rep (Fitzgerald Industries 10R-A111A; dilution for WB,
1:200), anti-RPA32 (Bethyl Laboratories BL-A300-244A; dilution forWB,
1:2,000; dilution for IF assay, 1:500), anti-RPA32-P-S4/8 (BL-A300-245A;
dilution forWB, 1:200; dilution for IF assay, 1:200), and anti-USP7 (CST-
3277; dilution for WB, 1:750). The following secondary antibodies were
used: rabbit anti-mouse IgG-horseradish peroxidase (HRP; SigmaA9044;
dilution, 1:10,000), goat anti-rabbit IgG-HRP (Sigma A6154; dilution,
1:10,000), rabbit TrueBlot, goat anti-rabbit IgG (HL)-Alexa Fluor 405
(AF405; Molecular Probes A31556; dilution, 1:500), goat anti-rabbit IgG
(HL)-AF594 (Molecular Probes A11012; dilution, 1:1,000), goat anti-
mouse IgG (HL)-AF594 (Molecular Probes A11005; dilution, 1:1,000),
goat anti-mouse IgG (HL)-fluorescein isothiocyanate (FITC; Southern
Biotechnology 1031-02; dilution, 1:200), goat anti-rabbit IgG (HL)-
FITC (Southern Biotechnology 4050-02; dilution, 1:200), and goat anti-
mouse IgG-Cy5 (Millipore AP181S; dilution, 1:500).
WB analysis. A total of 106 HCT116 cells, 5 106 AT22 IJE-T, or 5
106 MO59J fusion cells were seeded into 6-cm plates. The following day,
the cells were mock infected, infected with either AAV2 (multiplicity of
infection [MOI], 2,000) or HSV-1 (MOI, 1.5), or coinfected with AAV2
(MOI, 2,000) and HSV-1 (MOI, 1.5) in DMEM supplemented with 2%
FBS and 1% AB. Cells treated for 18 h with hydroxyurea (HU; 3 mM)
served as a positive control for activation of DDR proteins. After 3 h, 6 h,
9 h, 12 h, 24 h, or 48 h, cells were trypsinized, washed once with
phosphate-buffered saline (PBS), and resuspended in 200 l EBC-170
lysis buffer (50 mM Tris-HCl, 170 mM NaCl, 0.5% Nonidet P-40, Com-
plete Mini-EDTA-free protease inhibitor [Roche Diagnostics, Rotkreuz,
Switzerland]). After 30min of incubation at 4°C under constant agitation,
the suspension was centrifuged (20 min at 13,200 g) and the superna-
Vogel et al.
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tant was collected, mixed with 2 loading buffer (4% SDS, 10%
-mercaptoethanol, 20% glycerol, 0.005% bromphenol blue, 0.125 M
Tris-HCl, pH 6.8), and boiled for 10 min. Cell lysates were separated,
depending on themolecular weight of the protein of interest, on 8%, 10%,
or 12%SDS-polyacrylamide gels and transferred to Protran nitrocellulose
membranes (Whatman, Bottmingen, Switzerland). For detection of
H2AX, proteins were separated on a 12% SDS-polyacrylamide gel and
transferred to a polyvinylidene difluoride membrane with a pore size of
0.45 m (Amersham Hybond-P; GE Healthcare Bio-Sciences AB, Up-
psala, Sweden). The membranes were blocked with PBS-T (PBS contain-
ing 0.3% Tween 20) supplemented with 5% nonfat dry milk for 1 h at
room temperature (RT). Incubation with antibodies was carried out with
PBS-T supplementedwith 2.5%nonfat drymilk. Primary antibodies were
incubated overnight at 4°C, while secondary antibodies were incubated
for 1 h at RT.Membranes were washed three times with PBS-T for 10min
after each antibody incubation step. HRP-conjugated secondary antibod-
ies were detected with ECL detection reagent (ECL WB blotting systems;
GE Healthcare, Zurich, Switzerland). The membranes were exposed to
chemiluminescence detection films (Roche Diagnostics, Rotkreuz, Swit-
zerland). Detection of anti-actin served as a loading control for the lysate.
Fluorescence-activated cell sorting (FACS) andWB analysis.A total
of 6.6 106 AT22 IJE-T cells were seeded into 10-cm cell culture dishes.
Cells were mock infected, infected with rHSV-1vECFP-ICP4 (MOI, 2 or
4), or coinfected with rHSV-1vECFP-ICP4 (MOI, 2 or 4) and rAAV2CR
(MOI, 4,000). Cells positive for mCherry (rAAV2) or ICP4-ECFP
(HSV-1) were sorted and prepared for WB analysis as described above.
The same number of mock-infected and HU-treated cells (3 mM, 18 h
postinfection [hpi]) was used as a control.
Immunoprecipitation. AT22 IJE-T cells (90,000) were seeded into
6-well plates. The next day, cells were mock infected, infected with either
AAV2 (MOI, 2,000) or HSV-1 (MOI, 1.5), or coinfected with AAV2
(MOI, 2,000) and HSV-1 (MOI, 1.5) in DMEM supplemented with 2%
FBS and 1%AB. After 24 h, cells were trypsinized, washed once with PBS,
and resuspended in 200 l EBC-170 lysis buffer containing the primary
antibody. After incubation for 2 h at 4°C under constant agitation, 30 l
protein A Sepharose CL-4B (GE Healthcare, Zurich, Switzerland) was
added and the mixture was incubated for 2 h at 4°C under constant agi-
tation. Then, Sepharose beads were pelleted and the supernatant was col-
lected as loading and infection controls. The pellet was washed twice with
PBS for 15 min at 4°C under constant agitation, and protein was eluted
using 20 to 40 l of a 4 M urea solution (pH 7.5). After 10 min of incu-
bation at 4°C under constant agitation, beads were pelleted and the super-
natant was collected. Samples were analyzed by WB assay as described
above; however, for detection of immunoprecipitated proteins, the sec-
ondary antibody rabbit IgG TrueBlot (anti-rabbit IgG-HRP; eBioscience,
San Diego, CA) was used, which preferentially detects the nonreduced
form of rabbit IgG over the reduced, SDS-denatured form of IgG.
IF analysis.HCT116 cells (5 104), AT22 IJE-T cells (7,5 104), or
MO59J fusion cells (7,5  104) were seeded onto coverslips (12-mm di-
ameter; Glaswarenfabrik Karl Hecht GmbH & Co. KG, Sondheim, Ger-
many) in 24-well plates. The next day, cells were mock infected, infected
with HSV-1 (MOI, 1.5), or coinfected with rAAV2CR (MOI, 250) and
HSV-1 (MOI, 1.5), rHSV-1dl1403 (MOI, 0.9), or Ad2 (MOI, 12). UV-
exposed cells (10 J/m2) or HU (3 mM)-treated cells served as a positive
control for activation of DDR proteins. After 24 h, cells were washed once
with cold PBS and fixed with 3.7% formaldehyde in PBS for 15min at RT.
The fixation process was stopped by incubation with 0.1 M glycine for 10
min at RT. Cells were washed twice with cold PBS. For permeabilization,
cells were treated for 2 min with precooled (20°C) acetone and washed
three timeswith PBS.Cells were blocked for 30minwith 3%bovine serum
albumin (BSA) in PBS. For staining, cells were incubated with antibodies
diluted in PBS-BSA (3%) in a humidified chamber at RT in the dark.
Coverslips were placed on droplets (40 l) of primary antibody solution.
After incubation for 1 h, cells were washed three times with PBS. DAPI
(4=,6=-diamidino-2-phenylindole) staining was performed together with
the secondary antibody staining. For this, DAPI (0.5 g/ml) and the sec-
ondary antibody were diluted in PBS-BSA (3%). After incubation for 1 h
at RT in the dark, cells were washed three times with PBS and once with
H2O. Coverslips were embedded in Glycergel (DakoCytomation, Carpin-
teria, CA) containing DABCO (26 mg/ml; Fluka, Sigma-Aldrich Chemie
GmbH,Munich, Germany), and cells were observed using a confocal laser
scanning microscope (CLSM; Leica TCS SP2 AOBS; Leica Microsystems,
Wetzlar, Germany). To prevent cross talk between the channels for the
different fluorochromes, all channels were recorded separately and fluo-
rochromes with longer wavelengths were recorded first. Images from the
CLSMwere deconvolved with Huygens Essential 2.6.0p1 software (Scien-
tific Volume Imaging, Hilversum, Netherlands) and processed using
Imaris 5.0.1 (Bitplane AG, Zurich, Switzerland).
Flow cytometry. The day before infection, 106 HCT116 cells were
seeded into 6-cm tissue culture plates. The cells were mock infected; in-
fected with rHSV-1vEYFP-ICP4 (MOI, 1.5); or coinfected with AAV2
(MOI, 250), rAAV2GFP (MOI, 250), and HSV-1 (MOI, 1.5) in DMEM
supplemented with 2% FCS and 1%AB; and incubated for 20 h at 37°C in
a 5% CO2 atmosphere. Cells were trypsinized and washed once with PBS.
For fixation and staining, the BD Cytofix/Cytoperm Plus kit (BD Biosci-
ences) was used according to the manufacturer’s instructions. Flow cy-
tometrywas performedon a FACScalibur (BD).DNA-PKcs contentswere
analyzed in HSV-1-infected cells positive for EYFP-ICP4 (rHSV-1 en-
coded) and in coinfected cells positive for enhanced green fluorescent
protein (EGFP; rAAVencoded). Aminimumof 80,000 eventswere scored
for each sample. The mean fluorescence intensity of cell populations was
determined using FlowJo software (FlowJo version 8.6.3; Stanford Uni-
versity, Stanford, CA).
RESULTS
Activation of primary DNA damage markers Nbs1 and H2AX
upon virus infection. We compared the DDRs of cells infected
withHSV-1 alone or coinfectedwithAAV2. Aswe have previously
observed that at low MOIs, HSV-1-supported AAV2 RCs are not
detectable before approximately 18 hpi, we analyzed the cells for
up to 48 hpi.
The overall levels of Nbs1 were not altered by virus infection
(Fig. 1A). However, Nbs1 was phosphorylated upon infection
with HSV-1 alone or coinfection with AAV2 (Fig. 1B); moreover,
phosphorylated Nbs1-P-S343 colocalized with AAV2 RCs and
with HSV-1 RCs (Fig. 2A). Nbs1 expression was also examined in
AT22 IJE-T and HCT116 cells with similar results (data not
shown). In HCT116 cells, HSV-1 infection- and coinfection-
induced phosphorylation was also indicated by shifted Nbs1
bands (data not shown). In addition,H2AXwas found to be phos-
phorylated (Fig. 1A) and to surround HSV-1-supported AAV2
RCs (Fig. 2B). As previously observed, H2AX also surrounded
HSV-1 RCs (Fig. 2B) (94).
Coinfection with AAV2 and HSV-1 induces the phosphory-
lation of ATM and ATR. Previous studies revealed that ATM-
mediated signaling is induced (51, 76, 96) and that ATR-mediated
signaling is blocked in HSV-1-infected cells (58, 94). To examine
the activity of these two PIKKs in cells coinfected with HSV-1 and
AAV2, we first determined their phosphorylation status by WB
and IF analyses. While total ATM levels were similar in virus-
infected cells and mock-infected cells (Fig. 1A), ATM-dependent
staining with an antibody generated to autophosphorylated ATM
was detected only in cells infected with HSV-1 alone or coinfected
with AAV2 (Fig. 1B) and in these cells it colocalized with HSV-1
andAAV2RCs (Fig. 3A). As this antibody detects other phosphor-
ylated targets of ATM such as 53BP1, this finding only demon-
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strates that the staining requires ATM activity but does not neces-
sarily represent ATM itself.
Total ATR levels were also comparable in virus-infected cells
and mock-infected cells (Fig. 1A), but phosphorylated ATR-P-
S428 was present only in cells infected with either HSV-1 or AAV2
alone or coinfected with both viruses (Fig. 1A), and it colocalized
with approximately 85% of the HSV-1 RCs and approximately
87% of the AAV2 RCs (Fig. 3B). The observed phosphorylation of
ATR in cells infected with HSV-1 alone was surprising, as it ap-
peared to be in contrast to previous studies which did not find
HSV-1-induced activation of ATR (58, 94). We therefore further
investigated the phosphorylation/activation of ATR by (i) testing
the specificity of the ATR-P-S428 antibody (70), (ii) monitoring
ATRIP, a protein that is important for the recruitment of ATR to
sites of DNA damage (89, 106), and (iii) analyzing the phosphor-
ylation status of the ATR target Chk1. The results of these exper-
iments can be summarized as follows. (i) Immunoprecipitation
with an ATR-specific antibody resulted in ATR-P-S428-specific
FIG 1 DNAdamage signaling induced by viral infection. (A to C)WB analysis
of infected cell lysates.MO59J Fus1 cells weremock infected (m), infectedwith
AAV2 alone (MOI, 2,000) or HSV-1 alone (MOI, 1.5), or coinfected with
AAV2 (MOI, 2,000) and HSV-1 (MOI, 1.5) and harvested at the indicated
times postinfection. Total proteins were extracted, separated by SDS-PAGE,
blotted onto nitrocellulose membrane, and analyzed with the antibodies indi-
cated. Actin served as a loading control; detection of HSV-1 ICP8 and AAV2
Rep was used as an infection control.
FIG 2 Activation of primary DDR proteins. MO59J Fus1 cells were mock
infected, infected with HSV-1 (MOI, 1.5), or coinfected with rAAVCR (MOI,
250) and HSV-1 (MOI, 1.5). After 24 h, cells were fixed and processed for IF
analysis. rAAVCRRCs (AAVRCs) were visualized by binding of the rAAVCR-
encoded mCherry-Rep68/78 fusion protein (CR) to AAV DNA (red). HSV-1
RCs were visualized with a primary antibody specific for the HSV-1 major
DNA binding protein ICP8 and an AF594-labeled secondary antibody (red).
Cells treated withHU (3mM) served as a DDR control. To identify phosphor-
ylated Nbs1 (A) and H2AX (B), cells were stained with antibodies specific for
Nbs1-P-S343 or H2AX-P-S139 (H2AX) and an FITC-labeled secondary an-
tibody (green). DAPI was used to stain cellular DNA. Images were taken using
a CLSM and represent a single optical z slice of the nuclei. Scale bars, 10 m.
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bands in cells infected withHSV-1 and/or AAV2 but not inmock-
infected cells (see Fig. S1A in the supplemental material). (ii)
ATRIP was detected in both mock-infected cells and virus-
infected cells (Fig. 1A), where it colocalized with AAV2 and
HSV-1 RCs (Fig. 3C). (iii) WB analysis revealed no phosphoryla-
tion of the ATR target Chk1 at S345 (see Fig. S1B in the supple-
mental material) and S317 (data not shown) in infected cells.
From the results described above, it seems that although ATR is
phosphorylated in infected cells, the kinase is not activated and
therefore not able to transmit DDR signaling via its downstream
target, Chk1. Supporting this, Nam and Cortez (62) recently
showed that phosphorylation of ATR on S428 is not indicative of
ATR activity and cannot be inhibited by the commonly used ATR
inhibitor caffeine. Moreover, Liu et al. reported that the mutation
of S428 to A428 did not prevent the phosphorylation of Chk1 in
response to replicative stress (54).
HSV-1 ICP0-dependent degradation of DNA-PKcs is de-
layed during coinfection with AAV2. HSV-1 ICP0 is known to
induce proteasomal degradation of DNA-PKcs (48, 67), which,
together with Ku70 and Ku80, forms DNA-PK, the third main
PIKK besides ATM and ATR (reviewed in reference 55). Consis-
tent with these reports, our WB results displayed loss of DNA-
PKcs by 48 h after infection with HSV-1 or coinfection with
HSV-1 and AAV2 (Fig. 1A). Accordingly, at the single-cell level,
DNA-PKcs was not detected simultaneously with either the
HSV-1 immediate-early (IE) protein ICP0 or HSV-1 early (E)
protein ICP8 in cells infected with HSV-1 alone. However, DNA-
PKcs was readily detected in cells infected with rHSV-1ICP0
(Fig. 4A). Interestingly, IF analysis revealed that DNA-PKcs colo-
calized with HSV-1 proteins ICP0 and ICP8 in 80% and 76% of
the AAV RCs, respectively (Fig. 4B). This indicates that HSV-1
ICP0-mediated DNA-PKcs degradation in coinfected cells is not
as efficient as in cells that are infected with HSV-1 alone, even if
the intensity ofDNA-PKcs staining in largeAAVRCs is lower than
that in small AAV RCs (Fig. 4B). This possibility was further in-
vestigated by flow cytometry data. Cells infected with HSV-1 or
coinfected with HSV-1 and AAV2 were identified using rHSV-1
and rAAV expressing ICP4-EYFP or EGFP, respectively. Similar
FIG 3 Recruitment of ATM-P-S1981, ATR-P-S428, and ATRIP into HSV-1 and AAV2 RCs. MO59J Fus1 cells were infected and processed for IF, and viral RCs
(red) were visualized as described in the legend to Fig. 2. Cells were stained with an antibody specific for ATM-P-S1981 (A), ATR-P-S428 (B), or ATRIP (C) and
an FITC-labeled secondary antibody (green). DAPI was used to stain cell nuclei. In panel A, cells deficient for ATM (AT-22 IJE T) served as a control for the
phosphospecific ATM antibody. In panel B, the percentage of ATR-P-S428 in viral RCs is indicated. Scale bars, 10 m.
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FIG 4 Activation and delayed degradation of DNA-PKcs in cells coinfected with HSV-1 and AAV2. (A)MO59J Fus1 cells were infected with HSV-1 (MOI, 1.5)
or HSV-1ICP0 (MOI, 0.9) or mock infected. After 24 h, cells were fixed and processed for IF analysis. HSV-1 infection was detected using an antibody specific
for ICP0 or ICP8 and an AF594-labeled secondary antibody (red). Additionally, cells were stained with an antibody specific for DNA-PKcs and an FITC-labeled
Vogel et al.
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to the results obtained with wild-type HSV-1 (strain F), DNA-
PKcs was also degraded in cells infected with autofluorescent re-
combinant HSV-1 (strain17; Fig. 4C). In contrast, the fluores-
cence intensity of DNA-PKcs staining in cells coinfected with
wild-typeHSV-1 andAAV2was the same as that inmock-infected
cells (Fig. 4C). At the chosen MOIs, the ratio of cells that show
AAV RCs at 24 hpi is only approximately 10%, while 24 h after
infection with HSV-1 alone, more than 40% of the cells contain
HSV-1 RCs. This may explain why in the WB analysis of total cell
lysates shown in Fig. 1, the degradation of DNA-PKcs appeared
equally efficient in HSV-1-infected cells and in coinfected cells
while, on the single-cell level (Fig. 4B and C), DNA-PKcs degra-
dation appeared to be less efficient in coinfected cells.
To further examine this observation, we performed WB anal-
ysis of sorted cells at 22 and 26 hpi (Fig. 4D and E). Cells were
infected with rHSV-1 ICP4-ECFP or coinfected with rAAVCR
and rHSV-1 ICP4-ECFP. HSV-1-infected cells were sorted based
on the expression of ICP4-ECFP, and cells that contained
rAAV RCs were sorted based on the expression of mCherry-
Rep. Sorted mock-infected cells served as a control. Mock-
infected and HU-treated cells served as an activation control for
DNA-PKcs. Quantification of the WB assay shown in Fig. 4D re-
vealed 3-times-higher levels of DNA-PKcs at 22 hpi during AAV
replication than in cells infectedwithHSV-1 alone (Fig. 4D). At 26
hpi, the intensity of the DNA-PKcs staining was also decreased in
coinfected cells compared to that seen at 22 hpi but still approxi-
mately 2 times as high as that in cells infected with HSV-1 alone at
26 hpi. Moreover, phosphorylation of DNA-PKcs at S2056 was
detected only in cells coinfected with both viruses (Fig. 4E and F);
however, pDNA-PKcs levels also decreased in coinfected cells over
time (Fig. 4E). Staining for the cellular deubiquitinase ubiquitin-
specific peptidase 7 (USP7) at 24 hpi, which is another known
target of HSV-1 ICP0-induced proteasomal degradation (12), re-
vealed that the AAV-mediated delay of the ICP0 function was
specific for DNA-PKcs, as the degradation of USP7 was equally
efficient in cells infected with HSV-1 alone and in coinfected cells
(Fig. 4F).
Next, we analyzed the localization of DNA-PKcs-P-S2056
within infected cells. As positive and negative controls, we coin-
fected DNA-PKcs-positive cells and DNA-PKcs-deficient cells
with Ad and AAV2, which are known to activate DNA-PKcs and
recruit it into RCs (75). While DNA-PKcs-P-S2056 staining was
readily detected in cells coinfected with AAV2 and either Ad2 or
HSV-1, where it also colocalized with AAV2 RCs, we did not ob-
serve staining in cells that contained HSV-1 RCs (Fig. 4G).
Phosphorylation of Chk2 and p53. To explore a potential
DNA-PK-mediated signaling to downstream targets in coinfected
cells, we assessed virus-induced phosphorylation of Chk2 and p53
in normal cells and in cells defective for eitherDNA-PKcs (MO59J
Fus9) or ATM (AT22 IJE-T pEBS7). HSV-1 has previously been
shown to induce the phosphorylation of Chk2 in an ATM-
dependent manner (51, 76). Our results are in line with these
reports, as in normal cells (data not shown) and in DNA-PKcs-
deficient cells (Fig. 5A), Chk2 was phosphorylated at 24 h after
infection with HSV-1, and this also occurred in cells coinfected
with HSV-1 and AAV2. However, in ATM-deficient cells, Chk2
was phosphorylated only in cells coinfected with both viruses but
not in cells infected withHSV-1 alone (Fig. 5B). This suggests that
in these cells, Chk2 phosphorylationwas possibly facilitated by the
AAV2-mediated delayed degradation of DNA-PKcs. Also consis-
tent with previous observations, we detected that HSV-1 (13) and
AAV2 (68) induced the stabilization of p53 (Fig. 1C). Addition-
ally, we observed that p53 was phosphorylated at S15 in cells in-
fected with either HSV-1 or AAV2 or coinfected with both viruses
(Fig. 1C) and that p53-P-S15 was recruited into both HSV-1 RCs
and AAV2 RCs (data not shown). p53-P-S15 was also detected in
DNA-PKcs-deficient cells infected with HSV-1 alone or coin-
fected with HSV-1 and AAV2 (Fig. 5A); in these cells, phosphor-
ylation is likely ATMmediated. However, as opposed to the situ-
ation in normal cells infected with AAV2 alone, p53-P-S15 was
not detected in DNA-PKcs-deficient cells infected with AAV2
alone (Fig. 5A), indicating that in the absence of the helper virus,
AAV2-induced phosphorylation of p53 is DNA-PK dependent. In
ATM-deficient cells, p53was phosphorylated onlywhen cells were
infected with rHSV-1ICP0 or coinfected with AAV2 and HSV-1
(Fig. 5C) and not in cells infected with HSV-1 alone (Fig. 5C),
indicating again that in coinfected cells, p53 phosphorylation was
supported by the delayed degradation of DNA-PKcs.
Phosphorylation of RPA. The trimeric RPA complex com-
posed of RPA70, RPA32, and RPA14 is involved in DNA repair, as
well as replication and transcriptional regulation of both cellular
and viral DNAs (10, 97). RPA has a strong affinity for single-
stranded DNA (98) and was shown to be a component of Ad-
supported AAV2 RCs (79). Upon DNA damage, RPA32 becomes
phosphorylated at several residues (reviewed in reference 107). It
was suggested that phosphorylation at S33 is mediated by ATR,
secondary antibody (green). DAPI was used to stain cellular DNA. Scale bars, 10 m. (B) IF analysis of MO59J Fus1 cells at 24 h after coinfection with rAAVCR
(MOI, 250) andHSV-1 (MOI, 1.5). rAAVCRRCs (red)were visualized as described in the legend to Fig. 2. Additionally, cells were stainedwith antibodies specific
for ICP0 or ICP8 and an AF405-labeled secondary antibody (purple) and with an antibody specific for DNA-PKcs and an FITC-labeled secondary antibody
(green). The percentage of DNA-PKcs in rAAVCR RCs is indicated. Scale bars, 10 m. (C) Flow cytometric analysis of infected cells. DNA-PKcs-positive
HCT116 cells were mock infected (positive control), infected with rHSV-1ICP4EYFP (MOI, 1.5), or coinfected with HSV-1 (MOI, 1.5), AAV2 (MOI, 250), and
rAAVGFP (MOI, 250). HCT116 cells negative for DNA-PKcs served as a negative control. Cells were fixed at 20 h postinfection and stained with a DNA-PKcs-
specific monoclonal antibody and a Cy5-labeled secondary antibody. DNA-PKcs was analyzed in HSV-1-infected cells positive for EYFP-ICP4 (HSV) and in
coinfected cells positive for EGFP (HSVAAV). A minimum of 80,000 events were scored for each sample. Graphs were overlaid to show the fluorescence shift
of HSV-1-infected populations. (D and E) WB analysis of AT22 IJE-T cells sorted for productive HSV-1 and AAV2 infection at 22 and 26 hpi. Cells were mock
infected, infected with rHSV-1vECFP-ICP4 (rHSV; MOI, 2), or coinfected (rHSV rAAV) with rHSV-1vECFP-ICP4 (MOI, 2) and rAAV2CR (MOI, 4,000).
Lysates of sorted cells were processed forWB analysis and stained with the antibodies indicated. Quantification ofWB band intensities was done with a Gel Doc
systemusingQuantityOne software (version 4.6.1; Bio-Rad,Hercules, CA). (F)WBanalysis of AT22 IJE-T cells sorted for productiveHSV-1 andAAV2 infection
at 24 hpi. Cells were mock infected, infected with rHSV-1vECFP-ICP4 (rHSV; MOI, 4), or coinfected (rHSV rAAV) with rHSV-1vECFP-ICP4 (MOI, 4) and
rAAV2CR (MOI, 4,000). Lysates of sorted cells were processed for WB analysis and stained with the antibodies indicated. (G) MO59J Fus1 cells were mock
infected, infected with HSV-1 (MOI, 1.5), or coinfected with rAAVCR (MOI, 250) and either HSV-1 (MOI, 1.5) or Ad2 (MOI, 12.5). After 24 h, cells were fixed
and processed for IF analysis. rAAVCR and HSV-1 RCs (red) were visualized as described in the legend to Fig. 2. DNA-PKcs phosphorylation was detected with
an antibody specific forDNA-PKcs-P-S2056 and an FITC-labeled secondary antibody (green). As a negative control,MO59J Fus9DNA-PKcs-negative cells were
coinfected with rAAVCR (MOI, 250) and Ad2 (MOI, 12.5) and stained for pDNA-PKcs. DAPI was used to stain cellular DNA. Scale bars, 10 m.
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while phosphorylation at S4/8 is mediated in a DNA-PK-
dependent manner (4, 104). Here we examined the spatial local-
ization of the RPA subunit RPA32 and its phosphorylation at S4/8
in infected cells. Our results show that total RPA32 is recruited
into HSV-1 and AAV2 RCs (data not shown) and that its expres-
sion levels were not altered by virus infection (Fig. 6A). WB anal-
ysis of cells productively infected with either HSV-1 or AAV2 re-
vealed phosphorylation of RPA32 at Ser4/8 only upon AAV2
replication (Fig. 6A). More precisely, RPA32-P-S4/8 clearly colo-
calized with approximately 70% of the small and large AAV2 RCs
but with only 21% of the small and 11% of the large HSV-1 RCs
(Fig. 6B and C). UV-treated cells served as a positive control (Fig.
6B).Moreover, accumulation of RPA32-P-S4/8was observed only
in AAV2 RCs of DNA-PKcs-positive cells (Fig. 6D). In summary,
these data show that coinfection with AAV2 and HSV-1 induces
DNA-PKcs-dependent phosphorylation of RPA32 at S4/8.
DISCUSSION
In this study, we compared the phosphorylation status and spatial
organization of DDR proteins between cells infected with HSV-1
alone and cells coinfected with HSV-1 and AAV2. WB and IF
analyses demonstrated that HSV-1 and AAV2 coinfection in-
duced a strong DDR (Table 1 and Fig. 7). Specifically, HSV-1-
supported AAV2 replication induced the phosphorylation of
Nbs1 and H2AX, as well as ATM and its substrates Chk2 and p53.
These responses are similar to those induced by HSV-1 infection
alone, as observed here and in previous studies (13, 49, 67, 76, 81,
95).We also detected phosphorylation of ATR and recruitment of
pATR along with its binding partner ATRIP into HSV-1-
supported AAV2 RCs, as well as into HSV-1 compartments, al-
though kinase activity of ATR was blocked upon HSV-1 and
AAV2 replication, aswe did not detect phosphorylation ofChk1 at
ATR target sites S317 and S345. Our results are similar to those of
a previous study showing that ATR, although recruited together
with ATRIP into HSV-1 RCs, is unable to activate Chk1. In addi-
tion, Mohni et al. showed that both ATR and ATRIP, even if not
activated, contribute to efficient HSV-1 infection (58).
Due to the strong affinity of RPA32 for single-stranded DNA
(102, 107) and its function in recruiting the ATRIP-ATR complex
to sites ofDNAdamage (7, 26, 106), it is not surprising thatwe and
others (65, 79) detected RPA32 in HSV-1-supported AAV2 RCs.
In HSV-1-infected cells, RPA32 colocalizes with the HSV-1major
single-stranded DNA binding protein ICP8 (81) in HSV-1 RCs
(82, 93). Replicating HSV-1 DNA contains stretches of single-
stranded DNA (39) which may recruit RPA32 into HSV-1 RCs
also independently of ICP8. Single-stranded DNA binding pro-
teins such as RPA32 are proposed to stimulate AAV2 DNA repli-
cation (64, 79), e.g., by protecting the single-stranded replication
products from nucleases (63) and by enhancing the binding and
nicking of Rep proteins at the replication origins (79).
HSV-1 has been demonstrated to induce the degradation of
DNA-PKcs in an ICP0-dependentmanner (48, 67). AlthoughWB
analysis of total infected cells displayed a similar degradation of
DNA-PKcs, in cells infectedwithHSV-1 or coinfectedwithHSV-1
FIG 5 DNA-PKcs- and ATM-dependent activation of Chk2 and p53 upon viral infection. (A)WB analysis of DNA-PKcs-deficientMO59J Fus9 cells. Cells were
mock infected (m), infected with AAV2 (MOI, 2,000) or HSV-1 (MOI, 1.5), or coinfected with AAV2 (MOI, 2,000) and HSV-1 (MOI, 1.5). Total proteins were
extracted at the indicated times postinfection and subjected toWB analysis using antibodies specific for actin (loading control), ICP8 (HSV-1 infection control),
Chk2, Chk2-P-T68, and p53-P-S15. (B) Immunoprecipitation andWB analysis of ATM-negative AT22 IJE-T cells at 24 h after mock infection or infection with
AAV2 (MOI, 2,000), HSV-1 (MOI, 1.5), AAV2 (MOI, 2,000), and HSV-1 (MOI, 1.5). Lysates were analyzed using the antibodies indicated. (C) IF analysis of
ATM-negative AT22 IJE-T cells at 24 h after infectionwithHSV-1 (MOI, 1.5) and rAAVCR (MOI, 250), HSV-1 (MOI, 1.5), orHSV-1ICP0 (MOI, 0.9) ormock
infection. rAAVCR andHSV-1 RCs (red) were visualized as described in the legend to Fig. 2. p53 activation was detected with an antibody specific for p53-P-S15
and an FITC-labeled secondary antibody (green). DAPI was used to stain cellular nuclei. Scale bars, 10 m.
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and AAV2, a striking difference was observed at the single-cell
level, as well as in cells productively infected with HSV-1 and
AAV2 captured by FACS. Flow cytometry, IF analysis, and WB
analysis of sorted cells revealed an AAV2-mediated delay in the
HSV-1-dependent degradation of DNA-PKcs, as well as AAV2-
induced phosphorylation of DNA-PKcs. The observed discrep-
ancy in the results ofWB assays of total cell lysates and analyses on
the single-cell level is likely due to the fact that, under the chosen
experimental conditions, only approximately 10%of the cells sup-
ported AAV2 replication. In order to estimate the extent of the
delay in DNA-PKcs degradation, we covisualized DNA-PKcs and
the HSV-1 IE and E proteins ICP0 and ICP8, respectively, which
allowed monitoring of the progression of HSV-1 infection. While
DNA-PKcs and ICP0 or ICP8were not codetected in cells infected
withHSV-1 alone,DNA-PKcs and ICP0 or ICP8were consistently
codetected in cells coinfected with HSV-1 and AAV2, and they
colocalized with AAV2 RCs. As we did not observe an AAV2-
mediated inhibition of ICP0 in this study (see Fig. S1B in the
supplemental material) or in a previous study (31), we speculate
that AAV2 replication can prevent the ICP0-dependent degrada-
tion of DNA-PKcs (48, 67), e.g., by shielding DNA-PKcs in viral
RCs.We can exclude the possibility that AAV2 replication directly
inhibits the E3 ubiquitin ligase activity of ICP0 because USP7,
another target of ICP0-mediated proteasomal degradation (12),
was rapidly degraded in coinfected cells. In addition, we can ex-
clude a possible role for USP7 in preventing the degradation of
FIG 6 Phosphorylation of RPA32 upon AAV2 and HSV-1 replication. (A) WB analysis of sorted AT22 IJE-T cells at 24 hpi. Cells were mock infected, infected
with rHSV-1vECFP-ICP4 (rHSV; MOI, 4), or coinfected (rHSV rAAV) with rHSV-1vECFP-ICP4 (MOI, 4) and rAAV2CR (MOI, 4,000). Sorted cells were
subjected toWB analysis and analyzed with the antibodies indicated. (B) IF analysis of U2OS cells after infection withHSV-1 (MOI, 1.5) or rAAVCR (MOI, 250)
and HSV-1 (MOI, 1.5) or mock infection at 24 h. UV-treated cells (10 J/m2) served as a positive control. rAAVCR and HSV-1 RCs (red) were visualized as
described in the legend to Fig. 2. To detect phosphorylated RPA32, cells were stained with an antibody specific for RPA32-P-S4/8 and an FITC-labeled secondary
antibody (green). Cellular DNA was stained with DAPI. Scale bars, 10 m. (C) Quantification of RPA32-P-S4/8 colocalization with small and large AAV2 or
HSV-1 RCs in U2OS cells. Fifty cells per sample were counted. Black columns, RPA32-P-S4/8-positive viral RCs; open columns, RPA32-P-S4/8 negative viral
RCs. (D) IF analysis of MO59J Fus1 or Fus9 (DNA-PKcs-negative) cells at 24 h after mock infection or coinfection with HSV-1 (MOI, 1.5) and rAAVCR (MOI,
250). rAAVCRRCs (red) were visualized as described in the legend to Fig. 2. Cells were stainedwith an antibody specific for RPA32-P-S4/8 and anAF405-labeled
secondary antibody (blue). Scale bars, 10 m.
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DNA-PKcs by deubiquitinating (45) DNA-PKcs. Experiments
performed with ATM-deficient cells revealed that the AAV2-
mediated delay of DNA-PKcs degradation affected downstream
signaling via Chk2 and p53. In these cells, coinfection with both
viruses resulted in aDDR comparable to that induced by infection
with HSV-1ICP0, including phosphorylation of p53. Consistent
with previous data (51, 76), infection of ATM-deficient cells with
HSV-1 alone resulted in a broad reduction of DDR signaling with
undetectable levels of Chk2-P-T86 and p53-P-S15. We therefore
hypothesize that in coinfected ATM-deficient cells, DNA-PK is
responsible for the phosphorylation of Chk2 and p53 (Fig. 7). A
role for DNA-PK in the phosphorylation of Chk2 and p53 has
previously been reported (49, 50, 85, 86, 88). In fact, here we
demonstrate that DNA-PK is essential for the activation of p53 in
cells infected with AAV2 alone (Fig. 1C and 5A).
Recently, we reported hyperphosphorylation of RPA32 at the
DNA-PK target site S4/8 in cells transfectedwith a plasmid encod-
ing the AAV2 Rep68 or Rep78 protein (30). In the present study,
we detected phosphorylation of RPA32 at S4/8 and recruitment of
RPA32-P-S4/8 into HSV-1-supported AAV2 RCs. In contrast,
HSV-1 infection alone did not induce phosphorylation of RPA32
at S4/8. Similar to the phosphorylation of Chk2 and p53 in coin-
fected cells, phosphorylation of RPA32 at S4/8 may also be a con-
sequence of the delayed degradation of DNA-PKcs. Further sup-
port for this theory comes from the fact that DNA-PK has
previously been demonstrated to phosphorylate RPA32 at S4/8 (4,
11, 104).
In a comparison of our results obtained with coinfected cells
with those of previous studies examining the DDR signaling in
cells infected with HSV-1 alone (13, 51, 76, 96) or Ad2 alone (17,
78) or coinfected with AAV2 and Ad2 (25, 75), it is remarkable
that although Ad and HSV-1 by themselves induce very different
DDRs, in the presence of AAV2, the induction and activation pat-
terns of DDR proteins are more similar. It seems that during
AAV2 replication, the cellular DDR is modulated toward DNA-
PK-dependent signaling, which might have positive and/or nega-
tive impacts on AAV replication and transduction, depending on
the cellular environment and the viral genome structure (23, 25,
75). Further experiments will address the question of whether this
TABLE 1 DNA damage signaling in cells infected with HSV-1 or coinfected with HSV-1 and rAAV2a
Protein
HSV-1–rAAV2 coinfection HSV-1 infection
Inhibition Induction Phosphorylation Localization Inhibition Induction Phosphorylation Localization
ATM  NUCc RCs  RCs
ATR    RCs    RCs
ATRIP   NDd RCs   ND RCs
DNA-PKcs b   RCs    
USP7   ND RCs   ND ND
H2AX ND ND  NUC ND ND  NUC
NBS1    RCs    RCs
RPA32 (P-Ser4/8)    RCs    RCs
p53    RCs    RCs
Chk1    RCs    RCs
Chk2    RCs    RCs
a Shown is a summary of data fromWB analysis, IF analysis, and flow cytometry. Bold, AAV-induced modulation of DDR.
b Inhibition delayed.
c NUC, nucleus.
d ND, not done.
FIG 7 Models of the DDR signaling induced by HSV-1 replication and HSV-1-supported AAV replication. The analysis of the DDRs in ATM-deficient,
DNA-PKcs-deficient, and normal cells supports the followingmodels. Infection of cells with HSV-1 induces phosphorylation of ATM and ATR and signaling to
their targets Nbs1, H2AX, Chk2, and p53 but not to the ATR target Chk1. In cells infected with HSV-1 alone, DNA-PKcs is rapidly degraded in an HSV-1
ICP0-dependent manner and no DNA-PKcs-mediated signaling occurs. In contrast, coinfection with HSV-1 and AAV2 induces the activation of DNA-PKcs,
which enables the phosphorylation of RPA32 at S4/8. Further support for the activation ofDNA-PKcs in coinfected cells comes fromexperiments performedwith
ATM-deficient cells, as in the absence of ATM, HSV-1 and AAV2 coinfection still induced the phosphorylation of p53, Chk2, and RPA32 at S4/8. In ATM-
deficient cells infected with HSV-1 alone, the DDR signaling is broadly reduced, with undetectable levels of Chk2-P-T86 and p53-P-S15 (51, 76).
Vogel et al.
152 jvi.asm.org Journal of Virology
 o
n
 June 21, 2013 by UZH Hauptbibliothek / Zentralbibliothek Zuerich
http://jvi.asm.org/
D
ow
nloaded from
 
modulation can enhance HSV-1-supported AAV2 replication
and/or inhibit helper virus replication.
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4.2 Further examination of AAV2 and HSV-1 induced DDR
4.2.1 Materials and methods
Cells. DNA-PKcs positive (expressing one copy of DNA-PKcs) and DNA-PKcs
negative HCT116 cells were kindly provided by E. Hendrickson (University of
Minnesota Medical School, Minneapolis, USA) and maintained in growth medium
containing Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 100 units/ml penicillin G, 100 µg/ml streptomycin, and 0.25
µg/ml amphotericin B (1% AB). The fibroblast cells AT22 IJE-T yZ5 (expressing ATM)
and AT22 IJE-T pEBS7 (ATM-deficient) and GM0166 VA7 (NBS1-deficient) and
GM0166 VA7 (expressing NBS1) were kind gifts from Y. Shiloh (Department of
Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv
University, Tel Aviv, Israel). These cells were maintained in DMEM supplemented
with 10% FBS, 1% AB and 100 µg/ml hygromycin B. HeLa cells were purchased form
the American Type Culture Collection (ATCC, Manassas, USA).
Viruses. HSV-1 strain F was kindly provided by B. Roizman (Marjorie B. Kovler Viral
Oncology Laboratories, University of Chicago, Chicago, USA). wtAAV2 was kindly
provided by H. Buening (University of Cologne, Cologne, Germany). rHSV-1vEYFP-
ICP4 and rHSV-1 vECFP-ICP4 were kind gifts from R.D. Everett (MRC Virology Unit,
University of Glasgow, Glasgow, United Kingdom). Viruses were grown and titrated
on Vero cells. Recombinant AAV2mCerryRep (AAVCR) genomes containing the
AAV2 ITR flanking the rep ORFs fused at the 5’ terminus with the mCherry coding
sequence has been described previously (1). Recombinant AAV2YFPRep (AAVYR)
genomes contain the AAV2 ITR flanking the Rep ORFs fused at the 5’ terminus with
the enhanced yellow fluorescence protein (eYFP) coding sequence. See 4.1 for
production of recombinant AAV2 (AAVCR and AAVYR).
Plasmids. Plasmids pR68/78 (expressing Rep 78 and Rep 68 from the CMV
promoter) and pAAVlacO (containing the AAV2 inverted terminal repeats (ITR)
flanking 40 lacO binding sites) were described previously (9, 10, 14). The reporter
plasmid pSV2-EYFP/lacI, expressing eYFP fused to the lac repressor (LacI; (34)),
was kindly provided by D. L. Spector (Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY).
Antibodies. The following primary antibodies were used: Anti-actin (Santa Cruz
Biotechnology (SC) 10731; dilution WB 1:10’000), anti-ATM-P-S1981 (Rockland
Immunochemicals (RI) 200-301-400; dilution WB 1:500, IF 1:50), anti-HSV-1 ICP8
(Ab 20198; dilution WB 1:1000, IF 1:200), anti-Nbs1 (Novus Biologicals 100-143;
dilution WB 1:1000), anti-PARP1 (Sigma, P7605, dilution WB: 1:1000, IF 1:100), anti-
AAV2 Rep (Fitzgerald Industries 10R-A111A; dilution WB 1:200), anti-RPA32 (BL
A300-244A; dilution WB 1:2000, IF 1:500), anti-RPA32-P-S33 (BL A300-246A;
dilution WB: 1:2000, IF 1:1000), anti-RPA32-P-S4/8 (BL A300-245A; dilution WB
1:200, IF 1:200), anti-XRCC1-P-S518/T519/T523 (BL A300-059A-1; dilution WB
1:1000, IF 1:1000), anti-XRCC1 (ab1838 dilution IF 1:200). The following secondary
antibodies were used: Rabbit anti-mouse IgG-horseradish peroxidase (HRP, Sigma
A9044; dilution 1:10000), goat anti-rabbit IgG-HRP (Sigma A6154; dilution 1:10000),
goat anti-rabbit IgG (H+L)-AF594 (Molecular Probes A11012; dilution 1:1000), goat
anti-mouse IgG (H+L)-AF594 (Molecular Probes A11005; dilution 1:1000), goat anti-
mouse IgG (H+L)-fluorescein isothiocyanate (FITC, Southern Biotechnology 1031-02;
dilution 1:200), goat anti-rabbit IgG (H+L)-FITC (Southern Biotechnology 4050-02;
dilution 1:200), goat anti-mouse IgG-Cy5 (Millipore AP181S; dilution 1:500).
Transfection. For immunofluorescence analysis, AT22 IJE-T or HeLa cells (7,5x10^4)
were seeded onto cover slips (12 mm ø, Glaswarenfabrik Karl Hecht GmbH&Co KG,
Sondheim, Germany) in 24-well plates and transfected with 10ng pR68/78, 25ng
pAAVlacO, and 10ng pSV2-EYFP/lacI. Transfection was performed with
Lipofectamine® & Plus Reagent (Invitrogen 18324, 11514) according to the
manufacturer's protocol. After 3h incubation at 37°C, transfection medium was
removed. Cells were washed with optiMEM and infected with wtHSV-1 (MOI 2) for
24h in DMEM (2%FCS, 1%AB).
Western analysis. 106 HCT116 cells or 5x106 AT22 IJE-T cells were seeded into 6cm
plates. The following day, the cells were mock-infected, infected with either AAV2
(MOI, 2000) or HSV-1 (MOI 1.5), or coinfected with AAV2 (MOI 2000) and HSV-1
(MOI 1.5) in DMEM supplemented with 2% FBS and 1% AB. After 2h, 8h, 16h, or
24h, cells were prepared for Western analysis as described in (4.1.).
Southern analysis. 9x105 AT22 IJE-T or 2x106 NBS1+/- cells were seeded into 6 cm
tissue culture plates. The following day, the cells were mock-infected, infected with
wtAAV2 (MOI 10’000) or coinfected with wtAAV2 (MOI 10’000) and HSV-1 (MOI 1) in
DMEM supplemented with 2% FBS and 1% AB. After 24h, cells were harvested and
extrachromosomal DNA was extracted according to a protocol described by Hirt (15).
The DNA was separated on a 1% agarose gel and transferred to nylon membranes
(Amersham Hybond-N+ RPN119B). Hybridization with a digoxigenin (DIG)-labeled
probe specific for the AAV2 Rep 78-coding sequence and subsequent detection by
an anti-DIG antibody conjugated with alkaline phosphatase and activation with the
chemiluminescence substrate (CDP Star) was performed according to the
manufacturer's protocol (Roche). The DIG-labeled probe was produced with the PCR
DIG probe synthesis kit (Roche). PCR amplification was performed from a Rep 78
plasmid as a template. The PCR product was finally purified with the QIAquick PCR
purification kit (Qiagen).
ROS experiment. The day before infection, 9x105 AT22 IJE-T cells were seeded into
6 cm tissue culture plates. Cells were coinfected with wtHSV-1 (MOI 1.5) and
wtAAV2 (MOI 2000) in the presence or absence of 5mM N-acetylcysteine (NAC). 24h
post-infection, cells were subjected to Western analysis (see above) or flow
cytometry. For flow cytometry, cells were stained with an indicator for reactive oxygen
species (ROS), 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA). H2DCFDA is
a chemically reduced form of fluorescein. Upon cleavage of the acetate groups by
ROS, the nonfluorescent H2DCFDA is converted to the highly fluorescent 2',7'-
dichlorofluorescein (DCF). 50’000 cells per sample were counted.
Immunofluorescence analysis. AT22 IJE-T cells (7,5x104) were seeded onto cover
slips (12 mm ø, Glaswarenfabrik Karl Hecht GmbH&Co KG, Sondheim, Germany) in
24-well plates. The next day, cells were mock-infected, infected with wtHSV-1 (MOI
1.5), or coinfected with wtHSV-1 (MOI 1.5) and either AAV2CR (MOI 250) or
AAV2YR (MOI 250). For fixation and staining procedure see 4.1.
4.2.2 Results
4.2.2.1 RPA32 phosphorylation at S4/8 does not depend on a functional MRN
complex.
Although RPA32 was found recruited into both AAV2 and HSV-1 replication
compartments, phosphorylation of RPA32 at Ser4/8 was only observed in cells
coinfected with AAV2 and HSV-1 (see 4.1). In cells coinfected with Ad and AAV2,
phosphorylation of RPA32 at Ser4/8 was also detected and this DDR signaling event
was shown to be independent of a functional MRN complex (Mre11, Rad50, NBS1;
(28)), because Ad efficiently disrupts the MRN complex in coinfected cells (29) as
well as in cells infected with Ad alone (6, 32). In contrast to Ad, HSV-1 does not
inactivate the MRN complex but rather induces signaling via ATM, which promotes
HSV-1 infection (22). In cells coinfected with AAV2 and HSV-1, there is also no
indication for degradation or dislocation of proteins of the MRN complex. Rather, we
observed recruitment of at least one of the MRN proteins, NBS1, into AAV2 RCs and
its phosphorylation at Ser343 (see 4.1).
Here, we investigated whether phosphorylation of RPA32 at Ser4/8 in cells
coinfected with AAV2 and HSV-1 requires a functional MRN complex. In order to
abrogate MRN function during AAV2 replication, experiments were performed in cells
deficient for NBS1. For visualization of AAV2 DNA replication, we used a
visualization system previously developed in our group, employing the interaction of
the lac repressor (LacI) fused to eYFP (expressed from plasmid pSV2-EYFP/lacI)
with lac operator sequences (LacO) present on a recombinant AAV2 genome
(pAAVlacO; (9)). The pAAVlacO DNA contains the AAV2 ITRs flanking 40 lac
repressor (LacI) binding sites. Similar to wtAAV2 DNA, due to the presence of the
AAV2 ITRs, pAAVlacO serves as substrate for AAV Rep protein and helper virus-
mediated DNA replication (9). Immunofluorescence analysis of rAAV2 replication in
cells positive or negative for NBS1 revealed that independent of the presence (Fig.
1A) or absence (Fig. 1B) of NBS1, RPA32 is phosphorylated at Ser4/8 and recruited
into rAAV2 RCs.
4.2.2.2 Phosphorylation of RPA32 at Ser33 during AAV2 and early HSV-1 replication.
Although, RPA32 was found located in HSV-1 RCs (33, 37, 38), phosphorylation of
RPA32 was proposed to not occur upon HSV-1 replication. In line with this, we
observed phosphorylation of RPA32 at Ser4/8 only in cells coinfected with AAV2 and
HSV-1, but not in cells infected with HSV-1 alone (see 4.1). Surprisingly, when we
Fig 1. RPA32 phosphorylation at S4/8 is independent on a functional MRN 
complex. (A and B) Immunofluorescence analysis of cells, positive (NBS1+, A) or 
negative (NBS1-, B) for NBS1, transfected with 10ng pR68/78, 25ng pAAVlacO, 
and 10ng pSV2-EYFP/lacI and infected with wtHSV-1 (MOI 2) for 24h. rAAV RCs 
(green) were visualized by the binding of LacI-eYFP to LacO-repeats present in 
the rAAV genome (pAAVlacO). To detect phosphorylated RPA32, cells were 
stained with an antibody specific for RPA32-P-S4/8 and an AF495-labeled 
secondary antibody (red).  Cellular DNA was stained with DAPI.  Scale bar = 5 µm. 
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Fig 2. Phosphorylation of RPA32 at Ser33 during AAV2 and early HSV-1 
replication. (A and B) Immunofluorescence analysis of AT22 IJE-T ATM positive 
cells (yZ5) after infection with wtHSV-1 (MOI 1.5), AAVCR (MOI 250) and wtHSV-1 
(MOI 1.5), or mock-infection for 15h (A) or 24h (B). rAAVCR RCs (AAV RCs) were 
visualized by binding of the rAAVCR-encoded mCherry-Rep68/78 fusion protein 
(CR) to AAV DNA (red). HSV-1 RCs were visualized with a primary antibody 
specific for the HSV-1 major DNA binding protein ICP8 and an AF594-labeled 
secondary antibody (red). To detect phosphorylated RPA32, cells were stained 
with an antibody against RPA-P-S33 and an FITC-labeled secondary antibody 
(green). Cellular DNA was stained with DAPI. (A) Cell with early AAV2 and HSV-1 
RCs. (B) Cells with mature AAV2 and HSV-1 RCs late in infection. Scale bar = 10 
µm or 5 µm as indicated. 
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Fig 2. (C) Immunofluorescence analysis of AT22 IJE-T pEBS7 (ATM negative) 
cells after 15h (i) or 24h (ii) infection with HSV-1 (MOI 1.5), rAAVCR (MOI 250) and 
HSV-1 (MOI 1.5), or mock-infection.  rAAVCR and HSV-1 RCs (red) were 
visualized as described in Fig. 2 A and B.  To detect phosphorylated RPA32, cells 
were stained with an antibody specific for RPA32-P-S33 and an FITC-labeled 
secondary antibody (green).  Cellular DNA was stained with DAPI. Scale bar = 10 
µm. 
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Fig 2. (D) Western analysis of HCT116 cells at 24h and 48h after infection with 
wtAAV (MOI 2000), wtHSV-1 (MOI 1.5), wtAAV (MOI 2000) and wtHSV-1 (MOI 
1.5), or mock-infection. Lysates were processed for Western analysis and tested 
with antibodies against RPA32-P-S33, ICP8, and actin. (E) Western analysis of 
Vero cells at 12h, 24h, and 48h after infection with wtHSV-1 (MOI1.5) or mock-
infection. Cells treated with HU (3 mM) served as a RPA32 activation control. 
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used an antibody specific for RPA32 phosphorylated at Ser33 we did not only detect
RPA-P-Ser33 in cells coinfected with AAV2 and HSV-1, but also in cells infected with
HSV-1 alone, however with lower intensity (Fig. 2). Immunofluorescence analysis
revealed that RPA32-P-S33 colocalized with early AAV2 and HSV-1 RCs in 100%
and 90% of the cells, respectively (Fig. 2A). However, late upon infection when viral
RCs fill up the entire nucleus, RPA-P-Ser33 colocalization with AAV2 RCs is still
observed in most of the compartments (85%), while RPA-P-Ser33 is observed only in
few HSV-1 RCs (9%). This data indicates that although AAV2 and HSV-1 can induce
phosphorylation of RPA32 at S33, and RPA32-P-S33 is recruited into both AAV2 and
HSV-1 RCs, with the onset of HSV-1 infection RPA32-P-Ser33 levels decline and
disappear from HSV-1 RCs (Fig. 2B). Similar results were obtained in ATM-deficient
cells, in which RPA32-P-Ser33 was found in early and late AAV2 RCs and in early
but not in late HSV-1 RCs (Fig. 2C), indicating that ATM is not required for
phosphorylation of RPA32 at Ser33 in infected cells. Western analysis of cells
harvested at late time points of infection, showed increased levels of RPA32-P-Ser33
when infected with AAV2 or coinfected with AAV2 and HSV-1, but not when infected
with HSV-1 alone (Fig. 2D). Interestingly, when Vero cells were infected with HSV-1,
RPA32-P-S33 was readily detected at 12h and 48h after infection, while RPA32-P-
Ser33 levels were clearly reduced at 24hpi (Fig. 2E). A similar kinetic has been
observed also in AT22 cells (Fig. 2B and C). Accumulation of phosphorylated RPA32
especially at 12hpi is also supported by the observed band-shift of total RPA32 (Fig.
2E). As control for the induction of RPA32 phosphorylation, cells were treated with
HU (Fig. 2E).
4.2.2.3 Intracellular reactive oxygen species (ROS) levels during AAV2 and HSV-1
replication.
Reactive oxygen species (ROS) including superoxide radicals, hydroxyl radicals, and
hydrogen peroxides, are produced by the cellular metabolism and have important
roles in cell signaling (31). However, ROS levels can increase dramatically under
stress conditions, which can directly result in purine, pyrimidine, or deoxyribose
modifications (13). In addition, DNA ss breaks (SSBs) and, albeit at a much lower
frequency, DNA ds breaks (DSBs), can be induced by ROS (25). DSBs may not only
be a result of a direct attack by ROS, but may be also occur when the DNA
replication fork encounters unrepaired SSBs or other DNA lesions (25). Given that
elevated intracellular ROS can induce DNA damage and even DNA ds breaks, which
may further activate a cellular DDR (31), we investigated whether coinfection with
AAV2 and HSV-1 modulates the levels of intracellular ROS, and whether ROS
influences the activation of a DDR during viral infection. HSV-1 infection has
previously been described to increase ROS levels (2, 18, 19, 27). We also observed
an increase in ROS levels at 24h after infection of cells with HSV-1 (Fig. 3A). In
addition, a similar increase in cellular ROS levels was observed at 24h after
coinfected with AAV2 and HSV-1 (Fig. 3A). When using the ROS scavenger N-acetyl
cysteine (NAC), HSV-1 infected cells (data not shown) as well as cells coinfected
with AAV2 and HSV-1 did not display increased ROS levels at 24hpi (Fig. 3B).
However, although ROS levels were decreased to levels similar to those of mock-
Fig 3. Elevated intracellular ROS levels during AAV2 and HSV-1 replication. (A and 
B) AT22 IJE-T yZ5 cells were co-infected with wtHSV-1 (MOI 1.5) and wtAAV (MOI 
2000) in the absence (A) or presence of a ROS scavenger (B). Cells were stained 
with H2DCFDA at 24h after infection, and subjected to flow cytometry. 50’000 cells 
per sample were counted. (C) AT22 IJE-T ATM-positive (yZ5) and ATM negative 
(pEBS7) cells were mock-infected, infected with either wtAAV (MOI 2000) or 
wtHSV-1 (MOI 1.5), or co-infected with wtHSV-1 (MOI 1.5) and wtAAV (MOI 2000). 
After 24h, total protein was isolated and subjected to Western analysis with the 
indicated antibodies. 
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infected cells, we did not find a significant decrease in initial DDR signaling via NBS1
and ATM (Fig. 3C).
4.2.2.4 Activation and recruitment of cellular proteins involved in cellular base
excision/single-strand break repair (BER/SSBR) upon HSV-1 infection or AAV2 and
HSV-1 coinfection.
DNA damage at purine and pyrimidine bases as well as DNA ss breaks can be
repaired by the cells base excision/SSB repair (BER/SSBR) machinery (13). BER is
typically initiated by DNA glycosylase-mediated removal of the target base and
further processing by an endonuclease (APE1), creating a SSB (13). The resulting
free termini are processed by polymerase beta and APE1 in order to generate 3′OH
and 5′P ends, necessary for proper gap-filling and nick ligation (8). Independent
whether gaps result from SSB or BER-intermediates, gap filling and ligation occurs
via the same processes (8). It is likely that polymerase beta incorporates the first
nucleotide, however further elongation is carried out by replicative DNA polymerases
(e.g. polymerase delta; (8)). In addition, RFC is required to load proliferating cell
nuclear antigen (PCNA), the sliding clamp of the polymerase, onto the DNA (8). The
final ligation step is mediated by the X-ray repair cross complementing 1
(XRCC1)/DNA ligase IIIα complex, however in absence of XRCC1/DNA ligase IIIα,
DNA ligase I can also mediate ligation (8). It has been suggested that XRCC1 is
recruited to the sites of DNA strand breaks by the multifunctional poly (ADP‐ribose)
polymerase‐1 (PARP‐1, also referred to as ADP-ribosyltransferase Diphtheria toxin-
like 1 (ARTD1 (16)); (7)).
Because we and others observed elevated ROS upon HSV-1 replication (Fig. 3A; (2,
18, 19, 27)) and AAV2 replication (Fig. 3B), and ROS can result in oxidation of purine
or pyrimidine bases as well as SSBs (see above; (13)) we set out to investigate the
presence of BER/SSBR factors in HSV-1 and AAV2 RCs. We first assessed
expression levels and the localization of PARP1 in infected cells, as PARP1 was
shown to be able to recruit the scaffold protein of BER/SSBR, XRCC1, to sites of
DNA lesions (7). By immunofluorescence analysis we detected PARP1 within AAV2
and HSV-1 RCs (Fig. 4A). While early upon AAV2 replication, when several small
AAV2 RCs are formed within the cell nucleus, abundant PARP1 is located in the
entire nucleoplasm (Fig. 4A i), late in AAV2 replication, PARP1 localized exclusively
to AAV2 RCs (Fig. 4A ii). Western analysis of cells infected with HSV-1 alone or
coinfected with AAV2 and HSV-1 revealed cleavage of PARP1 at late time points of
infection, while PARP1 was not cleaved upon infection with AAV2 alone (Fig. 4B).
Cleavage of PARP1 in cells infected with HSV-1 was observed previously, and
processing of PARP1 was shown to correlate directly with a failure of HSV-1 to
prevent activation of apoptotic pathways at late time points of infection (3). The
observed decrease of PARP1 levels at 48hpi may be a result of the overall cellular
protein shut-off during HSV-1 infection (12) as well as the induction of apoptotic
pathways at very late time points (3).
Next, we investigated the localization and activation of XRCC1 upon viral infection.
Immunofluorescence analysis revealed that phosphorylated XRCC1 (at
S518/T519/T523) as well as total XRCC1 were induced and localized to both AAV2
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Fig 4. (A) Immunofluorescence analysis of AT22 IJE-T cells at 15h (i) and 24h (ii) after infec-
tion with wtHSV-1 (MOI 1.5), AAVCR (MOI 500) and wtHSV-1 (MOI 1.5), or mock-infection. 
AAV2 and HSV-1 RCs (red) were visualized as described in Figure 2. Cells were stained with 
an antibody against PARP1 and an FITC-labeled secondary antibody (green). Cells with early 
(i) and mature (ii) AAV2 RCs are shown. Cellular DNA was stained with DAPI. Scale bar = 10 
µm. (B) Western analysis of HCT116 cells at 24h and 48h after infection with wtAAV (MOI 
2000), wtHSV-1 (MOI 1.5), wtAAV (MOI 2000) and wtHSV-1 (MOI 1.5), or mock-infection. Ly-
sates were processed for Western analysis using the indicated antibodies.  
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Fig 5. (A and B) Immunofluorescence analysis of AT22 IJE-T cells at 24h after infection with 
rHSV-1ICP4YFP (A)/wtHSV-1(B MOI 1.5), AAVYR (A)/ AAVCR (B, MOI 500) and wtHSV-1 
(MOI 1.5), or mock-infection. AAV2 and HSV-1 RCs (red) were visualized as described in Fig. 
2. rAAVYR RCs (AAVYR RCs) were visualized by binding of the rAAVYR-encoded eYFP-
Rep68/78 fusion protein (YFPRep78/68) to AAV DNA (yellow). Cells were stained with an anti-
body against XRCC1 (A) or XRCC1-P-S518/T519/T523  (B) and an Alexa-Flour495-labled (A, 
red) or FITC-labeled (B, green) secondary antibody . Cellular DNA was stained with DAPI. 
Scale bar = 10 µm.  
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Fig 6. (A - C) Immunofluores-
cence analysis of HeLa cells 
transfected with 10ng pR68/78, 
25ng pAAVlacO, and 10ng pSV2
-EYFP/lacI and infected with 
wtHSV-1 (MOI 2) for 24h. rAAV2 
RCs (green) were visualized by 
the binding of LacI-YFP to LacO-
repeats present in the rAAV ge-
nome (pAAVlacO). In addition, 
cells were stained with an anti-
body specific for RFC1 (A), 
PCNA (B), or ligase I (C) and an 
AF495-labeled secondary anti-
body (red).  Cellular DNA was 
stained with DAPI.  Scale bar = 
5 µm 
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and HSV-1 replication compartments (Fig. 5A and B). In addition to XRCC1, we also
detected several other factors of the BER/SSBR machinery located to sites of
recombinant AAV2 DNA replication including RFC1, PCNA, and ligase I (Fig 6).
4.2.2.5 The influence of a functional MRN complex on HSV-1 supported AAV2 DNA
replication.
As discussed above, NBS1 is a component of the MRN complex (21). There are
several reports demonstrating that HSV-1 infection results in the phosphorylation of
NBS1 (see 4.1; (22, 30, 38)) and that cells deficient for NBS1 or Mre11 fail to support
efficient HSV-1 DNA replication (4, 22). Of note, loss of Mre11 was observed late in
HSV-1 infection but it is not clear if this loss has an impact on the efficiency of HSV-1
replication (11). To assess whether the MRN complex influences HSV-1 supported
AAV2 infection, AAV2 DNA replication was examined in cells positive or negative for
NBS1. In NBS1-positive cells, HSV-1 supported AAV2 replication was much more
efficient than in NBS1-negative cells (Fig 7A). We next asked whether reduced AAV2
replication in cells negative for NBS1 is a consequence of a reduced supply of HSV-1
helpervirus functions. HSV-1 helper functions required to induce efficient AAV2 Rep
synthesis and AAV2 DNA replication include the HSV-1 IE proteins ICP0, ICP4, and
ICP22, as well as the HSV-1 E proteins UL5/UL8/UL52 (helicase-primase complex),
ICP8, and UL30/UL42 (DNA polymerase complex; (1)). We investigated the influence
of NBS1 on HSV-1 gene expression by Western analysis. While HSV-1 L proteins
(VP16 and gC) were significantly reduced in absence of NBS1 (Fig 7B) and also the
levels of the E protein ICP8 were noticeably reduced (Fig 7B), levels of the IE protein
ICP4 were not affected by the presence or absence of NBS1 (Fig 7B). The levels of
other HSV-1 helper proteins in NBS1-deficient cells remain to be determined.
4.2.2.6 The influence of ATM on HSV-1 supported AAV2 DNA replication.
It was previously shown that autophosphorylated ATM is recruited into HSV-1 RCs
(see 4.1; (22, 30, 38)) and that cells deficient for ATM fail to support efficient HSV-1
DNA replication (22). Furthermore, it was demonstrated that phosphorylation of
NBS1, observed upon HSV-1 replication, requires the ATM kinase (22). As NBS1
turned out to be required for efficient HSV-1 supported AAV2 DNA replication (Fig.
7A), we set out to investigate the role of ATM in this process. Southern analysis of
coinfected cells in absence or presence of ATM revealed that, in contrast to HSV-1
DNA replication (22), AAV2 DNA replication is enhanced in absence of ATM (Fig.
8A). Therefore, we next investigated the influence of ATM on HSV-1 gene
expression. Western analysis showed that similar to the results observed in NBS1-
deficiecnt cells (Fig. 7B), HSV-1 L proteins (VP16 and gC) were significantly reduced
in absence of ATM (Fig. 8B) and also the levels of the E protein ICP8 was clearly
reduced (Fig. 8B); ICP4 levels were slightly increased at early time points (Fig. 8B).
4.2.3 Discussion
The MRN complex is inhibited in cells infected with Ad alone (6, 32) as well as in
cells coinfected with AAV2 and Ad (29). Thus, the observed phosphorylation of
Fig 7. (A) Southern analysis of cells positive (NBS+) or negative (NBS-) for NBS1. Cells were 
mock-infected, infected with wtAAV2 (MOI 10’000) or coinfected with wtAAV2 (MOI 10’000) 
and wtHSV-1 (MOI 1). After 24h, cells were harvested and processed for Southern analysis. 
DNA was separated on an agarose gel and transferred to nylon membranes. AAV2 DNA was 
visualized by hybridization with a DIG-labeled probe specific for AAV2 Rep78 and subsequent 
detection by an anti-DIG antibody conjugated with alkaline phosphatase. 1ng and 10ng of  
pAV2 DNA, containing the AAV2 Rep78 sequence, was loaded as a control. (i) AAV2 ssDNA; 
(ii) AAV2 replication form monomer; (iii) AAV2 replication form dimer/ trimer/tetramer. (B)  
Western analysis of cells positive (NBS+) or negative (NBS-) for NBS1. Cells were mock-
infected or infected with HSV-1 (MOI 2). After 2h, 8h, 16h, or 24h, cells were prepared for 
Western analysis. HSV-1 Immediate early  (IE), early (E), and late (L) proteins were detected 
using antibodies against ICP4, ICP8, VP16, and gC. Actin and NBS1 staining served as con-
trols. 
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RPA32 at Ser4/8 during AAV2 and Ad coinfection is independent of a functional MRN
complex (28). As HSV-1 does not inhibit the MRN-complex (22), it would be possible
that MRN is responsible for RPA32 phosphorylation in cells coinfected with AAV2
and HSV-1. However, our data show that neither RPA32 phosphorylation at Ser4/8
nor recruitment into AAV2 RCs depends on a functional MRN complex. Besides
phosphorylation of RPA32 at Ser4/8 (see 4.1), we also detected phosphorylation of
RPA32 at Ser33 during HSV-1 supported AAV2 replication. Surprisingly, we also
observed phosphorylation of RPA32 at Ser33 in cells infected with HSV-1 alone,
although phosphorylation of RPA32 at Ser4/8 does not occur in these cells (see 4.1).
Interestingly, RPA32-P-Ser33 can only be detected in early but not in late HSV-1
RCs. Because RPA32-P-Ser33 was detected in AAV2 and HSV-1 coinfected ATM
negative cells and ATR signaling, seems to be disrupted upon both AAV2 and HSV-1
replication (see 4.1), DNA-PK might be the kinase, responsible for RPA32
phosphorylation at Ser33. However, further investigations are necessary to prove
this, in particular RPA32 phosphorylation at Ser33 has to be investigated in cells in
which both ATM and ATR are inactivated.
ROS in form of superoxide anions and hydrogen peroxide react readily with proteins,
lipids, carbohydrates, and nucleic acids (5). ROS are produced by a large number of
enzymes (xanthine oxidase, nitric oxide synthetase, p450 cytochromes) and
organelles (mitochondria, peroxisomes) as a metabolic byproduct; however, elevated
ROS levels are produced by NADPH oxidases (NOX; (5)). Given that infection of
cells with HSV-1 was shown to increase ROS levels (2, 18, 19, 27) and ROS can
induce DNA damage (31), we investigated whether coinfection with AAV2 and HSV-1
also influences intracellular ROS levels and whether this is linked to the observed
activation of DDR signaling during viral infection. Although we observed elevated
ROS levels during both HSV-1 and AAV2 replication, by infecting cells in presence of
the ROS scavenger NAC, we did not observe a significant inhibition of two different
central components of DDR signaling, NBS1 and ATM. Therefore, we conclude that
viral DNA and/or viral proteins are sufficient to activate DDR signaling. Still elevated
ROS levels in infected cells may affect viral DNA integrity.
The most common types of DNA damage induced by ROS include oxidation of purine
or pyrimidine bases and DNA SSBs (13) which can be repaired by the cellular
BER/SSBR machinery. We therefore set out to investigate the presence of
BER/SSBR factors in HSV-1 and AAV2 RCs. PARP1 and phosphorylated XRCC1
were found in both, AAV2 and HSV-1 RCs. Similar to its role in cellular BER/SSBR
(7), PARP1 might mediate recruitment of XRCC1 into viral replication compartments.
We also detected several other proteins involved in cellular BER/SSBR, including
RCF1, PCNA, and ligase I in AAV2 RCs. Since HSV-1 infection alone (2, 18, 19, 27)
as well as coinfection with AAV2 and HSV-1 resulted in increased ROS levels, and
ROS is able to induce oxidized bases and single-strand breaks (SSBs), it is possible
that BER/SSBR proteins protect viral DNA from ROS induced DNA damage. During
AAV2 replication, the BER/SSBR machinery might also be involved in terminal
resolution of the ITR after Rep 78 induced nicking at the TRS. Further experiments
are needed to test this hypothesis. It has to be mentioned that although most studies
have focused on  the role  of PARP1  in  DNA damage sensing and repair pathways
there is increasing evidence that PARP1 also plays a central role in gene regulation
and chromatin modulation (20). In further experiments it would be very interesting to
examine a potential influence of PARP1 on viral gene regulation as well as
modification of histones associated with AAV2 DNA (24) in infected cells.
In a last set of experiments, we investigated the role of NBS1 and ATM in HSV-1
supported AAV2 DNA replication. Experiments in NBS1 negative cells indicated that
the presence of a functional MRN complex or NBS1 clearly aids HSV-1 supported
AAV2 DNA replication. Surprisingly, and in contrast to the results observed in cells
negative for NBS1, HSV-1 supported AAV2 DNA replication was shown to be
increased in ATM-deficient cells. These data indicate that although ATM signaling
seems to be necessary for efficient HSV-1 DNA replication (22), the presence of the
ATM kinase is a limiting factor for HSV-1 supported AAV2 DNA replication. Further
experiments are necessary to investigate whether alterations in expression levels of
HSV-1 IE and E genes in NBS1 and ATM negative cells also occur in coinfected cells
and whether this is linked to the efficiency of AAV2 DNA replication.
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4.3 Investigation of the AAV2 mediated interference with HSV-1-
ICP0-induced degradation of DNA-PKcs.
Background and aim of the project.
Immunofluorescence analysis, flow cytometry, as well as fluorescence-activated cell
sorting (FACS) and subsequent Western analysis of cells infected with AAV2 and/or
HSV-1 showed that HSV-1 induced degradation of DNA-PKcs is delayed in
coinfected cells. In addition, we observed phosphorylation of DNA-PKcs at S2056,
which is necessary for its kinase activity, only in cells coinfected with AAV2 and HSV-
1 but not in cells infected with HSV-1 alone (see 4.1). To explore potential
mechanisms responsible for the delayed degradation of DNA-PKcs in coinfected
cells, we first assessed the levels of HSV-1 ICP0 and USP7, another cellular target of
ICP0-mediated degradation. Corroborating previous published work (6), we did not
detect reduced levels of ICP0 in coinfected cells, when compared to cells infected
with HSV-1 alone. Moreover, we excluded the possibility of an overall inactivation of
ICP0-mediated cellular protein-degradation, as USP7 levels were comparable in cells
infected with HSV-1 alone and in coinfected cells (see 4.1).
Therefore, we investigated the question how AAV2 interferes with HSV-1 induced
degradation of DNA-PKcs?
4.2.1 Materials and methods.
Cells. The fibroblast cells AT22 IJE-T yZ5 (expressing ATM) and AT22 IJE-T pEBS7
(lacking ATM) were kind gifts from Y. Shiloh (Department of Molecular Genetics and
Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel).
These cells were maintained in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% FBS, 1% AB and 100 µg/ml hygromycin B. Cells were
maintained at 37°C in a 95% air/5% CO2 atmosphere.
Viruses. HSV-1 strain F as well as the HSV-1 ICP0 deletion mutant, rHSV-1 R7914,
carrying an aspartate-to-alanine substitution in the ICP0 coding sequence at amino
acid position D199 was kindly provided by B. Roizman (Marjorie B. Kovler Viral
Oncology Laboratories, University of Chicago, Chicago, USA). rHSV-1eCFP-ICP4
has been described in 4.2. The recombinant HSV-1, rHSV-1 D8, which lacks the
nuclear localization signal in the ICP0 coding sequences and therefore expresses
cytosol restricted ICP0, was a kind gift R.D. Everett (MRC Virology Unit, University of
Glasgow, Glasgow, United Kingdom). Viruses were grown and titrated in Vero cells.
AAV2 and Ad2 were kindly provided by H. Buening (University of Cologne, Cologne,
Germany) and U. Greber (University of Zurich, Zurich, Switzerland), respectively.
Recombinant AAV2 AAV2CR containing the AAV2 ITR flanking the rep ORF fused at
the 5’ terminus with mCherry has been described previously (1). In addition, a
recombinant AAV2eYFPRep (AAVYR), containing the AAV2 ITR flanking the rep
ORF fused at the 5’ terminus with the eYFP coding sequence was cloned by
replacing the mCherry sequence in the pAAVCR (1) with the eYFP sequence.
Recombinant AAVCR and AAVYR particles of AAV2 were produced by transient
transfection of 293 cells with an Ad helper plasmid purified on two successive CsCl
gradients, and genome containing particles were titered by qPCR. rAAV2GFP,
containing the AAV2 ITRs flanking the eGFP coding sequence under control of the
HCMV IE1 enhancer/promoter, was kindly provided by M. Linden (King's College
London School of Medicine, London, UK).
Plasmids. Plasmids pNLS(GFP), pRep52(GFP) and pRep78(GFP), which encode the
eGFP coding sequence fused with a nuclear localization signal (NLS), Rep 52 or 78,
respectively, under control of the HCMV IE1 enhancer/promoter were described
previously (5). Plasmid pICP0, containing the HSV-1 ICP0 coding sequence under
control of the HCMV IE1 enhancer/promoter, was kindly provided by P. F. O’Hare
(Department of Medicine, Imperial College, London, UK).
siRNAs. siRNA against three different Ku70 target sequences were used in Ku70-
knock down experiments: Ku70-1 5′-UUCAGGUGACUCCUCCAGGTT-3′, Ku70-2 5′
UUCUCUUGGUAACUUUCCCTT-3′ and Ku70-3 5′-
GAUGCCCUUUACUGAAAAATT-3′. Ku70 siRNAs were ordered from Microsynth AG
(Balgach, Switzerland). Scrambled siRNA (Control siRNA-A, sc-37007) was
purchased from Santa Cruz Biotechnology, Inc. (Heidelberg, Germany).
Antibodies. The following primary antibodies were used: Anti-actin (Santa Cruz
Biotechnology (SC) 10731; dilution WB 1:10’000), anti-DNA-PKcs (Ab 32566; dilution
WB 1:500, IF 1:50, Flow cytometry 1:250), anti-DNA-PKcs-P-S2056 (Ab 18192;
dilution WB 1:2000, IF 1:500), anti-HSV-1 ICP8 (Ab 20198; dilution WB 1:1000, IF
1:200), anti-Ku70 (NeoMarkers; dilution WB 1:5000), anti-HSV-1 ICP0 (Ab 6513;
dilution WB 1:8000, IF 1:2500), anti-AAV2 Rep (Fitzgerald Industries 10R-A111A;
dilution WB 1:200). The following secondary antibodies were used: Rabbit anti-
mouse IgG-horseradish peroxidase (HRP, Sigma A9044; dilution 1:10000), goat anti-
rabbit IgG-HRP (Sigma A6154; dilution 1:10000), goat anti-rabbit IgG (H+L)-
AlexaFlour(AF)405 (Molecular Probes A31556; dilution 1:500), goat anti-rabbit IgG
(H+L)-AF594 (Molecular Probes A11012; dilution 1:1000), goat anti-mouse IgG
(H+L)-AF594 (Molecular Probes A11005; dilution 1:1000), goat anti-mouse IgG
(H+L)-fluorescein isothiocyanate (FITC, Southern Biotechnology 1031-02; dilution
1:200), goat anti-rabbit IgG (H+L)-FITC (Southern Biotechnology 4050-02; dilution
1:200)
Transfection and infection. AT22 IJE-T cells, seeded the day before transfection,
were transfected with Lipofectamine® LTX and Plus Reagent (Invitrogen 15338030)
according to the manufacturer's protocol. Transfections were carried out in two
different plate formats: 12-well plates (Western analysis) and 24-well plates
(immunofluorescence analysis). For Western analysis, 2x105 AT22 IJE-T cells were
transfected with 0.5 μg of the individual pRepGFP plasmids or the control plasmid
pNLSGFP. After 3h incubation at 37°C and 5 % CO2, transfection medium was
removed, cells were washed with OptiMEM and mock-infected or infected with
wtHSV-1 (MOI 3) for 24h in DMEM (2%FCS, 1%AB). For immunofluorescence
analysis, AT22 IJE-T cells (7,5x104) were seeded onto cover slips (12 mm ø,
Glaswarenfabrik Karl Hecht GmbH&Co KG, Sondheim, Germany) in 24-well plates
and transfected with 0.25 μg of pRepGFP and 0.1ug of pICP0. After 3h incubation at
37°C, transfection medium was removed, cells were washed with optiMEM and
incubated for 24h in DMEM containing 2%FCS and 1%AB.
siRNA transfections and infections. One day before siRNA transfection, AT22 IJE-T
cells (7,5x104) were seeded onto cover slips (12 mm ø, Glaswarenfabrik Karl Hecht
GmbH&Co KG, Sondheim, Germany) in 24-well plates. Ku70 siRNA (20µM of each)
or scrambled siRNA transfection was performed with Lipofectamine® LTX & Plus
Reagent (Invitrogen 15338030) according to the according to the manufacturer's
protocol. After 4h, the transfection medium was removed, and cells were incubated
for 48h in DMEM containing 2%FCS and 1%AB. Subsequently, cells were coinfected
with AAVCR (MOI 2000) and HSV-1 (MOI 3) in DMEM containing 2%FCS and 1%AB
for 24h and then subjected to immunofluorescence analysis.
Western analysis. See 4.1
Fluorescence-activated cell sorting (FACS) and subsequent Western analysis.
6.6x106 AT22IJE-T cells were seeded into 10 cm cell culture dishes in DMEM
10%FCS, 1%AB. The next day, cells were mock-infected, coinfected with wtHSV-1
(MOI 3) and rAAVGFP (MOI 4000), or coinfected with wtHSV-1 (MOI 3), rAAVGFP
(MOI 2000), and wtAAV2 (MOI 2000). Equal numbers of eGFP-positive cells were
sorted and prepared for Western analysis as described in 4.1. The same number of
mock-infected cells was used as control. FACS and Western analysis of AT22IJE-T
cells infected with rHSV-1eCFP-ICP4 or coinfected with rHSV-1eCFP-ICP4 and
AAVCR was performed as described in 4.1.
Immunofluorescence analysis. AT22 IJE-T cells (7,5x104) in DMEM 10%FCS, 1%AB
were seeded onto cover slips (12 mm ø, Glaswarenfabrik Karl Hecht GmbH&Co KG,
Sondheim, Germany) in 24-well plates. The next day, cells were mock-infected,
infected with wtHSV-1 (MOI 3), or rHSV-1D8 (MOI 3), or rHSV-1 R7914 (MOI 3), or
coinfected with rAAV2CR (MOI 500) and either wtHSV-1 (MOI 3), or rHSV-1D8 (MOI
3) or rHSV-1 R7914 (MOI 3). For fixation and staining procedure see 4.1).
4.3.2 Results
4.3.2.1 Influence of ICP0 localization on degradation of DNA-PKcs in coinfected cells.
We confirmed that ICP0 localized both in the nucleus and in the cytoplasm of HSV-1
infected cells (Fig. 1A), as has previously been reported (7, 8). It has been shown
that the localization of HSV-1 ICP0 in infected cells depends on the progress of HSV-
1 infection (7, 8). Within several hours after infection, ICP0 translocates form the
nucleus to the cytoplasm (7). This translocation was dependent on a function
expressed late in infection (8) and could be blocked by treatment of the cells with the
proteasome inhibitor MG132 (10). Interestingly, translocation of ICP0 is not only
dependent on the progress of infection but also on the cell type. In Vero cells for
Fig 1. ICP0 localization in infected cells and degradation of DNA-PKcs. (A and C) 
Immunofluorescence analysis of AT22IJE-T cells infected with wtHSV-1 (MOI 1.5) 
for 24h or AAVYR (MOI 500) and wtHSV-1 (MOI 1.5, C) for 15h (i) or 24hp (ii). 
AAVYR replication compartments (AAV RCs, C) were visualized by binding of the 
AAVYR-encoded eYFP-Rep 68/78 fusion protein (YR) to AAV DNA (yellow). Cells 
were stained with an antibody specific for ICP0 and AF 594-labeled (red, A) or 
FITC-labeled (white, C) secondary antibody. DAPI was used to stain cell nuclei. 
Scale bars, 20 µm (A) or 10 µm (C). (B) Western analysis of Vero cells at 24h after 
infection with wtHSV-1 (MOI 1.5) or mock-infection. Lysates were processed for 
Western analysis and stained with antibodies against DNA-PKcs, ICP8, and actin. 
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Fig 2. Localization and degradation of DNA-PKcs in cells infected with nuclear or 
cytoplasmic  ICP0. (A) Western analysis of AT22IJE-T cells at 20h after mock-
infection or infection with wtHSV-1 (MOI 3), rHSV-1 D8 (MOI 3) or HSV-1 R7914 
(MOI 3). Lysates were processed for Western analysis and stained with antibodies 
against DNA-PKcs, ICP0, and actin. (B) Immunofluorescence analysis of AT22IJE-
T cells infected with rHSV-1 D8 (MOI 3) or HSV-1 R7914 (MOI 3) at 20h post 
infection. Cells were stained with antibodies specific for ICP0 (green) and DNA-
PKcs (red) and an FITC-labeled  or AF594-labeled secondary antibody, 
respectively. DAPI was used to stain cell nuclei. Scale bars, 10 µm. 
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Fig 2. (C) Immunofluorescence analysis of AT22IJE-T cells coinfected with rHSV-1 
D8 (MOI 1.5) and AAVCR (MOI 500) or HSV-1 R7914 (MIO 1.5) and AAVCR (MOI 
500) at 20h post infection. AAVCR replication compartments (RCs) were visualized 
by binding of the AAVCR-encoded mCherry-Rep 68/78 fusion protein  (CR) to AAV 
DNA (red). Cells were stained with a primary antibody specific for DNA-PKcs and a 
secondary FITC-labeled antibody (green).  DAPI was used to stain cell nuclei. 
Scale bars, 10 µm. 
C 
example, ICP0 does not translocate to the cytoplasm but remains in the nucleus
throughout infection (8). Interestingly, in this cell line, HSV-1 is not able to induce
degradation of DNA-PKcs (Fig. 1B; (14)). In cells coinfected with AAV2 and HSV-1,
we also observed ICP0 mainly in the nucleus of coinfected cells, both early (Fig. 1C i)
and late (Fig. 1C ii) during AAV2 replication; although in this fibroblast cell line
(AT22IJE-T), ICP0 translocation into the cytoplasm can be observed in cells infected
with HSV-1 alone (Fig. 1A and C). Based on these observations we set out to
investigate the role of ICP0-localization on degradation of DNA-PKcs in coinfected
cells. To study ICP0-localization-dependent degradation of DNA-PKcs, two different
HSV-1-ICP0 mutant viruses were used in the following experiments. The ICP0
mutant virus (HSV-1 R7914, strain F (13)) which carries an aspartate-to-alanine
substitution in the ICP0 coding sequence at amino acid position D199, is retained in
the nucleus (13). In contrast, rHSV-1 D8 (17syn strain, (4)) encodes an ICP0 protein
that lacks a nuclear localization signal and, therefore, ICP0 is restricted to the
cytosol. Western and immunofluorescence analysis of infected cells revealed that
degradation of DNA-PKcs depends solely on nuclear ICP0, without subsequent
localization to the cytoplasm (Fig. 2A and B). In cells expressing cytosol restricted
ICP0, DNA-PKcs was not degraded (Fig. 2A and B). In cells coinfected with AAVCR
(expressing mCherry fused to the Rep 68/78 ORF) and either rHSV-1 D8 or HSV-1
R7914, DNA-PKcs was readily detected within AAV2 RCs (Fig. 2C), supporting
pervious results in cells coinfected with AAV2 and wtHSV-1 (see 4.1).
4.3.2.2 Influence of Ku70 on localization and delayed degradation of DNA-PKcs in
coinfected cells.
As the results above showed that the interference with HSV-1 induced degradation of
DNA-PKcs cannot be explained by AAV2 induced inhibition of ICP0 expression, we
set out to examine the expression and subcellular localization of the DNA-PKcs
binding protein Ku70 (3). The heterodimers of Ku70 and Ku80 interact with DNA-
PKcs to form the DNA-PK complex that is involved in repair of DNA double-strand
breaks (DSBs) by NHEJ (3). Ku70 is responsible for initiation of NHEJ by recruiting
DNA-PKcs (12) and other NHEJ factors to sites of double-strand breaks (3).
Interestingly, immunofluorescence analysis revealed robust recruitment of Ku70 into
AAV2 RCs (Fig. 3A), while in cells infected with HSV-1 alone, Ku70 was within HSV-
1 RCs and in the surrounding nucleoplasm (Fig. 3A). We hypothesized that Ku70
might be involved in recruitment of DNA-PKcs into AAV2 RCs. Besides its recruiting
function, Ku70 might also be directly involved in extending the stability of DNA-PKcs
in coinfected cells, by its described function as de-ubiquitinating enzyme (2). Amsel
et al showed that Ku70 has a regulatory effect on Bax-mediated apoptosis by
decreasing the ubiquitination of Bax and thereby blocking Bax from proteasome-
dependent degradation (2).
We first looked at the expression levels of Ku70 in productively infected cells.
Western analysis showed no differences in Ku70 levels between mock-infected and
HSV-1 and AAV2 coinfected cells (Fig. 3B). As Ku70 has been identified as a
component of AAV2 RCs (see above, Fig.1A), we next investigated the role of Ku70
in recruitment of DNA-PKcs into AAV2 RCs. For this, cells were treated with siRNA
Fig 3. Influence of Ku70 on localization and delayed degradation of DNA-PKcs 
in coinfected cells. (A and B) Ku70 expression, localization, and post-
transcriptional knock-down in infected cells. (A) Immunofluorescence analysis of 
AT22IJE-T cells infected with wtHSV-1 (MOI 1.5) or coinfected with wtHSV-1 
(MOI 1.5) and AAVCR (MOI 500) at 24h post infection. AAVCR RCs (red) were 
visualized  as described in Fig. 2.  HSV-1 RCs were visualized with a primary 
antibody specific for the HSV-1 major DNA binding protein ICP8 and an AF594-
labeled secondary antibody (red). Ku70 was detected using a primary antibody 
specific for Ku70 and a secondary FITC-labeled antibody (green).  DAPI was 
used to stain cell nuclei. Scale bars, 10 µm. (B) Western analysis of AT22IJE-T 
cells sorted (FACS) for productive HSV-1 and AAV2 infection at 24 hpi.  Cells 
were mock-infected, infected with rHSV-1eCFP-ICP4 (rHSV-1; MOI 4), or co-
infected (rHSV-1 + rAAV) with rHSV-1eCFP-ICP4 (MOI 4) and AAVCR (MOI 
4000).  Lysates of sorted cells were processed for Western analysis and stained 
with the indicated antibodies.  
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Fig 3. (C) Transfection of AT22 IJE-T cells with Ku70 siRNA (Ku70-1/2/3, 20 µM of 
each) and mock-infected or coinfected with AAVCR (MOI 2000) and HSV-1 (MOI 
3) for 24h. AAVCR RCs (red) were visualized  as described in Fig. 2. Cells were 
stained with antibodies against Ku70 (green) and DNA-PKcs (purple) and an FITC-
labeled or AF405-labled secondary antibody, respectively. Scale bars, 10 µm. 
specific for Ku70 and coinfected with AAV2 and HSV-1. Immunofluorescence
analysis showed that DNA-PKcs recruitment into AAV2 RCs and stability (Fig. 3C)
did not depend on Ku70.
4.3.2.3 Influence of AAV2 Rep expression on delayed degradation of DNA-PKcs in
coinfected cells.
As Ku70 appears not to be involved in stabilization of DNA-PKcs in coinfected cells,
we proceeded to investigate the role of the AAV2 Rep proteins in delayed
degradation of DNA-PKcs. Western analysis of cells transfected with a plasmid
expressing Rep 68/78 from the constitutive cytomegalovirus (CMV) immediate-early
promoter/enhancer and infected with HSV-1, demonstrated that overexpression of
Rep 68/78 in absence of either AAV2 DNA or AAV2 RCs cannot prevent DNA-PKcs
from HSV-1 ICP0-mediated degradation, as neither phosphorylated nor non-
phosphorylated DNA-PKcs was detected in Rep-transfected and HSV-1-infected cells
(Fig. 4A and B). Similar results were observed in immunofluorescence assays of cells
transfected with pRep 78/68 and a plasmid expressing HSV-1-ICP0 (pICP0, Fig. 4C).
Independent of the presence or absence of Rep 78/68 expression, ICP0 induced the
degradation of DNA-PKcs in transfected cells (Fig. 4C).
4.3.2.4 Influence of AAV2 DNA and AAV2 RCs on delayed degradation of DNA-PKcs
in coinfected cells.
Similar to cells coinfected with wtAAV2 and Ad5 (Fig. 5A; (11)), we observed robust
phosphorylation of DNA-PKcs at S2056 in cells coinfected with Ad5 and a
recombinant, replication-incompetent AAV2 containing the AAV2-ITRs flanking a
eGFP coding sequence (rAAVGFP, Fig. 5B). Regarding a previous observation that
Ad5 infection alone failed to induce a lucid activation of DNA-PKcs (11), these data
suggest that the presence of AAV2 DNA is sufficient to induce vigorous
phosphorylation of DNA-PKcs. Therefore, we set out to investigate whether AAV2
DNA alone is sufficient to impede HSV-1 induced degradation of DNA-PKcs, possibly
by inducing its phosphorylation. To compare the stabilization of DNA-PKcs in AAV2
and HSV-1 coinfected cells in presence and absence of Rep expression, we
performed Western analysis of cells coinfected with HSV-1 and rAAVGFP (no rep
expression) or coinfected with HSV-1, rAAVGFP, and wtAAV2. Only the cells
coinfected with HSV-1, rAAVGFP, and wtAAV2 can support AAV2 DNA replication
and the formation of AAV2 RCs, due to the expression of AAV2 rep from wtAAV2.
Although AAV2 DNA in absence of viral replication was shown to be sufficient to
induce robust phosphorylation of DNA-PKcs (Fig. 5B), we observed a strong
decrease of DNA-PKcs levels in cells coinfected with rAAVGFP and HSV-1 (Fig. 5C).
However, in presence of wtAAV2, DNA-PKcs levels were stabilized (Fig. 5C). These
results were confirmed also in immunofluorescence assays of cells coinfected with
HSV-1 and either rAAVGFP (encodes eGFP but no Rep) or AAVYR (expressing
eYFP fused to the Rep 68/78 ORF, Fig. 5D). Only in cells coinfected with HSV-1 and
AAVYR, which supports AAV2 replication, DNA-PKcs was stabilized (Fig 5D), while
DNA-PKcs was efficiently degraded in cells coinfected with rAAVGFP (no rep
expression and therefore no replication) and HSV-1 (Fig 5D).
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Fig 4. Influence of AAV2 rep expression on delayed degradation of DNA-PKcs in 
coinfected cells. (A and B) AT22 IJE-T cells were transfected with 0.5 μg of the 
individual pRepGFP plasmids or the control plasmid pNLSGFP and mock-infected 
or infected with wtHSV-1 (MOI 3) for 24h. Cells treated with HU (3 mM) served as 
a DNA-PKcs activation control. Lysates were processed for Western analysis and 
stained with antibodies against DNA-PKcs, DNA-PKcs-P-Ser2056, GFP, ICP8, 
Ku70 and actin. (C) AT22 IJE-T cells were transfected with 0.1 μg of pICP0 and/or 
0.25 μg of pRepGFP. 24h post transfection cells were processed for IF and stained 
with antibodies against  ICP0 (blue) and DNA-PKcs (red) and an AF405-labled or 
AF594-labeled secondary antibody, respectively. Scale bars, 10 µm. 
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Fig 5. Influence of AAV2 DNA and the formation of RCs on delayed degradation of 
DNA-PKcs in coinfected cells. (A and B) Immunofluorescence analysis of 
AT22IJE-T cells infected with Ad2 (MOI 25) and either AAVCR (MOI 500, A) or  
rAAV2GFP  (MOI 500, B). AAVCR RCs were visualized as described in Figure 2. 
GFP is expressed constitutively from rAAV2GFP which contains the AAV2 ITR 
flanking the GFP coding sequence under a CMV promoter. Cells were stained with 
an antibody against DNA-PKcs and an FITC-labled (green, A) or AF594-labled 
(red, B) secondary antibody. DAPI was used to stain cell nuclei (A). Scale bar, 10 
µm. (C) Western analysis of AT22IJE-T cells sorted (FACS) for productive virus 
infection. Cells were mock-infected, coinfected with wtHSV-1 (MOI 3) and 
rAAVGFP (MOI 4000), or coinfected with wtHSV-1 (MOI 3), rAAVGFP (MOI 2000), 
and wtAAV (MOI 2000). Lysates of sorted cells were processed for Western 
analysis and stained with antibodies against DNA-PKcs, ICP0, Rep, and actin. (D) 
Immunofluorescence analysis of AT22IJE-T cells infected with wtHSV-1 (MOI 1.5) 
and either AAVYR (MOI 500) or rAAV2GFP  (MOI 500). AAVYR RCs were 
visualized as described in Fig. 1. Expression of GFP see above. Cells were stained 
with an antibody against DNA-PKcs and an AF594-labled (white) secondary 
antibody. DAPI was used to stain cell nuclei. Scale bar, 10 µm. 
4.3.3 Discussion
In order to investigate the question how AAV2 interferes with HSV-1 ICP0-mediated
degradation of DNA-PKcs we first explored ICP0 expression levels and a possible
role of ICP0-localization in degradation of DNA-PKcs. Experiments with an mutant
HSV-1 revealed that degradation of DNA-PKcs depends solely on nuclear ICP0, and
no subsequent translocation to the cytoplasm is required. Therefore, although AAV2
influences ICP0-localization in coinfected cells, by supporting retention of ICP0 in the
nucleus, delayed degradation of DNA-PKcs in these cells cannot be explained with
this observation.
Since Ku70 was observed in AAV2 RCs, we also investigated the role of Ku70 in
AAV2 mediated stabilization of DNA-PKcs. Although Ku70 has been described as
mediator of DNA-PKcs recruitment to sites of DNA damage (12), during AAV2
replication, recruitment of DNA-PKcs into AAV2 RCs as well as stabilization of DNA-
PKcs occurred independently of the presence of Ku70. In a previous study, it has
been shown that DNA-PKcs interact with Rep 68/78 in cells coinfected with AAV2
and HSV-1 (9). Therefore, Ku70-independent recruitment of DNA-PKcs into AAV2
RCs may be supported by binding of DNA-PKcs to Rep 68/78 proteins.
Nevertheless, in transfection experiments, Rep 68/78 expression was not sufficient to
impede ICP0 mediated degradation of DNA-PKcs. In addition, although AAV2 DNA in
absence of viral replication was sufficient to induce robust phosphorylation of DNA-
PKcs, delayed degradation of DNA-PKcs was only observed in presence of rep
expression, DNA replication and the formation of viral RCs, but not in cells coinfected
with HSV-1 and a replication-incompetent recombinant AAV2. These data suggests
that Rep mediates the recruitment of DNA-PKcs to sites of AAV2 DNA within AAV2
RCs, which further triggers phosphorylation of DNA-PKcs. Then, the AAV2 RC
environment impedes HSV-1 ICP0-indcued degradation of DNA-PKcs, resulting in a
delayed degradation of DNA-PKcs in cells coinfected with AAV2 and HSV-1.
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5 Concluding remarks and perspectives
Productive AAV2 replication, including transcription and DNA synthesis, depends not
only on functions provided by the host cell, but also by a helper virus (69). The main
goal of this PhD project was to contribute to our understanding of the molecular
mechanism of interaction between AAV2 and one of its helper viruses, HSV-1, and
the host cell. Similar to other DNA viruses, helper virus supported AAV2 replication
takes place in the host cell nucleus in so called RCs (18, 23, 24, 62, 68). Over the
past decade, many studies revealed that viruses interfere with the cellular DNA
damage sensing and repair machinery (27, 37, 46, 65, 67) and proteins of the DNA-
damage response (DDR) pathways have been shown to significantly influence virus
replication (27, 37, 46, 65, 67). While some DNA damage sensing and repair proteins
support virus replication (35, 41), other factors significantly inhibit the virus and are
suggested to belong to the cell’s intrinsic antiviral response, which not only affects wt
virus infection but also that of viral vectors (15, 36, 64). This work analyzes the
localization and activation of DDR proteins upon infection with HSV-1 alone or
coinfection with AAV2 and HSV-1, as well as the influence of these proteins on HSV-
1 supported AAV2 DNA replication. Since AAV2 is a widely used vector in biomedical
applications, the detailed knowledge of the activation and localization pattern of
cellular proteins during AAV2 infection, including AAV2 DNA replication and gene
expression, may have important practical implications in the field of AAV2 vector
research.
One of the central elements of DDR signaling is the MRN complex, composed of
Mre11, Rad50, and NBS1 (56). The MRN complex acts as main sensor of ds breaks
to further encourage HR or NHEJ processes to repair DNA lesions (32). The MRN
complex has been shown to be inhibited during Ad and Ad-supported AAV2
replication (6, 54, 61); therefore DDR signaling in cells coinfected with Ad and AAV2
occurred independent of a functional MRN complex (53). Interestingly, although in
HSV-1 infected cells DDR signaling is mediated by MRN and ATM (35), a functional
MRN complex is not necessary to mediate DDR downstream signaling to RPA32 in
cells coinfected with AAV2 and HSV-1. However, experiments in NBS1 negative cells
indicated that the presence of a functional MRN complex or NBS1 clearly aid HSV-1-
supported AAV2 DNA replication as well as HSV-1 DNA replication. When comparing
the results in Ad (54) and HSV-1 supported AAV2 replication, we hypothesize that
the role of the MRN complex in AAV2 replication is facilitated through its differential
effect on the helper virus; however, further experiments are necessary to support
this.
The three main kinases mediating signal transmission in response to cellular DNA
damage include ATM, ATR, and DNA-PK (63). Similar to cells infected with HSV-1
alone (35, 55, 70), activation of ATM and its down-stream targets p53 and Chk2 was
observed also during coinfection with AAV2 and HSV-1. However, in contrast to
HSV-1 infection which is enhanced by ATM (35), HSV-1 supported AAV2 replication
appeared to be inhibited by this kinase. This observation was even more surprising,
considering that activation of the ATM pathway was reported to be beneficial for Ad
supported AAV2 replication (11). The opposite effect of ATM on Ad- versus HSV-1-
supported AAV2 DNA replication indicates again that the function of cellular proteins
in AAV2 replication is at least in part governed by the type of helper virus. The
inhibitory effect of ATM-deficiency on HSV-1 replication might support AAV2
replication in coinfected cells, since HSV-1 supported AAV2 replication only occurs in
cells in which HSV-1 replication is efficiently repressed (3, 19, 20).
Although a robust ATR-mediated DDR has been observed in cell infected with AAV2
in absence of a helper virus (8, 28), ATR signaling was not observed in cells
coinfected with AAV2 and HSV-1 and, similar to previous reports, also not in cells
infected with HSV-1 alone (39, 40, 71). The fact that ATR signaling plays a minor role
also in Ad- supported AAV2 replication (53) implies an extensive influence of the
helper virus on modulation of the cellular DDR signaling pathways in coinfected cells.
By examining the third main kinase in DDR, DNA-PK, we observed HSV-1 ICP0-
mediated degradation of DNA-PKcs, which confirmed previous reports (34, 48). This
degradation was observed also in cells coinfected with HSV-1 and AAV2, but was
markedly delayed (66). The delayed degradation of DNA-PKcs by AAV2 affected the
signaling to the downstream targets RPA32, p53, and Chk2 (most evident in ATM-
deficient cells). Since DNA-PKcs has been shown to be the primary mediator of DDR
in cells coinfected with AAV2 and Ad, we suggest that DNA-PKcs might also play a
central role in transmission of DDR signaling in cells coinfected with AAV2 and HSV-
1. Overall by comparing our results from cells coinfected with AAV2 and HSV-1 with
those of previous studies examining the DDR signaling in cells infected with HSV-1
alone (4, 35, 55, 70), or Ad2 alone (6, 61), or coinfected with AAV2 and Ad2 (11, 53),
it is remarkable that although Ad and HSV-1 by themselves induce very different
DDRs, the induction and activation patterns of DDR proteins are more similar in the
presence of AAV2. Possibly, during AAV2 replication, the cellular DDR is modulated
towards DNA-PK-dependent signaling; however, the influence of DNA-PK on AAV2
replication is still under debate and might alter depending on the type of host cell and
helper virus. In one report, rAAV2 replication in the presence of HSV-1 or Ad helper
functions has been shown to be decreased in absence of DNA-PK (10) while another
report showed enhanced wtAAV2 genome replication in absence of DNA-PK activity
when Ad was the helper virus (11). In the latter case, it has been suggested that loss
of DNA-PK could lead to less circularization of the AAV2 genome which might
promote AAV2 DNA replication (11). DNA-PK might also be implicated in self
circularization (13, 58), concatemerization (42), and integration (38) of recombinant
AAV2 genomes. But analogous to wtAAV2 infection, the data cannot be generalized,
since also inhibition of rAAV2 genome integration by DNA-PKcs has been reported
(59). On the molecular basis, it is proposed that the hairpin shaped AAV2-ITRs are
targeted by cellular NHEJ proteins, including DNA-PK (10, 26), similar to DNA hairpin
structures in mammalian cells (emerge during the V(D)J recombination (33)).
Independent of its role in NHEJ events, there is preliminary evidence that DNA-PKcs
may mediate modification of the large Rep proteins upon AAV2 and Ad coinfection
(11). The group of J.P. Trempe showed that phosphorylation of the AAV2 Rep
proteins alters their interactions with the AAV2 ITRs (43), thus DNA-PK my play an
essential role in regulating Rep-mediated processes of viral DNA replication (11, 53),
including terminal resolution. Besides the effect on AAV2 ITRs, the observed
interaction between Rep68/78 and DNA-PKcs (44) may promote recruitment of DNA-
PKcs into AAV2 RCs, since Ku70 (mediator of DNA-PKcs recruitment to sites of DNA
damage, (60)), is not required for localization of DNA-PKcs in HSV-1-supported
AAV2 RCs.
Since modulation of the HSV-1-induced DDR by AAV2 was observed, we set out to
investigate the mechanism of delayed degradation of DNA-PKcs in coinfected cells.
In line with previous results (21), ICP0 expression levels were not affected by AAV2.
In addition, HSV-1-mediated degradation of another target of ICP0, USP7 was not
influenced by AAV2. Therefore, we exclude the possibility of an overall inactivation of
ICP0-mediated cellular protein-degradation in coinfected cells. Although AAV2
influences ICP0-localization, by supporting retention of ICP0 in the nucleus, delayed
degradation of DNA-PKcs in coinfected cells cannot be explained with this
observation. In contrast, we could show that degradation of DNA-PKcs by HSV-1
solely requires nuclear localization of ICP0, without translocation to the cytoplasm. As
mentioned above, we observed recruitment of DNA-PKcs into late AAV2 RCs in
absence of Ku70, indicating that Ku70 is not required for stabilization of DNA-PKcs.
We next assessed whether a direct influence of the AAV2 Rep proteins or the AAV2
DNA might support DNA-PKcs stability. Although Rep86/78 has been shown to
interact with DNA-PKcs (44), in transfection experiments, Rep68/78 expression was
not sufficient to impede ICP0-mediated degradation of DNA-PKcs. Finally, we could
also exclude AAV2 DNA as exclusive source of increased stabilization of DNA-PKcs
in coinfected cells. Although AAV2 DNA in absence of viral replication was sufficient
to induce robust phosphorylation of DNA-PKcs, delayed degradation of DNA-PKcs
was only observed in presence of Rep expression, DNA replication, and the
formation of viral RCs, but not in cells coinfected with HSV-1 and a replication
incompetent rAAV. On the basis of the results above, we hypothesize that Rep68/78
mediates recruitment of DNA-PKcs to sites of AAV2 DNA within AAV2 RCs, which
further triggers phosphorylation of DNA-PKcs. Only the formation of AAV2 RCs
creates an environment that impedes HSV-1 ICP0-induced degradation of DNA-
PKcs, resulting in the observed delayed degradation of DNA-PKcs in coinfected cells.
One potential function of DNA-PKcs and down-stream factors within AAV2 RCs might
be to trigger the recruitment of DNA damage repair factors. It is suggested that these
proteins are involved in AAV2 DNA replication, including initial second-strand
synthesis of the AAV2 genome (8, 16, 17, 45, 50). For a detailed discussion see
chapter 3.6.
Another potential function of cellular repair proteins in viral replication compartments
might be to protect viral DNA from DNA damage caused by viral DNA replication or
endogenous DNA damaging agents, such as reactive oxygen species (ROS) in form
of superoxide anions and hydrogen peroxides. ROS are produced by a large number
of different enzymes (xanthine oxidase, nitric oxide synthetase, p450 cytochromes)
and organelles (mitochondria, peroxisomes) as a metabolic byproduct; however,
elevated ROS levels are produced by NADPH oxidases (NOX, (5)). These radicals
react readily with proteins, lipids, carbohydrates, and nucleic acids (5). Indeed, we
and others observed elevated ROS levels during infection with HSV-1 (2, 29, 30, 52)
and coinfection with AAV2 and HSV-1. Since DDR factors are also activated in
infected cells in absence of elevated ROS levels, we conclude that viral DNA and/or
viral proteins are directly responsible for the activation of DDR signaling in infected
cells. Still, it is tempting to speculate that one effect of DNA repair factors within
AAV2 and HSV-1 RCs might be to protect viral DNA from ROS induced damage.
The most common types of DNA damage induced by ROS are oxidation of purine or
pyrimidine bases as well as DNA SSBs (22) which can be repaired by the cells
BER/SSBR machinery. Indeed we found several proteins of the cellular BER/SSBR
machinery in HSV-1 and AAV2 RCs. PARP1 and phosphorylated XRCC1 were found
in both, AAV2 and HSV-1 RCs. Similar to its role in cellular BER/SSBR (14) PARP1
might mediate recruitment of XRCC1 into viral replication compartments. In addition,
RCF1 and ligase I were found in AAV2 RCs, supporting a role of the BER/SSBR
machinery in AAV2 replication. Besides repair of DNA lesions caused by ROS, the
BER/SSBR machinery might be involved in terminal resolution of the ITR, after
Rep78 induced nicking at the TRS. Further experiments are necessary to test this
hypothesis.
In conclusion, we identified several factors of the cellular sensing and repair
machinery as components of HSV-1 and/or HSV-1 supported AAV2 RCs. In addition
we investigated the influence of two main players of the cellular DDR (NBS1 and
ATM) on AAV2 DNA replication. The data contribute to a better understanding of the
complex mechanisms of interaction between AAV2, its helper viruses, and the
coinfected cell.
Since induction of a cellular DDR can mediate a cell cycle arrest via checkpoint
activation (72), it will be interesting to investigate the induction of a cell cycle arrest in
cells coinfected with AAV2 and HSV-1, and to assess whether the observed
modulation of the cellular DDR by AAV2 might result in a differential cell cycle arrest
upon infection with HSV-1 or coinfection with AAV2 and HSV-1.
An interesting other future project to further define the function of identified cellular
proteins in AAV2 replication could be to systematically identify cellular factors that are
not only components of AAV2 RCs, but essential for AAV2 gene expression and viral
DNA replication, by small interfering (si)RNA screens. Such knockdown experiments
may also identify cellular proteins of AAV2 RCs which, although not preventing AAV2
replication, have an inhibitory effect. The identification of cellular inhibitors and
enhancers of helper virus supported AAV2 replication will further contribute to a
better understanding of the complex mechanisms of interaction between AAV2, its
helper viruses, and the coinfected cell. Moreover, as AAV2 is a widely used gene
therapy vector, the detailed knowledge of the function of cellular proteins in AAV2
gene expression and DNA replication will help to improve vector production and
transduction efficiency.
It has been shown previously that the HSV-1 major single strand DNA binding protein
ICP8 binds to replicating HSV-1 DNA and therefore accumulates in HSV-1 RCs (49).
The AAV2 Rep78/68 proteins contain also a DNA-binding motive which allows site-
specific binding of Rep78/68 to AAV2 DNA as well as its accumulation in AAV2 RCs
(9, 18, 20, 25, 47, 57). In order to determine the localization of DNA damage sensing
and repair proteins during HSV-1 replication or HSV-1 supported AAV2 replication, in
the present study cellular proteins were co-visualized with HSV-1 ICP8 or AAV2
Rep78/68 protein, respectively. However, it is important to note that due to limitations
in the resolution of Confocal Laser Scanning Microscopy, we cannot make any
conclusion concerning the co-localization on the protein level. In theory, the
resolution is limited to about half of the wavelength of the light. In our experiments,
fluorescent dyes with a wavelength in the range of 400-600nm were used for
imaging. To determine whether a specific cellular protein of interest is indeed
recruited into AAV2 or HSV-1 RCs, independent of its direct colocalization with AAV2
Rep78/68 or HSV-1 ICP8, we assessed the localization of that particular cellular
protein in the three-dimensional space (data not shown).
Altogether, the identification of cellular DNA sensing and repair proteins in HSV-1
supported AAV2 RCs indicates that AAV2 may replicate by using several of these
cellular proteins including NBS1, RPA, ATM, or DNA-PK. These findings provide a
basis for further examining how DDR proteins affect helper virus supported AAV2
replication. By comparing our results in cells coinfected with AAV2 and HSV-1 with
those of previous studies examining the DDR signaling in cells coinfected with AAV2
and Ad5 (11, 53), we can hypothesize on how AAV2 adapts its replication strategy to
the nuclear environment manipulated by the helper virus.
The present study was focused on the composition of viral RCs during AAV2 DNA
replication in cells simultaneously infected with AAV2 and HSV-1. In absence of a
helper virus, AAV2 establishes latent infection by the formation of stable episomes or
by integrating its genome into the host chromosome (31, 51). In presence of HSV-1,
reactivation from latency can occur, leading to the excision of the AAV2 DNA and
viral genome replication (69). Both, insertion and excision of the viral genome may
recruit and activate a certain set of DNA damage repair proteins.  It is very likely that
these proteins are distinct form those detected in AAV2 RCs during viral DNA
replication. However, there is indication that proteins of the cellular DDR including
DNA-PKcs, affect also AAV2 integration events (7, 12, 59). In further experiments, it
would be interesting to examine the influence of DNA sensing and repair proteins on
the establishment of latent AAV2 infection as well as reactivation from latency
including excision of the viral genomes form the host chromosome. In addition, using
a HeLa cell clone (HeLaAAVtCR, (1)) that contains the AAV2 genome integrated into
the cellular genome would allow examining the composition of cellular DDR proteins
of AAV2 RCs after helpervirus mediated rescue of the integrated AAV2 genome. In
this case the initial recruitment of cellular DDR proteins to the site of AAV2 DNA
might be altered due to the ds DNA nature of the rescued AAV2 genome compared
to the incoming ss AAV2 DNA in cells simultaneously coinfected with the helper virus.
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